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INTRODUCTION 

IN1RODUCTION 
Unstable angina encompasses a wide range of clinical presentations of myocardial 
ischemia, usually caused by sudden deteriorations of coronary lesions. Sometimes, 
extracardiac conditions disturbing the oxygen balance, such as severe anaemia, fever or 
thyrotoxicosis, may cause myocardial ischemia. In this thesis unstable angina is referred 
to as myocardial ischemia due to obstructive atherosclerotic coronary artery disease. In 
the literature and in clinical practice a variety of definitions is used to describe this 
particular clinical situation. These definitions are characterised by the description of 
chest pain, the clinical circumstances under which unstable angina occurs, the presence 
or absence of concomitant ECG changes during pain, and the intensity of treatment 
before pain occurs '"· Patients with anginal symptoms of unstable character, and no 
signs of acute myocardial infarction, are athnitted with an initial diagnosis of unstable 
angina pectoris. An observation period is necessary to come to a definite final diagnosis, 
as myocardial infarction may have already occurred in a number of such patients, but 
can not he recognised until an increase in cardiac enzyme concentrations can be detected 
in the circulation 3• Thus in addition to the characteristics of clinical signs and symptoms 
also the time of definition is of importance to characterise the patient population. 
Treatment of unstable angina is directed to relief of acute symptoms and to prevent 
progression to myocardial infarction or death. Various drugs are available, acting upon 
different underlying pathophysiologic mechanisms, and thereupon bypass surgery and 
angioplasty may be used to improve tl1e coronary blood supply. 
In the present study the application of these treatment options in the management 
of patients hospitalized for suspected unstable angina is described. Furthermore it was 
assessed how physicians in different hospital senings apply each of the alternative 
management strategies in their practice. Finally. the prognosis under the current 
management strategy is described. 
Chapter 1 is a literature review of the various aspects of the syndrome unstable 
angina. The diversity of defmitions is described and the underlying pathophysiology 
related to these defmitions. An overview of anti-anginal drugs is provided. Prognostic 
studies are summarised with identified risk factors for development of myocardial 
infarction or death, and the effect of different treatment strategies upon prognosis is 
delineated. 
A prospective study was performed in order to establish how physicians approach 
the syndrome unstable angina. In two hospitals in Rotterdam 417 patients with suspected 
unstable angina at hospital admission, were followed during hospital stay and during the 
subsequent six months. In chapter 2 the patient population of this study is described in 
terms of clinical characteristics of the initial presentation at athnission, and the fmal 
diagnosis after observation. The treatment given to these patients is documented in terms 
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of medical treatment and the rate of angiography procedures initiated to decide on 
subsequent coronary interventions. In addition, the occurrence of myocardial infarcti()n 
and death is reponed, with special interest to those events occurring during a waiting 
period between a decision to perform angiography and coronary interventions and the 
actual performance of these procedures (see figures 2.1 and 2.2.). Chapter 3 gives an 
overview of the events occurring within six months in patients with a final diagnosis of 
unstable angina and the number of interventions after discharge. Events during follow-up 
in patients with a final diagnosis of myocardial infarction and other causes of chest pain 
are described separately. 
A comparison of management strategies in each of the two hospitals is made in 
chapter 4. As both hospitals differ with respect to availability of angiography facilities, 
special attention is given to the difference in use of angiography with a view to 
subsequent interventions. Multivariate analyses are performed in order to describe which 
factors can explain the observed difference in angiography rate between the two 
hospitals. Cbapters 5 and 6 focus on understanding the management policies of 
individual cardiologists. Cardiologists were interviewed to reveal their opinion on the 
definition of unstable angina and the indications for several further treatment options 
(chapter 5). ln addition, individual judgments were exaroined using paper case vignettes 
in a so-called 'policy analysis' (chapter 6). Chapter 7 provides an example of an 
intervention study wlrich was directed to improve the safety of angioplasty procedures 
in patients with unstable angina. ln chapter 8 a general discussion of the f'mdings and 
a comparison with other long term follow-up srudies is provided, followed by some 
recommendations for furure research. 
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CHAPTER 1 
UNSTABLE ANGINA PECTORIS 
A REViEW OF PATHOPHYSIOLOGY, CUNICAL COURSE AND MANAGEMENT 
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Introduction 
Current understanding and recent literature on unstable angina are reviewed in tbis 
chapter. After a description of tbe various definitions of tbe syndrome 'unstable angina' 
an overview of tbe patbophysiologic mechanisms leading to unstable angina is provided. 
The 'natural history' of patients witb unstable angina and tbeir prognosis is described 
by summarizing several older studies. Results of more recent studies illustrate how this 
prognosis has been altered by modern treatment, including intravenous medication and, 
in selected patients, angioplasty an bypass surgery. 
I. Definition 
Angina pectoris is often described as: "chest discomfort caused by myocardial ischemia 
in tbe absence of infarction"'. Angina pectoris is commonly provoked by effort and is 
said to be stable when tbere has been no change in tbe frequency, duration or 
precipitating factors during a longer period of time. All otber presentations of angina 
pectoris are subsumed under tbe heading 'unstable angina'2• In tbis way unstable angina 
is defined as an ischemic syndrome intermediate between stable angina pectoris and 
myocardial infarction. Within this wide spectrum several categories can be distinguished, 
based on clinical presentation and on prognosis. Conti described tbree modes of 
presentation': l. recent onset angina pectoris, 2. changing pattern (progression of 
frequency or duration) of preexisting stable angina pectoris, and 3. angina at rest. Witbin 
tbese clinical presentations several subgroups can be distinguished, based on tbe clinical 
circumstances in which tbe unstable period develops. Pain at rest can be tbe first 
presentation or angina, or it can develop in patients with chronic stable angina4 . Also. 
pain which develops during recovery from a myocardial infarction (24 hours to 4 weeks 
after tbe infarct) is usually described separately as post infarction angina pectoris'. 
Braunwald6 speaks of subacute angina when tbe most recent pain episode occurred more 
tban 48 hours ago, whereas tbe situation in which tbe most recent episode occurred 
wifhin 48 hours is called acute angina. 
In various studies fhe definition 'unstable angina' is based on rypical symptoms 
witb concomitant ST-T changes on fhe ECG as objective evidence of ischemia7 • The 
label 'intermediate coronary syndrome' is applied to fhe situation in which pain at rest 
of longer duration(~ 15 min) occurs wifh concomitant ST-segment or T-wave changes'. 
Furthermore a subcategory is distinguished as 'variant angina', used to describe angina 
at rest accompanied by ST -elevations on fhe ECG in patients wifh normal exercise 
tolerance'. The severity of tbe condition depends on fhe level of maintenance 
pharmacologic treatment at fhe time of fhe development of unstable angina. Persisting 
pain episodes despite extensive antianginal fherapy is called 'refractory' angina6• 
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It is clear that the term 'unstable angina' is insufficient to delineate the exact 
situation of a patient. Imponant aspects of the clinical description of unstable angina 
are: the clinical circumstances in which unstable angina occurs, the severity of the 
clinical manifestations, the presence of transient ECG changes during pain and the level 
of medication at the onset of ischemia6• Therefore, it is necessary to describe the clinical 
situation of patients with 'unstable angina' in more detail such as, for example, 'post 
infarction angina', 'unstable angina of recent onset, pain atrest', 'progressive unstable 
angina occurring at minimal exertion' or 'unstable angina at rest with concomitant ST-
depression despite treatment with Jl-blockers and intravenous nitrates'. 
JJ. Pathophysiology 
Presentations of acute ischemic cardiac diseases include unstable angina pectoris, 
myocardial infarction and sudden death. These manifestations are usually expressions 
of a similar dynamic pathophysiologic process in the coronary arteries impeding 
myocardial oxygen supply (primary unstable angina)9•10• Myocardial ischemia may also 
be precipitated by non-coronary causes such as severe anaemia, hypotension or 
tachyarrhythmia: secondary (unstable) angina6• This review focusses on the primary 
forms of unstable angina, based on coronary artery disease. 
In patients with atherosclerosis, progression of an atherosclerotic plaque may lead 
to obstruction of the coronary lumen. Severe stenoses may result in inadequate coronary 
blood flow to the myocardium during periods of increased oxygen demand. This 
situation with a limited 'coronary flow reserve' corresponds with stable angina on effort. 
In contrast, unstable angina pectoris is caused by a sudden increase of the degree of 
obstruction in the coronary artery, followed by a (transient) reduction of coronary flow, 
unstable angina is not· directly related to an increased oxygen demand11 , although 
ischemic episodes may occur 5-30 minutes after a temporary increase of heart rate or 
blood pressure12• The conversion of a clinically stable situation into an unstable episode 
is initiated by rupture or ulceration of an atherosclerotic plaque, often in combination 
with increased vasomotor tone (or even spasm) and platelet aggregation'. Such sudden 
progression of !he coronary obstruction may progress to total thrombotic occlusion and 
myocardial infarction13• Alternatively, !he increase of obstruction can be of temporary 
character without myocardial necrosis (unstable angina)9•14• The plaque rupture can 
recover after some time resulting in a new, stable situation15• The thrombus may 
disappear by internal thrombolysis and fragmentation, but often thrombus material is 
incorporated in !he plaque. In !he new stable situation !he plaque will !hen be more 
severe !han before !he unstable period, which may manifest as stable angina at a lower 
threshold. By means of serial angiography progression of coronary obstruction was 
observed in 28/38 patients with unstable angina, whereas !his was seen in only 12/38 
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patients with stable angina pectoris16• Similarly, a pathologic study of 25 patients who 
died suddenly after an episode of unstable angina, revealed intraluminal thrombus in all 
patients, while a layered structure of the thrombus was observed in 81% of these 
patients. In most cases the underlying plaque showed rupture of the plaque surface and 
haemorrhage in the plaque. In 73% of the patients small thrombus fragments .and 
microinfarcts were found in the myocardium distal to the coronary thrombi". 
Angiographically, the severity of coronary atherosclerosis appears to be similar 
in patients with stable and unstable angina17•18• However, the morphology of the stenosis 
differs. Ambrose" reponed eccentric stenoses with convex intraluminal obstruction and 
narrow neck due to one or more overhanging edges or irregular scalloped borders in 
71% of patients with unstable angina versus 16% of patients with stable angina pectoris. 
In post monem studies this morphology appeared to be associated with ruptured 
atherosclerotic plaques, intraintimal haemorrhage and thrombus formation'9• Rehr and 
Cowley" described complex lesions, corresponding with the presence of intima rupture 
and thrombus formation, on the angiograms in 70% and 84% of patients with unstable 
angina and in only 21% and 15% of patients with stable angina. 
Using coronary angioscopy the lesions of patients with stable and unstable angina 
could be observed directly during angiographic procedures and during bypass surgery. 
In patients with stable angina pectoris the plaque surface was smooth and intact. In 
patients with progressive angina on effon t.>,e plaque surface was irregularly ragged, and 
showed intramural haemorrhage, while in patients with angina at rest thrombus was 
observed distal to the stenosis22.14• 
These findings suppon the concept that conversion from stable- to unstable 
angina is initiated by plaque rupture or endothelial ulceration. Rupture of the plaque 
surface probably is a random event in the evolution :md growth of an atherosclerotic 
plaque. The bending and twisting of the aneries which occur during every hean beat, 
haernodynamic stress such as pulsatile flow and variations in blood pressure, or changes 
in the vascular tone may be sufficient to disrupt the very thin cap of fibrous tissue. 
Direct contact of the lipids in the plaque and blood initiates platelet aggregation. 
Furthermore, a ruptured plaque surface allows platelets and red blood cells to enter into 
the plaque resulting in rapid plaque expansion. Further narrowing of the lumen may be 
caused by stimulation of the vascular smooth muscle (spasm) via break-down products 
of extravasated platelets and by progression of platelet aggregation and thrombus 
formation. This may progress to total occlusion and cause myocardial infarction. 
Thrombus fragmentation and embolization may result in distal microinfarcts causing 
cardiomyopathy or (fatal) ventricular arrhythmias. The extent and severity of the 
preexisting stenosis, the duration and completeness of the coronary obstruction and of 
the presence of collateral vessels determine the subsequent clinical presentation". 
CHAPTER 1 15 
III. Diagnosis of acute coronary syndromes 
When a patient presents with symptoms compatible with acute coronary insufficiency, 
the patient's history, physical examination and an ECG are immediately available to 
make a diagnosis. During the first hours a differentiation berween myocardial infarction 
and unstable angina can often not be made based on the clinical characteristics. Thus, 
an initial diagnosis will be made at the time of admission. After observation and new 
information is obtained !Iris initial diagnosis will be confirmed or revised and a final 
(discharge) diagnosis is made. 
The most important information for the initial diagnosis at admission is a careful 
assessment of the patient's history. The major attributes of the history are the character 
and location of the pain, the mode of onset and the course of symptoms as well as the 
reaction to medical therapy (sublingual nitrates)23• A history of coronary artery disease 
and the presence of risk factors (hypenension, smoking, hypercholesterolemia and a 
positive family history) may influence the interpretation of the presenting symptoms24.zs. 
Unfonunately a patient with acute coronary disease will often present with symptoms 
that do not meet the criteria for typical angina pectoris. On the other hand, symptoms 
suggestive for myocardial ischemia are sometimes caused by non-cardiac disease, such 
as gastrointestinal problems, gall bladder disease or pulmonary embolism". 
Physical exantination is of little help for the diagnosis 'unstable angina'. A 
patient with angina pectoris usually exhibits no abnormalities on physical examination, 
although a third heart sound or a murmur of mitral incompetence may be present during 
ischemia23• Signs of impaired left ventricular function (heart failure) or vegetative 
symptoms, such as severe perspiration are often associated with myocardial 
infarction27.28. 
Electrocardiographic information is of great value for the diagnosis, especially 
when serial electrocardiograms are recorded during and after pain. At admission often 
only an ECG without pain can be obtained. The value of such resting electrocardiogram 
is limited, because it is often normal or it shows abnormalities that give little 
information about the actual situation, such as abnormal Q-waves, intraventricular 
conduction disturbances or left ventricular hypenrophy, all of which may be 
accompanied by secondary ST-T abnormalities. Transient ECG changes during pain, 
particularly depression or elevation of the ST-segment or T-wave inversion indicate 
myocardial ischemia, whereas the absence of ECG changes during pain makes an 
ischemic cause less likely, but does not exclude ischemia'. 
When a patient is admitted with severe, typical chest pain of long duration (>30 
minutes) with concomitant ST-elevation on the electrocardiogram, the 'admission' or 
'initial' diagnosis is myocardial infarction. In a small percentage of these patients (2-
3%) the diagnosis 'infarction' is not confirmed by serial enzyme assays>"~' and in 
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retrospect the final diagnosis 'unstable angina' will be made and treatment will be 
continued accordingly. For patients with symptoms, suspected of unstable angina 
without signs of acute infarction (pain of shorter duration, without vegetative symptoms 
and without persisting ECG changes) a clinical observation period is warranted to make 
a definite diagnosis. In about 10% of such patients myocardial infarction may be present 
although it can not be recognised with certainty at that moment". In another 30% the 
symptoms appear in retrospect due to non-cardiac or non-specific causes". These 
findings were confirmed in a prospective registry in two hospitals in Rotterdam, which 
is described in this thesis (chapter 2). 
During a period of 7 months in 1988/89, 417 patients were admitted to the 
Thoraxcenter of the University Hospital Dijkzigt or to the Sint Franciscus Gasthuis for 
observation because of chest pain suspected of acute ischemia, 'unstable angina', 
admission 
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Figure 1.1. ln-/wspital course for 4I7 patients, admitted for chest pain suspected of unstable 
angina pectoris. A definitive diagnosis was made after an observation period of 24-48 /wurs. 
For patients with definitive unstable angina the subsequent course and management strategy 
is s/wwn. Six patients died in /wspital (t), I after infarction,, I after infarction and post 
infarction angina, 3 in relation to PTCA and 1 during medical treatment after angiography. 
Myocardial infarction occurred in 15 patients, 8 during observation or while waiting for an 
intervention and 7 during an intervention (4 during CABG and 3 during PTCA). 
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without signs of acute infarction or other diseases at the time of a!hnission. In figure 1.1 
the in-hospital course of these patients is depicted. After an observation period of 24 to 
48 hours serial electrocardiographic and enzymatic measures showed that myocardial 
infarction had already occurred in 38 patients (9%).ln 109 patients (26%) the symptoms 
were attributed to other or non-specific causes. In the other 270 patients (65%) the 
initial diagnosis unstable angina was maintained. This diagnosis was supported by 
objective ECG changes during observation or exercise tolerance tests or by a history of 
coronary disease in 256 patients (95%). The typical character of the pain was sufficient 
for the diagnosis in the other 14 patients. Furthermore, 12 out of 38 patients with 
myocardial infarction at admission still developed unstable post infarction angina with 
recurrence of pain 24 hours or more after the infarction. 
Additional diagnostic tools, such as exercise tolerance tests, scintigraphy and 
angiography are of imponance for the assessment of prognosis and for the choice of 
suitable therapy. In the Rotterdam registry an exercise tolerance test was perlormed in 
about 50% of all patients, usually to confirm the suspicion of non-specific origin of the 
pain or to assess the need for intervention. Eventually, a decision to perlonn 
angiography was made for 137 patients, and subsequent PTCA or CABG was perlormed 
in 53 and 47 patients, respectively. More details are provided in chapter 2. 
IV. Natural history I prognosis 
When patients present with unstable angina, there is danger for progression to infarction 
or sudden death. The pathophysiologic mechanisms underlying each of these three 
expressions of coronary disease are in fact different stages of the same process14.t5. 
Prognostic studies on unstable angina vary depending on the definition used, the 
duration of follow-up and treatment. These studies do not provide information on the 
real natural history, because most patients received treatment, including nitrates, 
B-blockers and calcium-antagonists. In the surgical studies4243 patients were included 
only if there had been neither 'medical failure', nor main stem disease or impaired left-
ventricular function. As a consequence, the patients with the worst prognosis were 
excluded. 
While the studies vary with respect to definitions and inclusion criteria, it appears 
that most infarctions in patients athnitted for unstable angina pectoris occur in an early 
stage. On average 9% of the patients develop myocardial infarction within the first six 
months, most of which occur within the first month. After 1 year an average of 14% of 
the patients has developed infarction. Mortality figures increased during follow-up. The 
mean percentages vary from 2% after 1 month to 4%, 6% and 10% after 3 and 6 
months and 1 year, respectively (figure 1.2). 
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Figure 1.2. Complications in unstable angina, derived from observational studiel.J2.38 and randomised triali5.J944 . The results of placebo 
controlled trials with platelet inhibitors are given for the placebo group3941 • The results ofrandomised studies of surgical versus medical therapy 
are given for the medically treated patients4244 The high mortality figures after 1 and 3 months and 1 year and the infarction rates after 1 and 
3 molllhs are from one, relatively small study from 19737• The lowest 1 year mortality was reported in the HINT study (6%) while in that smdy 
a high infarct percelltage at 1 year (17%) was found". 
A number of clinical, electrocardiographic and angiographic factors are related 
to the prognosis. An increased infarction or mortality risk is found in patients with 
frequent pain episodes and in patients with limited response to medical therapy 
(refractory angina)'-33, with progression of preexisting stable angina34•36, with persistent 
ST-T abnormalities or transient ECG changes during pain7 or with angiographically 
extensive coronary lesions and impaired left ventricular function17• Prognostic models 
derived from the Rotterdam registry are presented in chapter 3. 
Prognosis of patients with unstable angina is also determined by additional 
interventions. The proportion of revascularisation procedures during follow-up varies 
from 8 to 50%3~37•40•45• The 'cross-over' percentage of medical therapy to surgery in 
randomised studies amounts to 8% in the acute phase, 19% after 1 year and 31-34% 
after 2 years4~43 • In the Rotterdam registry a revascularisation procedure was performed 
in 100 out of 417 patients (24%), which corresponds to 35% of patients with a definite 
diagnosis of 'unstable angina'. 
V. Medical therapy 
Initial treatment of patients with unstable angina pectoris is directed to relieve pain and 
ischemia in the acute phase and to establish a new stable situation. Long term treatment 
is aimed to prevent recurrence of ischemic episodes and specifically to prevent 
infarction or death. 
Several drugs are included in the management strategy with different working 
mechanisms, representing the complex pathophysiology of unstable angina, consisting 
of a combination of changes in the underlying atherosclerotic plaque, increased coronary 
vasomotor tonus, (transient) platelet aggregation and thrombosis14• 
The classical management of (unstable) angina pectoris is directed to the 
reduction of oxygen demand of the myocardium with nitrates and £-blockers. Later 
calcium-antagonists were added to inhibit increased coronary vasomotor tone. During 
the recent years, since the role of platelet aggregation and thrombus formation in 
unstable angina was established, treatment has been extended with aspirin, heparin and 
thrombolytic therapy. 
Nitrates. Nitrates predominantly induce venous dilation, resulting in a reduction of the 
'preload' of the heart and in a decrease of the myocardial oxygen demand. At higher 
doses also relaxation of the coronary arteries will occur, resulting in better myocardial 
perfusion, as well as arterial dilation, resulting in a reduction of the 'afterload'. Such 
peripheral vasodilation may cause side effects, including reflex-tachycardia, flushes and 
headache. Relaxation of smooth muscle tissue by nitrates appears to be based on a 
similar mechanism as the so-called endothelium related relaxing factor (EDRF). EDRF 
is nitric oxide (NO) which accomplishes muscle relaxation by conversion of GTP into 
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Table 1.1. 
Author 
NITRATES 
Kaplan 
[48] 
Curfman 
[49] 
B~BLOCKERS 
Gottlieb 
[50] 
Wallis 
[51] 
HINT 
[25] 
Summary of the efficacy of alllianginal drugs in unstable angina pectoris. 
n Description of the study Results I conclusion 
35 Pts with angina at rest despite oral nitrates and B-blockers -
open study 
40 Pts with angina at rest + ECG changes or other evidence for 
coronary disease - iv-nitroglycerin vs oral isosorbide dinitrate + 
2%nitroglycerin ointment 
Reduction of the number of pain episodes after iv-NTG. 
In both groups a similar significant reduction of the number 
of pain episodes in the acute phase. 
81 Pts with angina at rest + ECG changes, treated with nitrates and. Addition of propanolol to vasodilating drugs reduces the 
nifedipin - propanolol vs placebo number symptomatic- and silent ischemic episodes. 
23 Pts with angina at rest and objective evidence of coronary 
disease ~ iv-metoprolol vs oral propanolol 
515 338 pts with suspected UAP at admission, without 6-blocker 
therapy at admission - metoprolol vs placebo 
In both groups a similar improvement of haemodynamic 
parameters and a reduction of Ute number of pain episodes. 
Metoprolol reduces the incidence of recurrent ischemia and 
infarction witllin the first 48 hours. 
CA~ANTAOONISTS 
nifedipin 
HINT 
[25] 
Gcrstenblith 
[52] 
Muller 
[53] 
515 338 pts with suspected UAP at admission, without 6-blocker 
therapy at admission - metoprolol, nifedipine or both vs placebo 
117 pts witlt suspected UAP at admission, with existing 6-
blockade ~ nifedipine vs placebo 
138 Pts with angina at rest+ ECG changes, treated with nitrates and 
6-blockers - nifedipine vs placebo 
126 Pts with angina at rest + ECG changes or other evidence for 
coronary disease - conventional (nitratest6-blockers) vs 
nifedipine 
Combination no additional effect to 6-blocker alone. 
Mono therapy with nifedipine increases the frequency of 
recurrent ischemia I infarction. 
Addition of nifedipine to 6-blocker therapy reduces the 
frequency of recurrent ischemia 1 infarction. 
Addition of nifedipine reduces the need for bypass surgery in 
order to control persisting symptoms. 
In pts witl10ut maintenance treatment with 6-blockers 
conventional Uterapy is more effective control ischemia. 
In pts with maintenance treatment with 6-blockers nifedipine 
is more effective to control ischemia. 
diltiazem 
Andre-Fouet 
[54] 
TI1eroux 
[55] 
70 Pts with angina at rest + ECG changes; Prinzmetal's angina 
not excluded - propanolol vs diltiazem 
100 Pts with progressive angina or angina at rest + ECG changes; 
Prinzmetal's angina excluded- diltiazem vs propanolol 
ANTICOAGULANTS/ ANlTPLATELET DRUGS 
heparine 
Telford 
[56] 
Theroux 
[40] 
RISC group 
[58] 
Semeri 
[45] 
aspirin 
Lewis 
[39] 
Cairns 
[57] 
214 Pts with progressive angina± ECG changes or subendocardial 
infarction - heparin, atenolol, or boUt vs placebo 
479 Pts with progressive angina or angina at rest+ ECG changes -
heparin, aspirin, or both vs placebo 
796 Pts with progressive angina + ECO changes or non-Q-wave 
infarction - heparin, aspirin or both vs placebo 
97 Pts with persisting (refractory) angina 48 hours after 
admission - heparin continuous infusion or heparin bolus 
injections vs aspirin 
1266 Pts with progressive angina or angina at rest+ ECO changes 
or other evidence of coronary disease - aspirin vs placebo 
555 Pts with ischemic chest pain, after exclusion of infarction or 
other diseases - aspirin, sulfinpyrazone, or both vs placebo 
In both groups a similar significant reduction of the number of 
pain episodes. 
Diltiazem is possibly more effective in angina at rest without 
previous angina of effort. 
In both groups a similar significant reduction of the number of 
pain episodes. Bypass surgery, infarctions and mortality 
during follow up (5 montl1s) similar. 
Reduction of infarction risk with heparin compared to atenolol 
and placebo. 
Reduction of persisting pain (refractory angina) with heparin. 
Reduction of infarction risk with heparin and aspirin. 
Combination no additional effect, but more bleeding 
complications. 
Reduction of infarction and mortality risk wiU1 aspirin alone 
and in combination with heparin, not with heparin alone. 
Reduction of the number of pain episodes with heparin 
infusion compared to heparin bolus or aspirin. 
Reduction of the infarction and mortality risk with aspirin, 
both short temt (!2 weeks) and long tenn (! year). 
Long tenn (18 months) reduction of infarction and mortality 
risk wiUt aspirin. No effect of sulfinpyrazone. 
Ticlopidine 
Balsano 
[41 J 
652 Pts with progressive angina or angina at rest + ECO changes - Reduction of infarction and mortality risk with ticlopidinc. 
conventional (nitrates, B-blockers and calcium antagonists) vs 
conventional therapy + ticlopidine (=platelet inhibitor) 
THROMBOLYTIC AGENTS 
urokinase 
Gotoh 
[66] 
rt-PA 
Gold 
[59] 
Topol, 
Nicklas 
[60,61] 
vd Brand 
[62] 
Williams 
[63] 
streptokinase 
de Zwaan 
[64] 
Saran 
[65] 
anistrep/ase 
Bar 
[83] 
37 Pts with recurrent angina at rest despite triple therapy (nitrates, 
13-blockers and ca-antagonisls) ln whom angiography during 
pain was possible - open study 
24 Pts with angina at rest + ECG changes - rt-PA vs placebo 
(continuous infusion during 12 hours) 
40 Pts with angina at rest and coronary stenosis> 60% - rt-PA vs 
placebo after diagnostic angiogram 
36 Pts with angina at rest + ECG changes- rt-PA vs placebo 
after diagnostic angiogram; PTCA after 24 hours 
67 Pts with angina at rest + ECG changes and coronary stenosis 
> 80% - high dose rt-PA (100 mg), low dose rt-PA (0.75 
mg/kg, max 60 mg) vs placebo after diagnostic angiogram 
41 Pts wilh angina at rest± ECG changes- open study: IC-SK or 
rt-PA iv after diagnostic angiogram 
48 Pts with angina at rest + ECG changes, persisting after 48 hrs 
despite treatment with triple-therapy+ iv-nitroglycerin - iv-SK 
vs placebo 
159 Pts with a typical history of unstable angina + ECG changes+ 
significant coronary lesions - anistrcplase vs placebo 
AirSfudies arc randomiscd trials unless mentioned otherwise. 
Angiographically: thrombus in 57%, reduction after ic-UK. 
Clinically: recurrence of pain I infarction associated with the 
presence of thrombus, independent of thrombolysis. 
Angiographically: fewer thrombi with rt-PA after l-3 days. 
Clinically: reduction of recurrent pain after rt-PA; recurrence 
of pain is associated with thrombus; bleeding risk high after 
rt-PA infusion. 
Angiographically: no reduction in dhuneter stenosis. 
Pacing threshold increases after rt-PA when thrombus present. 
Clinically: no difference in revascularisation procedures. 
Angiographically: no difference. 
Clinically: no difference in pain episodes or infarctions. 
PTCA: rt-PA no effect on procedural complications. 
Angiographically: no difference between groups. 
Clinically: no difference in pain, infarctions or emergency 
operations; increased bleeding risk in both rt-PA groups. 
Angiographically: in boUt groups a reduction of Ute number of 
Uuombi and a reduction of diameter stenosis. 
Clinically: number of pain episodes and revascularisation 
procedures independent of angiographic improvement. 
Clinically: earlier pain relief and reduction of the number of 
pain episodes after SK; infarct reduction after 6 months. 
Angiographically: significant reduction of diameter stenosis. 
Clinically: no difference in angina severity, infarction and 
mortality rate; increased bleeding risk after anistreplase. 
cGMP. Dissociation of NO from nitrates results in vasorelaxation independent of 
endothelial EDRF, also in an atherosclerotic environment without intact endothelium"'. 
fi-b lockers. B-blockers reduce the incidence of new ischemic episodes by reducing heart 
rate and blood pressure and depressing myocardial contractility, all of which lower 
myocardial oxygen demand. A low heart rate also results in a prolonged diastole and 
thus provides more time for coronary perfusion. B-blockers without intrinsic 
sympaticomimetic activity (ISA) are generally preferred because they are more effective 
to reduce heart rate. However, the clinical efficacy of the various B-blockers is not 
significantly different46•47• Side effects of B-blockers include heart failure, hypotension, 
peripheral vasoconstriction and bronchospasm, and seldom coronaty artery spasm. 
Calcium-antagonists. The three most important representatives of this group are 
nifedipine, diltiazem and veraparnil. These drugs act through a blockade of the calcium 
influx into the (muscle) cells. The anti-ischemic effect is established by improvement 
of the oxygen balance on both the supply side and on the demand side: by coronary 
vasodilation, peripheral arterial vasodilation and afterload reduction, by reducing the 
heart rate (except nifedipine) and by depressing contractility46.l. The three drugs very 
in their potency to affect the different components of the cardiovascular system. 
Nifedipine has a strong vasodilating effect and a modest negative inotropic effect. Side 
effects due to vasodilation may occur as reflextachycardia and hypotension and even 
'coronary steal', which can aggravate the anginal symptoms47 • In addition to a 
vasodilating effect, diltiazem also inhibits the sinoatrial node and A V -conduction, 
reducing heart rate. Verapamil has an even stronger inhibiting effect on the AV-node 
and reduces myocardial oxygen demand by negative inotropic action. This drug is often 
used to treat supraventricular arrhythmias. 
Both B-blockers and calcium-antagonists are effective in alleviating acute 
symptoms (table 1.1), but reduction in infarction rate by B-blocker treatment has only 
been shown in the HINT studf', and no reduction in mortality rate has been 
reponed50•52• 
Platelet inhibitors and anticoagulants. Platelet aggregation and thrombus formation are 
the key factors in an evolving unstable situation. Accordingly, a favourable effect of 
platelet inhibitors and anticoagulants may be expected to prevent progression to 
infarction or sudden death in patients with unstable angina. Indeed, aspirin and heparin 
have been shown to reduce infarction and sudden death in patients with unstable angina 
pectoris (table 1.1). These drugs are of value for both shon term treatment (reduction 
of ischemic episodes by heparin) and long term treatment (reduction of the risks for 
infarction and death by both heparin and aspirin)39•40•57~8• 
Thrombolytic agents The recognition of intracoronaty thrombus formation in unstable 
angina pectoris, as well as the efficacy of thrombolytic agents in treatment of acute 
infarction67' 70 have been a reason to investigate the clinical effect thrombolytic agents 
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in unstable angina. However, no salutary effect of these drugs has been found in 
patients with unstable angina, neither angiographically nor clinically (table 1.1). Some 
authors report an association between recurrence of pain and the presence of 
thrombus59•66• Possibly thrombolytic therapy might be effective in this subgroup of 
patients, but this has not yet been shown. 
A stepwise approach to treatment of unstable angina is generally recommended". 
The first step is admission to hospital, bed rest and pain relief with sublingual 
nitroglycerin or morf'momimetic drugs. Additional problems, such as high blood 
pressure and heart rate, arrhythmias, anaemia or thyrotoxicosis should be treated when 
present. The second step includes administration of heparin and B-blockers immediately 
at admission, even when the ECG is normal. Nitrates (oral or intravenous) are 
administered at the same time. Finally, calcium-antagonists can be added. It should be 
noted that nifedipine is only beneficial for patients who are already on maintenance 
treatment with B-blockers, while its administration is discouraged without concomitant 
B-blocker therapy>'·". Addition of aspirin to heparin treatment in the acute phase may 
provide extra protection although it may also be reserved for long term therapy"'·". 
Such stepwise combination therapy will control the symptoms in 80-90% of the 
patients admitted to the hospital with unstable angina47•71 • In case of persisting symptoms 
in spite of intensive pharmacological therapy, coronary angiography is indicated to 
prepare subsequent angioplasty or bypass surgery. Although a thrombus is frequently 
present, especially early after the most recent pain episode and in the presence of 
concomitant ST-T changes72, thrombolytic therapy has at present no place in the 
treatment strategy for unstable angina, unless complete coronary occlusion has been 
documented by angiography66• If the patient has stabilised it is often suggested to 
perform angiography after several weeks, either after or without intermediate exercise 
testing, and to decide for elective angioplasty or bypass surgery, depending on the 
angiographic results"7•71 • 
VI. Coronary angiography, angioplasty and bypass surgery 
Coronary angiography is performed to assess the possibilities for revascularisation if 
such intervention is being considered. In addition, in some patients an angiogram may 
be helpful to establish the diagnosis of coronary disease, when the symptoms are 
suggestive for coronary artery disease, but without concomitant ECG changes. Clear 
indications for angiography are post infarction angina (within 4 weeks after infarction), 
'refractory' angina (persisting despite extensive medical therapy), angina at rest with 
ECG changes indicative for ischemia in a large myocardial area, or the development of 
deep negative T -waves in the anterior leads (suggestive of proximal LAD obstructionf'. 
The frequency of angiography procedures in patients admitted for unstable angina varies 
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considerably between regions and institutions74, depending in part on descriptions and 
patient referral patterns. In the Rotterdam study a decision to perform angiography was 
made for 31% of the patients admitted with an initial diagnosis of unstable angina 
(chapter 2). In the hospital with in-house angioraphic facilities the decision for 
angiography was made twice as often as in the hospital without a catheterisation 
laboratory (chapter 4). The intensity of medication at the onset of the unstable period 
appears to be an important factor for this variability74, but also considerable variation 
in the decision making process is observed between individual cardiologists (chapter 5). 
It should be appreciated that the risk of coronary angiography is low but not 
negligible, varying from 0.1 to 0.5%75 • Procedural mortality is positively associated with 
elderly age and with severe coronary artery disease, especially left main disease. Thus, 
a decision to perform angiography should not be made lightly. 
Although the angiographic appearance of the culprit lesion in patients with 
unstable angina may differ from the appearance of the lesions in patients with stable 
angina, the extent of coronary artery disease appears similar in both patient groups, 
independent of the clinical presentation"·". ln approximately 5-10% of patients no 
significant lesions are found. Left main disease is observed in about5%, and 1-, 2-, and 
3-vessel disease are present in equal amounts. Apparently, the dynamic obstruction in 
unstable angina, as described in paragraph 2, is responsible for the unstable situation 
and not the severity of the fixed obstruction per se. 
Both bypass surgery and angioplasty are often performed in patients with 
unstable angina pectoris. However, if possible, such interventions should be deferred 
until symptoms have been stabilised76•77• In patients with three-vessel disease and 
impaired left ventricular function survival may be improved by surgery44• Angioplasty 
of the culprit lesion may be efficacious in case of failure of medical therapy as well as 
after initial stabilisation78•79• Initially angioplasty was performed only in patients with 
single vessel disease and circumscript lesions with smooth borders. More recently also 
irregular 'unstable' lesions in patients with multivessel disease have been treated by 
PTCA. Such angioplasty procedure of the ischemia-related, 'culprit' lesion is successful 
in 85-90% of the patients"·". Complications occur more often in patients with unstable 
angina than in patients with stable angina, especially when intracoronary thrombus is 
present and also if the procedure is performed within one week after the most recent 
pain episode82• Restenosis after initially successful procedures occurs in 25-35% of the 
patients in the first 6-8 months81 • The choice between PTCA or surgery in practice will 
be based on the angiographic fmdings, as well as on the availability of both procedures, 
and waiting list. A formal of PTCA comparison with medical therapy or with surgery 
is not yet available. Therefore, the long term effects of PTCA and CABG in patients 
who are eligible for either procedure are currently being compared in several 
randomised trials (CABR!,BAR!,EAST,RITA,GABI)84•85• 
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Conclusion 
The term 'unstable angina pectoris' encompasses a broad spectrum clinical presentations 
of coronary artery disease and has to be specified in greater detail when the clinical 
condition of an individual patient is described. The pathophysiology of unstable 
coronary disease includes abrupt disruption of an atherosclerotic plaque, often with an 
increase in vasomotor tone, platelet aggregation and thrombus formation. In patients 
with prolonged complete coronary occlusion myocardial infarction will develop. The 
risk of progression to infarction in patients presenting with symptoms compatible with 
unstable angina varies form 1-6% in the acute phase and from 5-15% within 1 year. 
This risk depends in pan on patient selection and on the definition of unstable angina, 
as well as on the intensity of medication. Presently available medication for short-term 
and long-term treatment acts on different pathophysiologic mechanisms. Besides the 
traditional nitrates and B-blockers, calcium-antagonists, heparin and aspitiu have been 
added to the treatment regimen. So far, thrombolytic drugs have not shown a salutary 
effect in patients with unstable angina. Angioplasty and bypass surgery are efficacious 
to prevent of complications in selected patients. However, is has not been determined 
by controlled studies in which cases angioplasty or surgery should be preferred and in 
wbich cases medical therapy would be the best option. 
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ABSTRACT 
A follow up study was performed in order to examine the management and clinical 
course in unstable angina. 417 consecutive patients admitted to the Thoraxcenter 
(TXC) or Sint Franciscus Gasthuis (SFG) for chest pain deuoted as unstable angina, 
suspected of reversible ischemia, without signs of acute myocardial infarction, were 
followed during hospital stay. 
After an initial observation period the final diagnosis was myocardial infarction 
in 38 patients (9%), unstable angina in 270 patients (65%) and non-cardiac or non-
specific pain in 109 patients (26% ). 
All patients received medical therapy as indicated. A key question in unstable 
angina is whether medical therapy will suffice, or whether coronary angiography and 
additional interventions are required. During hospital stay it was decided to perform 
angiography in 137 patients (33%), including 16 patients for whom this decision was 
made immediately at admission, because of the history and the severity of symptoms. 
Subsequently, 100 patients (24%) were scheduled for angioplasty or bypass surgery. 
Angiography was performed more often in the TXC (47%) than in the SFG (25%). 
During follow-up 211 patients (53%) had recurrent pain episodes. New myocardial 
infarction occurred in 16 patients (4%), 9 during observation or waiting for an 
intervention and 7 related to PTCA (3) or CABG (4). Six patients died (1.4%), of 
which 3 during observation and 2 in relation to PTCA. Mortality was associated with 
advanced age (<! 70 years) and recent infarction. 
We conclude that patients admitted for suspected unstable angina have benign 
in-hospital course if intensive therapy is available. Recurrent ischemia occurs 
frequently but it can be treated with low morbidity and mortality. 
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IN1RODUCTION 
The syndrome unstable angina pectoris encompasses a variety of clinical 
presentations caused by transient episodes of myocardial ischemia. These episodes 
are precipitated by changes in the degree of coronary flow obstruction caused by 
different pathophysiological mechanisms, including intracoronary atheromatous 
plaque rupture, platelet aggregation and thrombus formation, and increased 
vasomotor tone1.2. Other terms that have been used to describe the syndrome, such as 
impending myocardial infarction, pre-infarction angina, acute coronary insufficiency 
or intermediate coronary syndrome', indicate concern for progression to myocardial 
infarction. However, morbidity and mortality in patients with unstable angina vary""", 
which occur in 1-6% respectively 2-12% in the acute phase. Accordingly the 'label' 
or diagnosis can change over dme7.I. 
In a patient with chest pain severe enough to warrant hospital admission an 
early working diagnosis of suspected unstable angina is made when symptoms and 
signs are such that transient myocardial ischemia is believed to be the underlying 
cause. New information acquired during admission, such as the occurrence or 
absence of new episodes of chest pain, ECG changes or elevated serum enzyme 
levels, will contribute to a final diagnosis which can be either acute myocardial 
infarction, unstable angina, non cardiac disease, or 'non-specific' chest pain. 
Most reports address specific selected subgroups of patients with unstable 
angina, such as patients in whom myocardial infarction has been 'ruled out' by serial 
enzyme determinations'·', or patients referred for angioplasty10·" or bypass 
surgery"·". Accordingly, data on the clinical course and management in the whole 
spectrum of patients with unstable angina are scarce. 
In an attempt to collect such data we conducted a prospective two-center 
follow-up study in 417 consecutive patients who were primarily admitted to hospital 
for chest pain of suspected ischemic origin, labelled 'unstable angina', without signs 
of acute infarction or other diseases at the time of admission. The specific aim of the 
study was to assess the diagnostic and therapeutic procedures used in various 
subgroups and to assess the incidence of in-hospital events, including development of 
myocardial infarction and mortality and the need for emergency revascularisation 
procedures. Also the management strategy in the two hospitals was compared. 
PATIENTS AND METHODS 
Study site 
The study was conducted in the Thoraxcenter (TXC) of the University Hospital 
Dijkzigt and the Sint Franciscus Gasthuis (SFG) in Rotterdam. The TXC is a 
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teaching hospital with facilities for diagnostic angiography, angioplasty, and cardiac 
surgery, where approximately 1100 patients are admitted to the CCU per year. The 
SFG is a large community hospital with about 1700 CCU admissions per year, but 
without in-house angiography facilities. Most diagnostic catheterization procedures in 
patients admitted to the SFG are performed by cardiologists from the SFG who have 
their own schedule in the TXC and in another hospital in Rotterdam. Most 
emergency angiograms, as well as the majority of revascularisation procedures are 
performed in the TXC. 
Patient selection and definitions 
All patients admitted to the cardiac department for chest pain diagnosed as unstable 
angina by the physician on duty, were included in the registry. The initial diagnosis 
suspected unstable angina was based on a history of severe chest pain at rest or at 
minimal exertion, probably of ischemic basis without electrocardiographic signs of 
acute infarction or signs of other causes of chest pain such as aneurysm or 
arrhythmia. ST-T changes were not required for inclusion. Patients admitted for 
suspected myocardial infarction were also included as unstable angina when 
subsequent enzyme levels remained below twice the normal value. Patients who were 
referred to the TXC from other hospitals for further treatment were excluded. 
The final diagnosis definite unstable angina was based on the evaluation of 
symptoms and on the documentation of objective ECG criteria during observation or 
exercise testing. Patients with initial infarction who had recurrent anginal pain after 
24 hours were included as post infarction unstable angina. 
Data collection and follow-up 
The data were prospectively collected and recorded on a form which was designed in 
such a way that registration followed the various decision moments during a patient's 
hospital stay. 
The in-hospital stay was divided in three periods: an observation period lasting 
from admission until the decision either to discharge or to initiate coronary 
angiography; a waiting period lasting from the moment of decision to perform 
angiography until the execution of the procedure; in patients for whom the decision 
was made to perform angioplasty or bypass surgery a second waiting period was 
distinguished between the decision and the procedure; in patients for whom was 
decided to continue medical therapy a second observation period was distinguished 
between this decision and discharge. 
Demographic data, history and characteristics of presentation were recorded at 
admission. During all follow-up periods a log was kept of new pain episodes, new 
infarctions or death. The following diagnostic and therapeutic measures were 
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recorded: electrocardiograms, exercise tests, and medication. After an observation 
period of 24-48 hours the final diagnosis was noted. Furthermore the frequency of 
and reasons for changes of initial decisions were recorded. 
Electrocardiograms were coded with respect to the presence or absence of Q· 
waves, indicating old infarction (Q-waves > 0.03 sec or Q-wave equivalents: R-wave 
> 0.03 seconds in VI and R > S in V2), signs of left ventricular hypertrophy (R ~ 
2.6mV in V5 or V6, or R in V5 or V6 plus S in VI ~.5mV), intraventricular 
conduction disturbances (QRS > 0.12 seconds) or neither of these14• The ST-segment 
was scored as ST elevation or ST depression 2: 0.1m V and/or T-wave inversion. If 
an electrocardiogram dnring pain was obtained, the occurrence of ST 
elevation/depression 2: O.lmV or T-wave deviation 2: O.lmV was described. 
Serum creatine kinase levels and other enzymes were determined at various 
moments during hospital stay according to local routine. Myocardial infarction was 
defined as the presence of serum creatine kinase levels above twice the local upper 
limit of normal. The time of onset of infarction was determined from analysis of 
history, ECG and enzyme changes. 
Statistical analysis 
Comparisons between groups were analyzed with a student t·test for continuous 
variables and x·square test for discrete variables. 
RESULTS 
Patient flow and final diagnosis 
Between October 1988 and September 1989, 148 patients were admitted for 
suspected unstable angina to the Thoraxcenter (TXC), University Hospital Dijkzigt 
and 269 to the Sint Franciscus Gasthuis (SFG). This includes 11 patients with an 
initial diagnosis of myocardial infarction but without serial enzyme changes. A flow 
chart of these 417 patients with respect to the fmal diagnosis and clinical events 
between admission and the decision to perform angiography is given in figure 2.1. 
For 16 patients the decision to perform angiography was made immediately at 
admission because of the history and the severity of symptoms, including 7 with a 
history of recent infarction or angioplasty. For the other 401 patients a final 
diagnosis was made after a 24-48 hour observation period. In 270 patients the final 
diagnosis was definite unstable angina, 38 patients appeared to have an infarction at 
the time of admission, according to enzyme levels that became available after several 
hours and for 109 other patients the final diagnosis was non-specific chest pain or 
chest pain of other causes, including gall bladder and liver disease (2), 
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Figure 2.1. Flow of patients admitted for chest pain suspected of unstable angina from 
admission until the decision either to perform angiography or to discharge without 
angiography. PIAP = post infarction angina; norm. enz. = normal enzymes: patients 
admitted for suspected myocardial infarction without elevated enzyme levels. 
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Figure 2.2. Flow of all patients with definite of unstable angina from the time of decision 
to perform angiography until the eventual procedure, subsequent interventions and 
discharge. CAD = coronary anery disease 
gastrointestinal problems (4), musculoskeletal pain (1), heart failure (5), arrhythmias 
(3), and pericarditis (1). Twelve out of 38 patients with initial infarction developed 
post infarction angina, bringing the total number of patients with unstable angina to 
282. 
Patients with 'definite' unstable angina. 
After the diagnosis unstable angina was made, 52 out of 282 patients were scheduled 
for angiography without further delay and angiography was scheduled for another 85 
patients after recurrent ischemic episodes. The subsequent course of these 137 
patients with unstable angina scheduled for angiography is illustrated in figure 2.2. 
All planned angiography procedures were performed without complications. After 
angiography 100 patients were scheduled for revascularisation procedures, 37 
patients were treated medically including seven patients in whom the angiogram did 
not show significant coronary disease. Two patients scheduled for surgery eventually 
underwent angioplasty, because of infectious disease in one patient and because of 
recurrent pain episodes that warranted an emergency procedure in the other patient. 
Angioplasty was performed during the same session as the angiography in 14 
patients, including 8 patients undergoing a repeat procedure within six months of an 
earlier angioplasty. One patient who waited for angioplasty underwent surgery 
instead after revision of the angiogram. One other procedure was cancelled because 
of fever. This patient subsequently died after reinfarction despite medical therapy. 
Medical treatment failed in one patient who subsequently underwent angioplasty 
because of recurrent pain episodes with ECG changes. 
Table 2.1 In hospital mortality 
gender age symptoms time after admission cause of death 
1 female 85 infarct at admission 4 days -observation period reinfarcti.on 
-recurrent ischemia 
2 female 75 infarct at admission 31 days -waiting for PTCA reinfarction 
-recurrent ischemia (cancelled) 
3 male 70 angina after recent 0 days -during PTCA hean failure, asystole 
infarct and PTCA -thrombus formation 
4 male 73 recent onset angina 5 days -2 days after PTCA retroperitoneal 
bleeding 
5 male 79 infarct at admission 1 day -observation period infarction and bean 
failure 
6* female 73 angina after recent 12 days -during PTCA intracerebral 
infarct bleeding 
* Decision for angiography was made immediately at admission. 
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Mortality and morbidity. 
Six out of 417 patients (1.4%) died in hospital. All six patients were 70 years or 
older. Five of these six patients died after recent infarction. Three patients died 
during observation, while the three other deaths were related to angioplasty 
procedures. Details are provided in table 2.1. 
Myocardial infarction occurred in 16 patients (3.8%). This was associated with 
prehospital acceleration of angina and ST-T abnormalities on the baseline ECG. Four 
patients developed infarction during initial observation (figure 2.1). Four patients 
suffered infarction during a waiting period, two waiting for angiography, one for 
surgery and one other for angioplasty and seven infarctions were related to 
revascularisation procedures, four to surgery and three to angioplasty (figure 2.2). 
Baseline characteristics 
Demographic and historical data of the 417 patients who were admitted for 
observation are presented in table 2.2. There was no difference in mean age between 
patients with a !mal diagnosis of unstable angina, myocardial infarction or chest pain 
of other causes. However there were less patients younger than 50 years with 
unstable angina (16%) compared to the other two groups (29%, p<O.Ol). Patients 
with unstable angina had more often a history of documented coronary artery disease 
than patients who in retrospect had an infarction or other diagnosis. At hospital entry 
42% of all patients were without antianginal medication. Medication before 
admission was more extensive in patients with unstable angina since only 31% 
entered the hospital without medication against 63% of the other patients, p<O.OOL 
Thirty percent of all patients had one, 20% two and 7% three antianginal drugs 
(nitrates, B-blockers or calcium antagonists) before admission. 
A short history of pain was seen more often in patients with acute infarction or 
other causes than in patients with unstable angina. In half of the patients with other 
causes the pain was of sudden onset (table 23). In case of myocardial infarction the 
pain was usually still present at admission and lasted for more than one hour. 
However a high number of patients with unstable angina (33%) had pain of long 
duration. This may partly be due to interpretation of a sequence of many shorter 
episodes. However, it is not a sensitive indicator for myocardial infarction on its 
own. Patients with unstable angina and myocardial infarction had more pain episodes 
during 24 hours before admission than patients with other causes (46% and 29% 
respectively with multiple episodes, p<0.05). 
The initial diagnosis of suspected unstable angina in the 417 patients who were 
admitted for initial observation was supported by dynamic ECG changes during or 
shortly after pain in 147 patients, aod by abnormal repolarisation considered as 
ischemia on the painftee ECG in 67 patients (28 patients had ST-T abnormalities on 
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Table 2.2 Baseline characteristics 
fmal diagnosis 
Total UAP AMI Other 
n~l7 n=270 n=38 n=109 
n (%) n (%) n (%) n (%) 
age 
,;; 50 years 80 (21) 44 (16) 11 (29) 32 (29) 
50-70 years 203 (49) 145 (54) 18 (47) 40 (37) 
> 70 years 127 (30) 81 (30) 9 (24) 37 (34) t 
male 267 (64) 172 (64) 29 (76) 66 (61) 
hypertension1 152 (36) 93 (34) 19 (50) 40 (37) 
diabetes mellitus 49 (12) 35 (13) 4 (11) 10 (9) 
hypercholesterolemia2 59 (14) 45 (17) 6 (16) 8 (7) 
smoking' 142 (34) 95 (35) 13 (34) 34 (31) 
positive family history4 151 (36) 108 (40) 9 (24) 34 (31) 
previous history 
unstable angina 95 (23) 78 (29) 6 (16) 11 (10) t 
myocardial infarction 193 (46) 133 (51) 15 (39) 41 (38) * 
angiography (documented CAD) 112 (27) 87 (32) 8 (21) 17 (16) t 
angioplasty 51 (12) 45 (17) 1 (3) 5 (5) t 
bypass surgery 63 (15) 49 (18) 4 (11) 10 (9) 
one of above 230 (55) 165 (61) 20 (53) 45 (41) t 
medication before admission5 
long acting nitrates 104 (24) 82 (30) 7 (18) 15 (14) t 
beta blockers 167 (39) 130 (48) 12 (32) 25 (23) t 
calcium antagonists 113 (25) 89 (33) 9 (24) 15 (14) t 
platelet inhibitors 87 (21) 66 (24) 5 (21) 16 (15) * 
oral anticoagulants 55 (13) 29 (11) 4 (11) 22 (20) * 
* p<0.05 t p<O.Ol; UAP::::unsrable angina pectoris; AMI=acute myocardial infarction; 
Other=non-specific chest pain or chest pain of other causes. 
1 Blood pressure >160/90 or current treatment. 2 serum cholesterol >6.5 mmol/1 or current 
treatment. 3 current smoking and smoking until less than a year ago. 4 infarct or cardiac 
death at age under 60 in first or second degree relative. 5 total number of antianginal drugs 
is displayed in figure 2.3. 
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Table 2.3 Presentation at admission 
final diagnosis 
Total UAP AMI Other 
n=417 n=270 n=38 n=I09 
n (%) n (%) n (%) n (%) 
pain before presentation1 
none 133 (32) 61 (23) 15 (39) 57 (52) 
::;; 4 weeks, progressive 105 (25) 77 (29) 13 (34) 15 (14) 
> 4 weeks, stable 77 (18) 50 (19) 6 (16) 21 (19) 
> 4 weeks, progressive 101 (24) 81 (30) 4 (II) 16 (15) t 
pain still present at admission 227 (54) 138 (51) 33 (87) 56 (51) t 
duration of pain episodes 
<15 min 109 (26) 83 (31) 4 (10) 22 (20) 
15-60 ntin 126 (30) 88 (32) 3 (8) 35 (32) 
<:60 ntin 169 (41) 89 (33) 31 (82) 49 (45) 
u.'"lknown 13 (3) 10 (4) 0 (-) 3 (3) t 
thalamonal for pain relief 63 (15) 38 (14) 13 (34) 12 (II) t 
electrocardiogram 
QRS 
Q-wave 131 (31) 91 (34) 12 (32) 28 (26) 
intraventricular conduction disturbances 37 (9) 20 (7) 7 (18) 10 (9) * 
left ventricular hypertrophy 24 (6) 15 (6) I (3) 8 (7) 
none of the above 225 (54) 144 (53) 18 (47) 63 (58) 
ST-T segment 
ST-elevation > 0.1mV 47 (II) 29 (II) 6 (16) 12 (II) 
ST-depression > 0.1mV 73 (18) 47 (17) 8 (30) 18 (17) 
T-wave inversion 137 (33) 101 (37) 10 (26) 26 (24) * 
ST-T segment judged as ischentia2 95 (23) 73 (27) 10 (26) 12 (II) t 
ST-T change during pain 
t. ST-elevation > O.lmV 31 (7) 24 (9) 7 (18) 0 (0) * 
t. ST-depression > 0.1mV 79 (19) 59 (22) 15 (39) 5 (5) t 
t. T-wave > 0.1mV 31 (7) 24 (9) 3 (8) 4 (4) 
ST-T change judged as ischemia2 147 (35) 110 (41) 25 (66) 12 (11) t 
* p<0.05 t p<O.Ol. 1 none=no pain before present episode; s; 4 weeks=pain for less than 
four weeks with progression; > 4 weeks, stable=:::chronic stable chest pain before admission 
without acceleration before present episode; > 4 weeks, progressive=chest pain present for 
more than four weeks with gradual acceleration. 2 interpretation of the ST-T segment by 
the anending physician. ~ = difference in ST-segment or T-wave deviation in comparison 
to the ECG without pain. 
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both ECGs). ln 203 patients it was based on history alone. Although a history of 
myocardial infarction was more frequent in patients with UAP, this was not reflected 
in the frequency of Q-waves on the electrocardiogram. Ischemic ST-T abnormalities 
on the admission electrocardiogram at rest and/or ST-T changes during or after pain 
were seen at admission in more than half of the patients, while 20 percent of the 
patients with 'other' causes had ST-T abnormalities. 
Clinical course 
Observation from admission until the decision for angiography or discharge. 
New episodes of chest pain in hospital were frequent in all categories of patients 
(table 2.4). The pain was accompanied by ST-T changes and was reason for 
additional medication in one third of the patients with unstable angina. Two third of 
the patients with infarction had new episodes of pain in hospital, although post 
infarction angina (> 24 hours after initial infarct) occurred in only 12 patients. An 
exercise test was performed in half of the patients in all categories. Pain or ECG 
changes were observed in 54% of the tests in patients with unstable angina while but 
also in 10% of the patients with chest pain of other causes. 
Patients in whom the decision was made to perform angiography differed from 
the other subjects in the following respects: they had more often post infarction 
angina, more recurrent pain episodes during the initial observation, which were 
accompanied by ECG changes and treated with additional medication more often. 
Fewer patients underwent an exercise test, but if exercise testing was performed, pain 
and ECG changes during the test were observed more frequently. 
Waiting period for angiography. 
Angiography was followed by angioplasty or bypass surgery in similar frequencies, 
although emergency angiography was followed by angioplasry more often (table 2.5). 
This was due in part to the relatively high number of patients (8) with clinical 
suspicion of restenosis after recent angioplasty. 
Multiple pain episodes occurred more frequently in patients who were later 
scheduled for bypass surgery, and ECG changes during pain were observed less 
often in patients were treated medically after angiography. The severity of coronary 
artery disease was a decisive factor for subsequent management. Among the patients 
who were subsequently treated medically or with angioplasty 47% had single vessel 
disease, whereas 58% of the patients who were scheduled for bypass operation had 
three vessel or left main disease. Still, nine out of 37 patients with three vessel 
disease were treated medically. Eight of them had undergone bypass surgery in the 
past and non-invasive management was chosen because of technical difficulties 
related to renewed surgical procedures or angioplasty, or because of the relative 
mildness of the symptoms. 
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Table 2.4 Clinical course during observation period 
final diagnosis 
Total UAP AMI Other 
n=401 n~254 n~38 n~109 
n (%) n (%) n (%) n (%) 
medication in hospital1 
oral nitrates 79 (20) 66 (26) 1 (3) 12 (11) t 
intravenous nitrates 231 (58) 146 (57) 34 (89) 51 (47) t 
&-blockers 229 (57) 171 (67) 25 (66) 33 (30) t 
calcium-antagonists 125 (31) 97 (38) 13 (34) 15 (14) t 
platelet inhibitors 147 (37) 102 (40) 15 (39) 30 (28) 
heparin 273 (68) 185 (73) 32 (84) 56 (51) t 
new pain episodes2 193 (48) 125 (49) 27 (71) 41 (38) t 
number (>1) 101 (25) 69 (27) 16 (42) 16 (15) t 
max duration (> 15 min) 58 (14) 35 (14) 11 (30) 12 (11) * 
ECG changes 
during pain 104 (26) 78 (31) 19 (30) 7 (6) t 
without pain 18 (4) 18 (J) 0 (-) 0 (-) 
no pain or ECG changes 190 (47) 111 (44) 11 (29) 68 (62) t 
thalamonal for pain relief 43 (II) 18 (J) 16 (42) 9 (8)t 
additional medication after pain 121 (30) 86 (34) 20 (53) 15 (14) t 
oral medication 107 (27) 73 (29) 19 (50) 15 (14) t 
(re)stan intravenous medication 42 (12) 33 (13) 7 (18) 2 (2) t 
thrombolytic therapy 8 (2) 7 (3) 1 (3) 0 (-) 
exercise test 199 (50) 120 (47) 19 (50) 60 (55) 
no ischemic signs 117 (29) 55 (22) 13 (34) 49 (45) 
chest pain only during test 16 (4) 11 (4) 0 (-) 5 (5) 
ECG changes during test 66 (17) 54 (21) 6 (16) 6 (5) t 
* p<0.05 t p<O.Ol; I total number of antianginal drugs is displayed in fignre 2.3. 
2 progression to infarction or death is displayed in figures 2.1 an 2.2. 
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Table 2.5 Clinical course during waiting period for angiography and subsequent 
results by decision after angiography. 
Total medRx PTCA CABG 
(n;137) (n;37) (n;52) (n=48) 
n (%) n (%) n (%) n (%) 
priority of angiography1 
emergent 20 (15) 4 (11) 11 (21) 5 (10) 
urgent 100 (73) 28 (76) 35 (67) 37 (77) 
elective 17 (12) 5 (13) 6 (12) 6 (13) 
infarction 2 (I) 2 (4) 
new pain episodes 58 (42) 12 (32) 22 (42) 24 (50) 
number (>I) 27 (19) 4 (II) 8 (15) 15 (31)* 
duration (> 15 ntin) 12 (9) I (3) 6 (12) 5 (10) 
ECG changes 31 (23) 5 (14) 12 (23) 14 (29)t 
no ECG changes 16 (12) 6 (16) 6 (12) 4 (8) 
no ECG available 11 (8) I (3) 4 (8) 6 (13) 
ECG changes without pain 2 (I) 2 (4) 
no pain or ECG changes 77 (56) 25 (68) 30 (58) 22 (46) 
additional medication 31 (23) 8 (22) 10 (19) !3 (27) 
oral medication 21 (15) 5 (14) 6 (12) 10 (21) 
(re )stan intravenous medication 11 (8) 3 (8) 5 (10) 3 (6) 
thrombolysis 2 (I) I (2) 1 (2) 
angiography results 
no significant lesions 7 (5) 7 (19) 
one vessel disease 44 (32) 18 (49) 24 (46) I (2) 
two vessel disease 42 (31) 3 (8) 21 (40) !8 (38) 
three vessel disease 40 (29) 9 (24) 7 (14) 24 (50) 
left main disease 4 (3) 4 (8) t 
* p<0.05 t p<O.O! 
1 emergent;on the same day or the next day; urgent=during the present admission period; 
elective;af'ter discharge, according to waiting list. 
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Medication. 
The number of antianginal drugs (nitrates, B-blockers, calcium-antagonists and 
platelet inhibitors) prescribed at each decision moment in hospital is illustrated in 
figure 2.3 for patients with chest pain from other causes and unstable angina. Forty· 
six percent of all patients discharged without angiography and 23% of the patients 
who underwent angiography entered the hospital without medication (p<O.OOl). 
However, four of the 16 infarctions and three of the six deaths in hospital occurred 
in patients without medication before admission. At admission and during hospital 
stay more drugs were prescribed in unstable patients than in patients with chest pain 
from other causes (p<O.Ol), although half of the patients with 'other causes' were 
temporarily treated with intravenous nitroglycerin and heparin. 
At the time of the decision to perform angiography or not the number of 
medications was significantly higher for patients who underwent angiography than 
for those who were discharged (p<O.OOJ). Of the former patients 84% were treated 
with heparin or aspirin and 47% of the patients were treated with intravenous 
nitrates. 
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Figure 2.3. Anti anginal drugs (nitrates, fi-blockers, calcium antagonists and platelet 
inhibitors) at each decision moment for patients with chest pain of other causes (A), 
patients with definite unstable angina who were discharged without angiography (B) and 
patients with definite unstable angina who underwent angiographY (C). 
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The medication patterns were similar for those who were treated medically after 
angiography and those who were scheduled for angioplasty or bypass surgery. 
Nitrates were usually continued intravenously in the latter two groups until the 
intervention, while these were replaced by oral nitrates in the medically treated 
group. These medically treated patients left the hospital with slightly more 
medication than unstable patients who were discharged without angiography (not 
statistically significant). 
Duration of observation and waiting periods 
The time in hospital until the final diagnosis was made and subsequent management 
strategy was determined is depicted in figure 2.3. The median observation period was 
2 days in both hospitals, with a maximum of 32 and 14 days for TXC and SFG 
respectively. Ninety-five percent of patients with 'other causes' were discharged 
within seven days. 
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Figure 2.4. Observation time in days until the decision to perform angiography or to 
discharge without angiography was made, separated by final diagnosis. From left to 
right the curves represent 
- time until discharge in patients with "other diagnoses" 
- time until angiography in patients with unstable angina 
- time until discharge in patients unstable angina who did not undergo angiography 
- time until discharge in patients with myocardial infarction. 
The decision to perform angiography was made on average two days earlier 
than the decision to discharge without angiography in patients with 'definite' 
unstable angina (p=O.OOl). The median time until discharge without angiography was 
similar for both hospitals (4 and 5 days). The decision to perform angiography was 
made on average one day earlier in the TXC than in the SFG (p<0.04), with median 
times of 1 (max. 7) and 2 (max. 10) days respectively. Twenty-two percent of these 
decisions were made on the day of admission, 34% in the TXC and 9% in the SFG. 
Angiography was performed within a median of two (max. 48) days after the 
decision. The waiting time was significantly shorter in the TXC than in the SFG, 1 
(max. 9) day and 5 (max. 48) days respectively (p=O.OOOl). All procedures in the 
TXC were done during the same admission period, but 24% of the procedures in the 
SFG were done after discharge, although the decision had been made during 
admission. Eight angiography procedures were performed earlier than planned 
because of aggravation of symptoms, which progressed to infarction in one patient 
who waited at home. Seven procedures were delayed two to seven days, because of 
myocardial infarction, fever, temporary stabilization of symptoms and side effects of 
medical treatment. In three cases organizational problems in the catheterization 
laboratory caused delay, without serious consequences. 
The median waiting time for angioplasty was 2 (max. 8) day. Eleven out of 32 
procedures in the TXC and 2 out of 20 in the SFG were done during the same 
session as the angiography procedure, eight of these for restenosis following previous 
angioplasty. Angioplasty was performed earlier than planned in 2 patients, because of 
increasing angina. Three procedures were delayed three to nine days, because of 
other ailments and organisational problems. 
The waiting time for bypass surgery was similar for both hospitals, median 10 
(max. 140) days. Seven percent of the bypass operations were emergency procedures 
and 30% were performed electively. Five bypass operations had to be performed 
earlier because of increasing symptoms. One of these patients developed myocardial 
infarction while waiting at home. Four procedures were delayed one to 24 days, for 
medical or organizational problems. In one patient the waiting period of one day was 
covered with intra-aortic balloon counterpulsation. None of these delays led to 
serious consequences such as myocardial infarction or death. 
A total of 33 procedures were planned electively, after discharge. Two patients 
developed infarction as described above. Another 10 patients were readmitted and 
the procedures were performed earlier than planned because of recurrent chest pain 
without infarction. 
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Difference between both hospitals 
During the study period twice as many patients were admitted to the SFG compared 
to the TXC. In both hospitals 65% of the patients were male. Patients admitted in the 
TXC were on average 4 years younger. Seventeen percent of patients in the TXC 
and 38% in the SFG were older than 70 years (p<O.Ol). There was no difference 
between both hospitals with respect to the rmal diagnosis (table 2.6), although more 
TXC patients had a history of coronary disease (prior infarction, angioplasty of 
bypass snrgety) or the risk factors hypenension and hypercholesterolemia. 
Antianginal medication at admission was more extensive in this hospital. Fony-four 
percent of patients were admitted without antianginal medication in the SFG and 
29% to the TXC, (p<O.Ol). The initial diagnosis was based on history alone in more 
patients in the TXC (p<0.05). 
Table 2.6 Diagnosis in each hospital 
Total TXC SFG 
n=401 n=134 n=267 
n (%) n (%) n (%) 
Initial diagnosis 
suspected unstable angina, based on 
history alone 198 (49) 76 (57) 122 (46) 
ECG abnormalities 203 (51) 58 (43) 145 (54) * 
Final diagnosis 
unstable angina 254 (64) 89 (67) 165 (62) 
myocardial infarction 38 (9) 14 (10) 24 (9) 
other 109 (27) 31 (23) 78 (29) 
* p<0.05; TXC = Tboraxcenter, University Hospital Rotterdam, Dijkzigt 
SFG = Sinr Franciscus Gasthuis. 
The clinical course until the decision to perform angiography for patients with 
unstable angina did not differ between hospitals. Angiography was performed in 47% 
of all patients in the TXC and in 25% in the SFG. The waitiog period for 
angiography was on average 4 days shoner in the TXC, with fewer pain episodes or 
ECG changes during this period. In both hospitals medication was increased after 
pain in half of the patients, but intravenous therapy was staned more frequently in 
the SFG. At the time of the decision to perform angiography 23% of the patients in 
the TXC and 34% of the patients in the SFG had intravenous nitrates (not 
significant). In both hospitals angiography revealed similar severity of coronary 
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anery disease. Five percent had no significant coronary disease, 33% had single 
vessel disease. 30% two-vessel disease, 30% three-vessel disease and 2.% left main 
disease. Also the strategy following angiography was not significantly different 
between both hospitals, although physicians in the TXC tended to do more 
angioplasty procedures, whereas in the SFG bypass surgery was the preferred option 
for revascularisation. 
The number of emergency procedures was significantly higher in the TXC than 
in the SFG for angiography (20% and 9%) as well as for angioplasty (52% and 
10%). One patient from the SFG who underwent immediate angioplasty because of 
restenosis after previous angioplasty died during the procedure. During hospital stay 
the total number of events was small and not significantly different for both 
hospitals. New infarction occurred in 4 patients in the TXC and in 12 patients in the 
SFG (3 resp 4%). Two patients in the TXC and four patients in the SFG died during 
the study period (both 1.5%). 
DISCUSSION 
During one year in two hospitals all patients admitted for chest pain, suspected for 
unstable angina pectoris were followed prospectively with respect to clinical course 
and management strategy. This wide entry criterium and the selection of patients 
immediately at admission ensured that the whole spectrum of unstable angina was 
included in this registry. This is in contrast with most other studies on unstable 
angina, where only selected patients were included, restricted by age15•9, absence of 
recent myocardial infarction or bypass surgery1"'1'·9, duration of pain episodes17.16•19 or 
the presence of objective ischemic signs on the electrocardiograrn18.20, or to patients 
with confrrmed coronary artery disease after angiography18•21 , or those selected for 
angioplasty10•11 or bypass surgery'2.13• In most studies patients were selected 24 to 48 
hours after admission when myocardial infarction was ruled out by serial enzyme 
analysis. Such delay also excludes most patients who in retrospect had chest pain of 
other causes and who were included in the present study. The only exclusion 
criterium in the present study was evidence of other disease which was believed to 
cause the chest pain, e.g. aneurysm dissecans, and referral from other hospitals for 
further treatment of patients in whom already a complete diagnostic workup was 
performed. 
The full spectrum of suspected unstable angina at admission represents a patient 
population with a dynamic pattern of diagnoses. New information during observation 
revealed three major diagnostic groups: myocardial infarction that had already 
occurred but was not recognized as such at admission, a defmite diagnosis of 
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unstable angina, and other causes of chest pain. In one quaner of all patients, after 
observation the complaints were attributed to causes other than coronary 
insufficiency. This proportion is much lower than Duncan" reported in an out-patient 
study of 616 men aged under 70 who were referred for chest pain, suggestive for 
myocardial ischemia, by general practitioners. Mter a cardiological analysis 365 
patients (60%) did not satisfy the criteria for unstable angina. This suggests that a 
considerable proportion of patients with chest pain from other causes may be filtered 
before admission. At the other side of the spectrum, myocardial infarction had 
already occurred in 9% of all admitted patients, which could only be recognized 
from the serum enzyme assays that became available six to eight hours after 
admission. Similarly, in the HINT study19 myocardial infarction had occurred in 
retrospect at the time of admission in 12% of patients with prolonged chest pain and 
concomitant ECG changes. 
ECG changes were not required for the final diagnosis of unstable angina. In 55 
out of 282 patients with unstable angina as final diagnosis no ECG changes were 
observed during the clinical observation period or during exercise testing. Forty-three 
of these 55 patients (78%) had a history of coronary disease (myocardial infarction 
or prior angiography, angioplasty or bypass surgery) and in the other twelve patients 
the diagnosis of definite unstable angina was made on the present history alone. 
Morbidity and mortality. 
The in-hospital infarction rate was low. New myocardial infarctions occurred in 16 
patients (4%) during the registry period. One of these occurred after initial infarction 
at admission and two infarctions occurred in patients waiting at home for 
angiography or bypass surgery. The overall mortality rate was low: 1.2% for the total 
group and 1.5% in patients with 'definite' unstable angina. These figures are 
comparable with earlier prognostic studies which mention in-hospital infarction rates 
from 4-20% and mortality rates from 1-6%15.22.8•4-'6• In other recent studies these 
figures are 1.7-11.9% and Ll-1.7% for infarction and mortality rates 
respectively"'·'""· The infarction rate of 1 1.9% in the study of Theroux24 applies to 
patients treated with placebo, whereas this number was 1.9% for patients treated with 
aspirin, heparin or both. These drugs were prescribed in more than 80% of the 
patients with unstable angina in our registry. Mulcahy reported in hospital morbidity 
and mortality rates of 10.1% and 3.2%25 in patients without routine medical 
treatment of 8-blockers, calcium antagonists or anticoagulants. The extensive 
medication in the present study may explain the lower numbers infarctions and 
death. In hospital 78% of all patients received oral or intravenous nitrates, 58% 
received B-blockers, 33% calcium-antagonists and 78% of the patients was initially 
treated with either aspirin or heparin. It should be noted that in the present study 
many infarctions and deaths were related to interventions, and such cases were 
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usually not included in the above mentioned studies. Furthermore all deaths occurred 
in patients older than 70 years, a group that is excluded in many other studies. 
Within the group of 'definite' unstable angina coronary angiography was 
performed in only 137 out of 282 ( 49%) patients and in 100 patients a subsequent 
revascularisation procedure was scheduled (figure 22). Although many patients had 
recurrent pain episodes in hospital they could often be treated satisfactorily with 
medication, at a low risk for infarction or death. Angiography was performed 
predominantly in patients with multiple new pain episodes and ECG changes in 
hospital and in patients with post infarction angina. These patients have relatively 
high risks for death or myocardial infarction'·"s.u. Other characteristics at admission 
associated with a high risk of infarction or death were a gradual acceleration of pain 
before admission and abnormal repolarisation on the admission ECG without pain. 
Within the group of patients with a definite diagnosis of unstable angina only an 
abnormal admission ECG indicated higher risk. Deterioration of angina and ST-T 
abnormalities were also found to be associated with a more complicated clinical 
course in the studies of Krauss and Robettr1• 
Some infarctions occurred during the waiting period for angiography or 
intervention. However, it remains doubtful whether all of these infarctions could 
have been prevented by earlier intervention. Four infarctions during the initial 
observation period occurred between one and four days after admission, while on 
average three days were needed before a decision for an intervention was made and 
another five days until the procedure was performed. On the other hand two 
infarctions while waiting at home for angiography and for bypass surgery. These 
complications might have been prevented by an earlier intervention. 
Differential diagnosis at admission. 
The differentiation between unstable angina or infarction and other causes of chest 
pain remains difficulr'·29• Based on symptoms and signs available at admission that 
do not suggest acute infarction one has to accept a considerable false positive 
diagnostic rate. About ten percent will tum out to have acute infarction after all on 
the basis of cardiac enzyme levels. An ever higher percentage does not suffer 
ischemic disease at all. Predictive rules that have been developed based on admission 
criteria still leave 30% of all admissions without a !mal diagnosis of ischemia29• 
Although in the present study patients with chest pain of other causes differed 
from patients with myocardial ischemia with respect to the previous history of 
ischemic disease, medication, presentation at admission and electrocardiographic 
signs of ischemia, the admission characteristics were of little value to differentiate 
patients with and without ischemic heart disease. In many patients careful clinical 
observation is required to rule out ischemic disease or to assess the severity of 
angina for further treatment. Nevertheless the amount of medication that was started 
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in hospital was less in patients with other causes of chest pain than in those with 
'defmite' unstable angina. This indicates that the attending physicians recognized the 
symptoms as less severe in the former group. 
Difference between both hospitals. 
The patient populations in both hospitals differed with respect to cardiac history, risk 
factors and medication before admission. The proportion of patients older than 70 
years was twice as high in the SFG, while patients in the TXC had more often a 
history of known coronary artery disease. However there was no difference in the 
final diagnoses and the clinical course in hospital. The most prominent difference 
between the two hospitals was the management strategy. In the TXC nearly twice as 
many patients underwent angiography. Decisions were made earlier and the 
procedures were performed earlier than in the SFG. Whether this is only due to the 
availability of facilities for angiography, angioplasty or bypass surgery, or also to 
specific patient characteristics and personal decision making processes remains 
uncertain. As a consequence of the longer waiting period for angiography and further 
interventions in the SFG patients suffered more new pain episodes and more 
intravenous medication was needed. Nevertheless no difference was observed with 
respect to infarction rate or mortality. 
Conclusion. 
Unstable angina is a relatively benign syndrome under the current management 
strategy. Many patients can be stabilized on medication, in particular with iv-heparin 
and long-term treattnent with aspirin, which have become 'standard' treatment during 
the past years in addition to B-blockers and nitrates. ln clinical practice further 
intensive treatment is requested in a quarter of hospitalized patients with unstable 
angina. Although these procedures are not free of risk the morbidity and mortality in 
hospital is low. Further studies will attempt to reduce the rate of these complications 
further by, for example, more intense antiplatelet therapy30• Such therapy may also 
prevent complications of PTCA as were observed in a few patients in this study. 
Currently, angiography and revascularisation can be reserved for selected patients, 
particularly patients with post infarction angina, elderly patients and patients with 
recurrent chest pain and concomitant ECG changes. 
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ABSTRACT 
A six months follow-up smdy was performed in 417 patients hospitalised for suspected 
unstable angina in the Thoraxcenter (TXC) and the Sint Franciscus Gasthuis (SFG). Six 
patients died in hospital and 411 patients were discharged alive with a final diagnosis 
of unstable angina in 277 patients, myocardial infarction in 25 patients and non-cardiac 
or non-specific chest pain in 109 patients. Coronary angiography was initiated in 60% 
of the patients with a !mal diagnosis of unstable angina. Forty-eight percent of these 
procedures were performed within 28 days after admission and 9% after 28 days. 
Angioplasty and bypass surgery were performed in 22% each. Six months mortality rate 
for patients with a final diagnosis of unstable angina was 4.3%, 2.1% within 28 days 
and 2.2% after 28 days. Non-fatal infarction occurred in 9.6% of these patients, 7.4% 
within and 2.1% after 28 days. Age over 70 years, a history of myocardial infarction, 
and ECG changes during pain were identified as independent predictors of death or 
myocardial infarction. Male gender, hypenension and the absence of B-blocker use 
served as additional predictors for monality alone. For patients with chest pain of other 
causes the six month mortality rate was 5% and non-fatal infarction occurred in 2% of 
these patients. These results indicate a favourable prognosis of unstable angina, with a 
risk for infarction predominantly during the early phase, and a high intervention rate. 
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IN1RODUCTION 
Patients hospitalised for unstable angina can usually be stabilised during the in-hospital 
period. Nevertheless, in spite of initial 'stabilisation' patients remain at risk for future 
events. Progression of unstable angina to myocardial infarction or death within the first 
six months has been reported in 5-12% and 3-11%, respectively, of patients admitted 
for unstable angina, depending on the selection criteria and the time of diagnosis'·'. 
Many prognostic studies were performed in early years, when medical treatment was 
limited to nitrates and B-blockers. During the last decade medical treatment with nitrates 
and B-blockers has been extended with the use of calcium-antagonists .. •, heparin"·" and 
aspirin12.13• Furthermore, bypass surgery and angioplasty are being used on larger 
scale''"". More recent studies have described the prognosis with the use of the newer 
drugs, bypass surgery and angioplasty'·"·"·'9•21 • However, mortality and morbidity 
figures in these studies apply to selected patient groups who were treated according to 
a fixed study protocol, and few data are available regarding prognosis in unselected 
patients with unstable angina. 
This study aimed at assessment of the risk of death and myocardial infarction in 
patients with unstable angina in present clinical practice. All patients athnitted for chest 
pain suspected for unstable angina, without signs of acute infarction or of other diseases 
at the time of admission, were followed for six months after admission. Patients were 
treated according to local practice without the restrictions of a study protocol. The in-
hospital clinical course and management strategies were described in the previous 
chapter. In this chapter the prognosis up to six months after admission is presented of 
patients who were discharged with a diagnosis of unstable angina, and of those patients 
with a discharge diagnosis of myocardial infarction or chest pain of other causes. The 
analysis included mortality, morbidity as well as the frequency of revascularisation 
procedures after hospital discharge. 
PATIENTS AND METHODS 
Patients 
During a seven months study period in 1988 and 1989, 417 consecutive patients 
admitted for suspected unstable angina to the Thoraxcenter (TXC) of the University 
Hospital Dijkzigt or to the Sint Franciscus Gasthuis (SGF) in Rotterdam were included 
in the registry. 
Patients entered the study as soon as the attending physician decided to athnit them for 
observation of 'unstable angina'. This initial diagnosis suspected unstable angina was 
based on a history of chest pain at rest or at minimal exertion, probably of ischemic 
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origin without signs of acute infarction or of other causes of chest pain. ECG changes 
were not required for inclusion. Patients admined for suspected myocardial infarction 
were also included as unstable angina when subsequent enzyme levels remained below 
twice the normal value. Patients who were referred to the TXC from other hospitals 
with a defmite diagnosis of unstable angina in order to undergo invasive treatment were 
excluded. 
Since patients were included immediately upon admission the fmal diagnosis as 
registered 24-48 hours after admission often differed from the initial diagnosis. A fmal 
diagnosis of myocardial infarction (AMI) was determined by analysis of enzyme 
changes in 38 patients. Definite unstable angina (UAP), based on evaluation of 
symptoms and on the documentation of objective ECG criteria during observation or 
exercise testing, was present in 270 patients. Futthermore 12 of the 38 patients with 
initial infarction had recurrent anginal pain after 24 hours and were included as post 
infarction unstable angina. A fmal diagnosis of atypical chest pain or pain of other 
causes (other) was made in 109 patients. 
Data collection and analysis 
In-hospital clinical course and management strategy were registered. Details are 
provided in chapter two. 
Follow-up data after discharge were acquired by review of the clinical records or 
through a simple questionnaire sent to the general practitioner. The occurrence of 
myocardial infarction, death or any coronary intervention was recorded until six month 
after admission. 
Mortality, morbidity and frequency of revascularisation procedures are reported 
in relation to the final diagnosis, making a distinction between the in-hospital period and 
the time after discharge. Myocardial infarction followed by death was defined as non-
fatal infarction when both events did not occur during the same athnission. In case of 
fatal infarction only death is reported. For multiple events or interventions only the frrst 
infarction or procedure is reported in the tables. The period after discharge was divided 
in 'early' period, i.e. within 28 days after admission, and 'late', i.e. between 28 days 
and 6 months. Combined end points are presented in terms of 'survival without 
myocardial infarction' and 'survival without infarction or revascularisation'. 
Clinical variables known at admission and during the frrst 24-48 hours (until the 
final diagnosis was made) were examined for a relationship with complications during 
six months. Univariate analysis of categorical data was performed using ax-square test 
and differences in continuous variables were evaluated with Student's t-test. The 
probability of survival and survival without infarction was estimated using the Kaplan 
Meier method. A stepwise proportional hazard model was used to select predictors of 
survival. Variables were entered into the model or removed at a significance level of 
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0.10. The following variables were considered: age at admission, gender, a history of 
myocardial infarction, pattern of presentation of angina (gradual acceleration of angina 
or sudden exacerbation), hypettension (blood pressure >165/90 or current treatment for 
hypenension), medication at admission, pathologic QRS-complex on the baseline 
electrocardiogram, recurrent pain in hospital, and ECG-changes during pain. 
RESULTS 
Mter hospitalisation for suspected unstable angina 411 patients were discharged alive, 
277 with f"mal diagnosis of unstable angina (UAP), including 10 patients with post 
infarction angina after initial infarction at admission, 25 patients with myocardial 
infarction (AMI), and 109 patients with non-specific chest pain or chest pain from other 
causes. Follow-up data after discharge were available for 276 patients with definite 
unstable angina, for 25 patients with myocardial infarction and 106 patients with chest 
pain of other causes. Four patients were lost to follow-up. 
Patients with definite unstable angina 
Mortality and morbidity 
Monality and non-fatal infarctions during hospitalisation and follow-up after discharge 
are summarised in table 3.1, separated for the in-hospital period, 'early' (28 days) and 
'late' (28 days to 6 months) after discharge. One in-hospital event occurred after 31 
days. Early death occurred in 6 patients (2.1 %) and late death in 6 patients (2.2%). Total 
six months monality was 4.3%. 
Myocardial infarction occurred predominantly dming the f"rrst months after 
admission. A total of 21 patients (7.6%) developed non-fatal myocardial infarction 
Table 3.1. Number of events in hospital, at 28 days and 6 months in patients with a final 
diagnosis of unstable angina (n~282). 
in-hospital 28 days 6 months total (%) 
events 
monality s· 2 5 12 (4.3) 
non-fatal infarction 14 7 6' 27 (9.6) 
TOTAL patients with events1 19 8 9 36 (12.7) 
* 1 death occurred after 31 days. t 1 infarction occurred after 53 days during elective PTCA 
for which the decision had been made in-hospital. 
1 Three patients sustained non-fatal infarction and died later during follow-up. 
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Table 3.2. Determinants of monality and/or myocardial infarction within six months in 
patients with a fmal diagnosis of unstable angina (n=282). 
'event' crude adjusted 
N (%) RR (95% CI) RR (95% CI) 
mortality 
age 90yrs 199 (2.0) 
>70 yrs 83 (9.6) 5.2 (1.4-21.2) 7.1 (2.0-12.2) 
gender female 101 (3.0) 
male 181 (5.0) I. 7 (0.4-14.5) 5.1 (1.2-22.9) 
hypertension no 180 (3.0) 
yes 102 (6.9) 2.6 (0.7-9.7) 6.2 (1.7-22.5) 
history of MI no 201 (3.0) 
yes 216 (6.0) 2.1 (0.7-6.3) 
B-blocker use yes! 134 (1.5) 
no 148 (6.8) 4.8 (1.0-24.2) 7.5 (1.5-38.6) 
QRS-complex normal 151 (2.7) 
abnormal 131 (6.1) 2.4 (0.6-9.7) 
LlECG during pain no 103 (1.0) 
yes 179 (6.2) 6.7 (0.9-54.9) 6.2 (0.8-48.3) 
rum-fatal infarction 
ca-antagonist use no 304 (6.3) 
yes 113 (11.5) 1.9 (0.9-4.3) 
pain in-hospital no 145 (5.5) 
yes 137 (13.9) 2.8 (1.1-7.2) 2.6 (12-6.02) 
LillCG during pain no 103 (6.8) 
yes 179 (11.2) 1.7 (0.7-4.7) 
death or infarction 
age 90yrs 199 (10.0) 
>70 yrs 83 (19.3) 2.1 (1.0-4.6) 2.0 (1.0-3.78) 
history of MI no 133 (9.8) 
yes 149 (15.4) 1.7 (0.8-3.7) 
ca-antagonist use no 191 (11.0) 
yes 91 (16.5) 1.6 (0.7-3.5) 
pain in-hospital no 145 (10.0) 
yes 137 (16.1) 1.8 (0.8-3.9) 
LillCG dnring pain no 103 (7.8) 
yes 179 (15.8) 2.2 (0.9-5.5) 2.1 (1.0-4.56) 
crude rate ratios (crude RR) were estimated by univariate analysis; adjusted rate ratios were 
calculated with multivariate Cox analysis; 95% CI = 95% confidence interval. test-based. 
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Figure 3.1. Kaplan-Meier survival curves in patients with unstable angina for both 
hospitals. Six months survival was 96% and survival without infarction was 87% 
within 28 days after admission and 6 patients (2.2%) between 28 days and six months. 
Total infarction rate was 9.6% for patients with unstable angina. Tbree patients died 
several weeks after non-fatal infarction. Thus the infarct free survival of patients with 
unstable angina was 87% after six months. 
Despite the different management strategies, as described in chapter 2, patients 
treated for unstable angina in the two participating hospitals had a similar prognosis. 
The Kaplan Meier curves for survival and for infarct free survival are depicted for both 
hospitals in figure 3.1. The six month survival was 96.3% and 95.4% for the TXC and 
the SFG respectively, infarct free survival at six months was 86.9% and 87.4%. 
Univariate analysis revealed age over 70 years, abnormal QRS-complex on the 
baseline ECG, and the absence of £-blocker use before admission as significant risk 
factors for death, while male gender, hypenension, a history of infarction and ECG 
changes during pain indicated increased risk with confidence intervals overlapping 1 
(table 3.2). Patients who died were on average 11 years older than the survivors, 
respectively 72±6 and 61±11 years (means±SD, p=0.0001). Only one patients died 
younger than 65 years, 3 patients were between 65 and 70 years old, and 8 patients 
were older. A history of myocardial infarction as such was not associated with monality. 
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However, all but two patients who died had documented vascular disease before 
admission, either cardiac (previous myocardial infarction), peripheral (CV A, claudication 
or kidney disease) or both. In particular 4 of the 5 in-hospital deaths occurred after 
myocardial infarction at admission or shortiy before admission (post infarct angina), and 
one death after discharge was associated with post infarct angina. 
Three in-hospital deaths were related to a PTCA procedure (see chapter 2). None 
of the patients who died after discharge was treated invasively during or before 
admission. One patient underwent PTCA after discharge because of recurrent angina and 
died while waiting for subsequent CABG. The relation between clinical characteristics 
and the occurrence of myocardial infarction was weak, and only in-hospital recurrent 
paio and ECG changes during pain were significantly associated with subsequent 
infarction (table 3.2). Mean age of patients who developed myocardial infarction and 
those who did not were respectively 65±10 and 61±12 years (p=0.09). More than half 
of the patients who developed myocardial infarction were younger than 65 years and 
27% older than 70 years. 
Stepwise multivariate Cox analysis identified elderly age, male gender, 
hypenension, absence of the use of B-blockers, and ECG changes during paio as 
independent predictors for monality, with wide confidence intervals because of the small 
number of deaths (table 3.2). Recurrent pain and ECG changes predicted non-fatal 
infarction. Survival without infarction was impaired for elderly patients, with a history 
of infarction, and in the presence of ECG changes during paio. 
Interventions 
A total of 169 patients underwent coronary angiography during the first six months after 
admission (table 3.3). Several procedures were performed after discharge while the 
decision had been made in-hospital (see chapter 2). The total number of angiography 
procedures within 28 days was 135 (48%) and 34 (12%) during the late phase, followed 
by revascularisation in 44% of the patients. Fifty of the 63 angioplasty procedures could 
be performed within 28 days, whereas nearly half of the bypass operations were 
performed after more than one month. 
Thiny-two patients (12%) who were initially discharged without (a decision for) 
angiography underwent as yet coronary angiography because of recurrent symptoms 
after discharge, followed by revascularisation in 24 patients (9% ). 
Patients who had undergone a revascularisation procedure in hospital, or for 
whom this was decided during hospital stay, had a better prognosis after discharge than 
patients without revascularisation, since none of these patients died and fewer infarctions 
occurred during follow-up. However, the rate of revascularisation procedures during 
follow-up was similar for those with and those without in-hospital initiation of 
revascularisation (table 3.4). 
68 CHAPTER 3 
Table 3.3. Number of interventions in hospital, at 28 days and 6 months in patients with 
a final diagnosis of unstable angina (n=282). 
in-hospital 28 days 6 months total (%) 
Interventions 
Coronary angiography 121 1410 34' 169 (60) 
PTCA 45 5' 13' 63 (22) 
CABG 33 3' 2513 61 (22) 
The numbers in superscript indicate the number of procedures that were performed after 
discharge, while the decision was made in-hospital 
Table 3.4. Prognosis of hospital survivors with UAP related to in-hospital 
revascularisation. 
total 
mortality 
non-fatal MI 
death or MI 
revascularisation 
* p=0.04 
revascularisation 
97 
0 
2 
2 
11 
* 
no revascularisation 
179 
7 
10 
14 
24 
total 
276 
7 
12 
!6 
35 
During the six month follow-up period 124 patients underwent a revascularisation 
procedure (table 3.3). Twenty-two of these patients died or developed myocardial 
infarction within these six months. After six months a total of 144 patients (51%) was 
alive without myocardial infarction and without coronary interventions. 
Patients with myocardial infarction and chest pain of other causes 
The number of patients with acute infarction was small. Four patients (15%) developed 
reinfarction and/or died within six months (table 3.5). One in hospital death occurred 
after reinfarction. Coronary angiography and revascularisation were performed in 19% 
and 15% of these patients, respectively. 
A total of five patients (5%) with 'other' diagnosis at discharge died during 
follow-up (table 3.5) including two with a final diagnosis of heart failure and thtee with 
symptoms of non-specific cause. The group of patients with chest pain of other causes 
included 46 patients with known coronary heart disease such as previous myocardial 
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Table 3.5. Number of events and interventions related to hospital stay, at 28 days and 6 
months in patients with myocardial infarction and patients with chest pain of 
other causes. 
AMI (n~26) 
monality 
non-fatal re-Mf 
Coronary angiography 
PTCA 
CABG 
Other (n~I09) 
mortality' 
non-fatal Ml' 
Coronary angiography 
PTCA 
CABG 
in-hospital 
1 
2 
2 
1 
28 days 
1 
2' 
1 
1 
2 
1 
1 
6 months 
1 
I 
1 
1' 
4 
4 
2 
total 
2 (8) 
3 (12) 
5 (19) 
3 (12) 
1 (4) 
5 (5) 
2 (2) 
5 (5) 
1 (1) 
2 (2) 
AMI~ acute myocardial infarction; ·One patient sustained non-fatal infarction and died later 
during follow-up; ' One late death and both infarctions occurred in patients without a history 
of coronary artery disease before admission; The numbers in superscript indicate the number 
of procedures that were performed after discharge, while the decision was made in-hospital. 
infarction or revascularisation, and 63 patients without a history of coronary disease. 
Four patients with previous infarctions died during follow-up. Furthermore, one of 63 
patients without known coronary artery disease died of unknown cause 6 months after 
discharge, and 2 other patients developed myocardial infarction 8 and 18 days after 
discharge respectively. Neither of them had a cardiac history or showed ECG changes 
during hospital stay, although both patients had several risk factors for coronary disease. 
In spite of a final diagnosis of 'chest pain of other causes' five patients 
underwent angiography during follow-up, two of them after a myocardial infarction and 
another three because of recurrent angina. Three of these procedures were followed by 
coronary revascularisation. 
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DISCUSSION 
The in-hospital course of patients admitted to hospital for suspected unstable angina was 
favourable, with a mortality rate of 1.4% and infarction rate of 3.8% (chapter 2). This 
was similar for both hospitals despite differences in patient population and management 
strategy. After six months survival and infarct free survival were still identical. Total 
mortality and infarction rate after six months were respectively 6.0%, and 7.7%. In 
contrast to most other studies, the present study included all patients admitted for 
suspected unstable angina. As a consequence patients with a discharge diagnosis of 
myocardial infarction, non-specific chest pain or other diseases were included in this 
registry. For those patients in whom the diagnosis unstable angina was maintained after 
observation in hospital, six month mortality and infarction rates were 4.3% and 9.6% 
respectively. 
The low mortality rate in the present registry compares favourably with other 
reports1.2.4-6.!0.22-:U_ This is particularly noteworthy since 25% of patients were older than 
70 years, while in many studies patients older than 70 or 75 years as well as patients 
with recent infarction were excluded1.2.4·5·10.12.l3•19.22.23.25. Advanced age was identified as 
an independent predictor of death or infarction. Other risk factors by multivariate 
analysis were hypertension and ECG changes23.26.27, while other authors also mentioned 
persistent pain, or previous MI123.26·28• In this study a history of myocardial infarction 
alluded to an increased risk in the univariate analysis, but this association was not 
apparent after adjustment for other factors by multivariate analysis. As in other 
studies22629, patients with multiple episodes of recurrent pain and ECG changes in 
hospital were at increased risk for development of myocardial infarction. These 
infarctions occurred predominantly in the first 28 days, which is consistent with the 
observations reponed in earlier studies6•10~6_,._ The prognostic factors were calculated for 
patients with a f'mal diagnosis of unstable angina. The same models were also calculated 
for all patients, which resulted in similar prognostic factors. In addition a separate 
analysis was performed to establish which factors could differentiate between death and 
mocardial infarction in the 36 patients died or experienced myocardial infarction. 
Advanced age, male gender and the absence of B-blocker use remained in the model as 
independent determinants for death in these patients. 
The relatively good prognosis in the current registry may be related to intensive 
medical therapy and high intervention rates. After hospital admission 78% of all patients 
received either oral or intravenous nitrates, 58% received B-blockers, 33% calcium-
antagonists and 78% of the patients was initially treated with either aspirin or heparin. 
For comparison, Mulcahy reponed in hospital mortality rates of 3.2% within one month 
and 10.1% after 1 year". Similarly, Theroux reported an infarction rate of 11.9% in 
patients treated with placebo whereas this was only 1.9% for patients treated with 
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aspirin, heparin, or both10• Patients receiving B-blockers before athnission had a lower 
monaliry risk (table 3.2) which was in agreement with the need of B-blockers for 
treatment of unstable angina' and secondaty prevention as established in other 
studies30~1 • 
In addition to medical therapy 35% of the patients with a final diagnosis of UAP 
underwent a revascularisation procedure, mostly during the hospital period. Similar rates 
of additional revascularisation procedures after extensive medical treatment were 
reported by Cairns and Theroux13•10, while others reported lower numbers of 4% and 
18% within the first 3-8 months19"". 
Patients who underwent or were scheduled for PTCA or CABG in-hospital had 
a relatively bener prognosis than those without revascularisation. However, this does not 
imply that revascularisation should be performed in all, or most, patients. It should be 
noted that despite the favourable course after discharge, the revascularisation procedures 
themselves were not free of risk, nor was this therapy fully satisfactorily in a number 
of patients. Three in-hospitals deaths and seven infarctions were related to interventions 
(chapter 2). Eleven patients (I!%) underwent a new PTCA or CABG after initial 
revascularisation in hospital. 
The group of patients not revascularised included elderly people and patients who 
were not suitable for PTCA or CABG because of anatomical reasons, either known 
before admission or found during in-hospital angiography, or because of concomitant 
diseases (44%). On the other hand this group also comprised patients whose symptoms 
were not severe enough to warrant revascularisation therapy (56%). In fact this group 
represents the patients at high risk for complications in combination with the patients 
with the mildest symptoms. Seven of the 14 patients who died or sustained myocardial 
infarction belonged to the high risk group in whom revascularisation was judged to be 
not suitable. 
The current management of unstable angina results in a favourable prognosis. Six 
months after admission for unstable angina 87 percent of the patients survived without 
myocardial infarction, while 50 percent had an uncomplicated course with medical 
therapy alone. Patients discharged with a diagnosis of chest pain of other causes had a 
good prognosis, although still 5 percent had died and two percent had developed 
myocardial infarction after six months. This was partly due to the presence of earlier 
cardiac disease, but myocardial infarction occurred in patients without any history of 
coronaty disease. 
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ABSTRACT 
Medical services are being used in different rates between countries and regions. The 
use of coronary angiography in patients with unstable angina differs with a factor 2 
to 4. We examined the management strategies in two hospitals that differed with 
respect to angiography facilities and served a different patient population. Patients in 
the hospital with angiography facilities where younger and had a more severe history 
of coronary anery disease. Data of a prospective registry of 314 patients admitted to 
the two hospitals were analyzed in order to explain an observed difference in 
angiography rate between both hospitals. Angiography was performed more often in 
the hospital with angiography facilities (crude odds ratio: 2.3 with 95% confidence 
interval of 1.4-3.7). Multivariate analysis identified the following clinical variables as 
independent predictors for angiography: age under 70 years, hypercholesterolemia, 
progression of angina, multiple pain episodes, B-blocker or calcium-antagonist use 
before admission, ST-T deviations on the baseline ECG and ECG changes during 
pain present at admission. When corrected for the patient characteristics the odds 
ratio for hospital was lowered to 1.8 but still significant. Examination of interaction 
terms of clinical characteristics and hospitals revealed no indication of different 
interpretation of these variables between physicians in each hospital. 
Thus, the difference in angiography rate for unstable angina could be explained 
in pan by a difference of patient population and of hospital resources, but not by a 
difference of the physicians' assessment of patient characteristics. 
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!N1RODUCTION 
Delivery of heath care services varies considerably among countries and regions'·2• 
For example, rates for coronary angiography differed two to fourfold between areas 
in recent studies from the USA and The Netherlands'·•. Variation between practices 
can be explained by a difference in patient populations'·', by the lack of consensus 
on indications for particular services because of insufficient knowledge about 
treannent outcomes6•7, and by the (limited) availability of resources4•8• However, the 
relative contribution of these factors is often unclear. 
Considerable differences were observed in treannent of patients with unstable 
angina between two hospitals in the same city (chapter 2). Treannent of unstable 
angina is directed to the relief of symptoms and to prevention of recurrent ischemic 
episodes or progression to infarction or death. Initially, hospitalization and medical 
treatment is recommended for these patients'. In 80-90% of patients, the unstable 
situation can be stabilized by combination therapy with various drugs"'12• In case of 
failure of medical therapy physicians agree about the need for (urgent) angiography 
followed by angioplasty or bypass surgery, if feasible13.14• Also coronary angiography 
is often recommended for patients who stabilize on medical therapy, either to 
confirm the diagnosis or to assess whether the patient may benefit from angioplasty 
or bypass surgery10• 1~15• 
ln order to examine the differences in management strategy in patients with 
unstable angina data were analyzed from two hospitals, one with and one without 
facilities for angiography and coronary interventions. Special attention was paid to 
the decision to initiate coronary angiography, because this is the key decision in 
view of subsequent angioplasty or bypass surgery. The analysis was directed to 
answer the questions: 1) which clinical variables do doctors respond to when they 
make a decision about angiography and interventions; 2) do doctors at the two 
hospitals respond differently to clinical variables; and 3) how much practice variation 
is explained by the difference in the patients' characteristics at the two hospitals, by 
differences in how doctors respond to those characteristics, or by other factors, such 
as the availability of angiography facilities. 
PATIENTS AND METHODS 
Study site 
Two hospitals participated in a prospective registry of patients with unstable angina: 
the Thoraxcenter (TXC) of the University Hospital Rotterdam and the Sint 
Franciscus Gasthuis (SFG) in Rotterdam. The TXC is a teaching hospital with in-
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house facilities for coronary angiography, angioplasty, and cardiac surgety. The SFG 
is a large community hospital without in-house angiography laboratory. Patients are 
transported for diagnostic angiography procedures, either to the TXC or to another 
hospital in Rotterdam. In both the TXC and the SFG usually several physicians 
(staff, residents) are involved in the decision making process. 
Patient selection and definitions 
Consecutive patients admitted for chest pain, suspected of unstable angina, without 
electrocardiographic signs of acute infarction and without signs of other causes of 
chest pain were included in the registry. The admission diagnosis suspected W'LStable 
angina was made by the physician on duty. The presenting symptoms were classified 
as pain of recent onset (within the last four weeks), pain progressive in frequency or 
duration, and pain at rest Type of onset of the present episode was described as 
'sudden' (without previous acceleration) or 'progressive' (gradually accelerating of 
pre-existing angina). ST-T changes or other ECG abnormalities were not requited for 
inclusion. A final diagnosis was made after evaluation of in hospital symptoms, 
electrocardiograms, and cardiac enzyme assays. Three categories of the final 
diagnosis were distinguished: myocardial infarction (AMI), unstable angina (UAP), 
and other causes of chest pain. 
Myocardial infarction was defined by serum creatine kinase levels above twice 
the upper limit, in addition to typical chest pain, and/or compatible ECG changes. 
Other causes included non-cardiac illnesses or chest pain of other cardiac- or 
uncertain etiology. 
Patients with a definite diagnosis of unstable angina referred from other 
hospitals for further treatment in the TXC were not included in the registry. For the 
comparison of strategies between the two hospitals, patients older than 80 years were 
excluded, as well as patients with an infarction within the last four weeks or with 
angioplasty or bypass surgery within the previous six months. 
Analysis of the data 
Univariate analysis 
Univariate analysis of the baseline characteristics, the in-hospital course and the 
applied mode of treatment was used to compare patients and management strategy in 
both hospitals. Differences were tested by Student's t-test for continuous variables 
and by chi-square test for discrete variables. 
Multivariate analysis 
In order to correct statistically for the variable case-mix, multivariate models were 
built to describe the relation between clinical variables and the decision to initiate 
coronary angiography or to discharge and continue medical treatment. The selection 
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of clinical variables was based on the results of the univariate analysis. Differences 
in policy, or physicians' assessment of clinical characteristics, between hospitals 
were then analyzed using interaction terms. Hospital was also used in the model as a 
main effect, to test the hypothesis of a different threshold for angiography in each 
hospital. To study the impact of clinical course during admission, such as recurrent 
pain episodes in hospital and the timing of these pain episodes as well as of the 
eventual decision, the same data were used to test this hypothesis with a proportional 
hazards model for competing risks. 
LOGISTIC REGRESSION 
A logistic regression model was built using patient characteristics available at 
admission. The following variables were used: age under 70 years, 
hypercholesterolemia (cholesterol more than 6.5 mMoi/L), diabetes mellitus, 
smoking, gradual progression of angina (vs sudden onset or sudden increase of 
previously stable symptoms), multiple pain episodes during 24 hours before 
admission, use of Jl-blockers or calcium antagonists prior to admission, QRS 
abnormalities -and normal ST segment- on the baseline ECG (pathologic Q-waves, 
signs of left ventricular hypertrophy or of intraventricular conduction disturbances), 
ST-T deviation -and normal QRS complex- on the baseline ECG, both QRS- and 
ST-T abnormalities, and the absence of ST-T changes while pain still present at 
admission (as opposed to the presence of ST-T changes during pain or the absence 
of pain or a pain ECG). All variables were coded as indicator variables, which 
assume the value 1 if the property at issue is present and 0 if otherwise. The hospital 
variable was coded 1 for the TXC and 0 for the SFG. 
After such a model was built, we tested the hypothesis of different judgment 
strategies by testing all interaction terms of hospital and the respective clinical 
characteristics for significance, using the generalized likelihood ratio test statistic. lf, 
for example, the presence of multiple pain episodes in the 24 hours interval prior to 
admission had been selected in the first stage, we tested whether the coefficient for 
this term had significantly different values in one hospital compared to the other. 
Interaction terms were tested in a stepwise inclusion strategy, selecting the one with 
the largest contribution to the likelihood !rrst. After this stepwise procedure, we 
tested whether the addition of the hospital as a single term in the regression equation 
led to a significant improvement of the likelihood. If any of the interaction terms 
was included in the regression equation, we would conclude that judgment of the 
importance of patient characteristics differed between the two hospitals. If the 
hospital was included in the model as a main term, it would be interpreted as a 
lower threshold for ordering angiography and interventions in one of the hospitals. 
PROPORTIONAL HAZARDS MODEL 
The same three questions concerning the origin of the difference in angiography rates 
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between hospitals were also studied using proportional hazards regression. In this 
case the data were studied as if they were competing risks data". This means that the 
hazard, or the inclination of the physician at any moment in time, that a decision will 
be taken in a particular patient in a particular hospital h hours after admission is 
modelled as a sum of two hazards, each one related to the outcome of the decision: 
hazard (decision; h, patient, hospital) = 
hazard (angiography; h, patient, hospital)+ hazard (discharge; h, patient, hospital) 
We assume that at each point in time, h hours after admission, a choice may be 
made between two decisions: either to initiate angiography in order to prepare an 
intervention (the first component) or to discharge the patient on medication, without 
ordering angiography (the second component). The "hazard" in this case can be 
interpreted as the cardiologists' inclination to make either decision. The higher the 
overall hazard at h hours, the more likely it is that a decision will be taken at that 
time. The relative balance between the hazard for angiography and the hazard for 
discharge denotes the more likely direction of the decision, if any. If for a patient 
with a specified profile the hazard for discharge is relatively high compared to that 
for angiography, the cardiologists in that particular hospital seem more inclined 
towards discharging on medication without coronary intervention. 
Using proportional hazards modelling, regression equations were defined to 
model each of the two components of the hazard: 
Am,;Jh,x1 . .x.,hosp) = 'Ao~(h) * exp(B.1x1 + B,x2 + ... + Bmx, + Y.hosp) 
l.""""(h,x1 • .x •• hosp) = 'Ao.ih) * exp(Bd1x1 + Bd2x2 + ... + Bdnx, + ydhosp), 
where 'A,(h) indicates the baseline hazard for each of the decisions at time h. The 
expression 'B1x1 + B2x2 + ... + Bnx. + yhosp' indicates the risk function for a patient 
with a specified set of characteristics in one of the hospitals. The coefficients 
(B1 • .ll0,y), indicating the weight of the terms in the risk function, depend on the type 
of the decision and may be different for each hospital. A positive coefficient B.u 
indicates that for a patient with characteristic x, present it is more likely that the 
decision for angiography will be made compared to patients with x, absent. A 
negative coefficient means the opposite. Similarly a positive coefficient Bdi indicates 
that for a patient with characteristic x, present it is more likely that the decision for 
discharge will be made compared to patients with x, absent, and a negative 
coefficient means the opposite. 
This proportional two-component hazards approach has two advantages: it allows us 
to correct statistically for unmatched in-hospital histories (recurrent pain episodes and 
ECG changes during pain), in addition to the differences in patient characteristics at 
admission. Furthermore, it allows us to study the relation between the inclination to 
order angiography and the availability of relevant facilities over time, after 
admission. 
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Recurrent pain was introduced as a time-dependent variable (see appendix). 
This means that once pain recurs, one, or both components of the hazard rate are 
multiplied by the relative risk factor. Since this effect on the hazard probably does 
not remain constant over time, it is hypothesised that after some time the hazard will 
return to its initial value. Several models were compared to explore the time elapsed 
until this 'normalisation' has taken place. Using the likelihood as a criterion, the 
approach was selected which best fitted the data. 
The same three-stage strategy discussed for logistic regression was used. In the 
first stage a model was built to correct statistically for the difference in case-mix. 
This resulted in two sets of variables with corresponding coefficients: one set of 
variables for the hazard for angiography, another for the hazard for discharge. If a 
variable contributes to the inclination to make a decision, its contribution to the 
hazard for angiography is not necessarily related to its contribution to the hazard for 
discharge and vice versa. It may very well be that a patient characteristic increases 
the inclination to order angiography, without affecting the inclination to discharge 
without angiography. In a second stage, all interactions of the selected variables with 
the hospital variable were tested in a stepwise strategy. In the thitd stage, the 
threshold hypothesis was tested by adding the hospital term to the model. 
Comparison of the proportional hazard models with the actual angiography rate 
After derivation of the models the risk functions were calculated for each 
individual patient, resulting in two scores, one for angiography and one for 
discharge. Both set of scores were ranked from the lowest to the highest score. For 
each score, patients were assigned to four groups, according to the quartiles, leading 
to a total of 16 possible groups. For each group the percentage of angiography 
procedures actually performed was calculated. 
RESULTS 
During the study period a total of 417 patients were admitted for suspected unstable 
angina in the two hospitals. Seventy six patients were excluded from this analysis, 23 
patients because of advanced age, 33 with post infarction angina, and 20 patients 
because of recent revascularization procedures. Thus 341 patients were available for 
the present analysis, 118 patients in the Tboraxcenter (TXC) and 223 patients in the 
Sint Franciscus Gasthuis (SFG). 
Baseline characteristics 
Patient characteristics at admission are listed for each hospital in table 4.1. Patients 
in the TXC were on average 2.3 years younger than in the SFG, had a more severe 
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Table 4.1 Baseline characteristics 
Total TXC SFG 
n=431 n=ll8 n=223 
n (%) n (%) n (%) 
age ;, 70 years 93 (27) 20 (17) 73 (33) 
-I 
male 126 (66) 77 (66) 149 (67) 
previous history of 
unstable angina 76 (22) 40 (34) 36 (16) t 
myocardial infarction 140 (41) 57 (49) 83 (37) * 
angiography 96 (28) 53 (45) 43 (19) t 
angioplasty 31 (9) 23 (20) 8 (4) t 
bypass surgery 53 (16) 29 (25) 24 (11) t 
hypertension1 123 (36) 54 (46) 69 (31) t 
diabetes mellitus 40 (12) 16 (14) 24 (11) 
hypercholesterolemia2 51 (15) 31 (27) 20 (9) t 
smoking' 120 (35) 40 (34) 80 (36) 
positive family history4 124 (36) 51 (44) 73 (33) * 
medication before admission 
long acting nitrates 83 (24) 37 (32) 46 (21) * 
Jl-blocker.; 128 (30) 52 (44) 76 (34) 
calcium antagonists 92 (27) 46 (39) 46 (21) t 
platelet inhibitors 55 (16) 15 (13) 40 (18) 
pain before presentation5 
none 108 (31) 36 (31) 72 (32) 
s 4 weeks, progressive 91 (26) 22 (18) 69 (31) 
> 4 weeks, stable 63 (18) 29 (25) 34 (15) 
> 4 weeks, progressive 79 (23) 31 (27) 48 (22) * 
baseline ECG 
QRS 
Q-wave 92 (27) 41 (35) 51 (23) 
IV -conduction disrurbance6 31 (9) 14 (12) l7 (8) 
left ventricular hypertrophy 18 (5) 8 (7) 10 (4) 
none of above 200 (59) 55 (46) 145 (65) * 
SIT-abnormalities 175 (51) 66 (56) 109 (49) 
ECG during pain 
ECG recording during pain present 180 (53) 52 (45) 127 (57) 
ST-T changes 108 (32) 33 (28) 75 (34) 
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Table 4.2 In-hospital course 
Clinical course 
recurrent pain 
multiple pain episodes 
ECG changes during pain 
Interventions 
medication 
oral nitrates 
intravenous nitrates 
B-blockers 
ca-amagonists 
platelet inhibitors 
heparin 
exercise test 
angiography 
PTCA 
CABG 
Final diagnosis' 
AMI 
UAP 
Other 
(tahles 4.1 and 4.2) 
Total 
n=34! 
n (%) 
154 (45) 
85 (25) 
104 (30) 
65 (19) 
198 (58) 
194 (57) 
106 (31) 
117 (34) 
232 (68) 
175 (51) 
105 (31) 
37 (11) 
39 (11) 
34 (10) 
211 (62) 
96 (28) 
TXC SFG 
n=118 n=223 
n (%) n (%) 
52 (44) 102 (46) 
27 (23) 58 (26) 
32 (27) 72 (32) 
49 (42) 16 (7) t 
45 (38) 153 (69) t 
68 (58) 126 (57) 
47 (40) 59 (26) * 
10 (8) 107 (48) t 
73 (62) !59 (71) 
49 (42) 126 (57) t 
50 (43) 55 (25) • 
20 (17) 17 (8) * 
17 (14) 22 (9) 
13 (II) 21 (9) 
78 (66) 133 (60) 
27 (23) 69 (31) 
* p<0.05 t p<O.OI; TXC=Thoraxcenter; SFG=Sint Franciscus Gasthuis; ' blood 
pressure > 160/90 or current treatment. 2 serum cholesterol >6.5mmol/l or current 
treatment with cholesterol lowering drugs. 3 current smoking or smoking until less than a 
year ago. 4 infarct or cardiac death at age under 60 in first or second degree relative. 
5 none=no pain before present episode; < 4 weeks=pain for less than four weeks with 
progression; > 4 weeks. stable=chronic stable chest pain before admission without 
acceleration before present episode; > 4 weeks. progressive=chest pain present for more 
than four weeks with gradual acceleration. 6 IV =intraventricular. 
7 AMI = acute myocardial infarction; UAP = unstable angina pectoris; Other = non-
cardiac or non-specific chest pain. 
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history of coronary artery disease and a longer history of symptoms. However, there 
was no difference in signs of acute ischemia on the electrocardiogram at admission. 
A history of either unstable angina, myocardial infarction or revascularisation was 
present in 60% of the patients in the TXC and in 43% of the patients in the SFG 
(p=0.003). This is compatible with the difference in risk factors for coronary disease, 
and explains the difference in medication before admission between the hospitals. 
In-hospital course and management 
Despite the differences at admission the clinical course in-hospital was sintilar in 
both hospitals with respect to recurrent pain and ECG changes. Also the distribution 
of final diagnoses after observation was similar in both hospitals (table 4.2). 
Nevertheless, the management differed between hospitals, particularly with respect to 
medical therapy, the use of exercise testing, and the frequency of angiography and 
interventions. 
Nitrates were predominantly administered intravenously in the SFG, with 
supplementary Jl..blockers and both aspirin and heparin, while oral nitrates were 
prescribed more often by physicians in the TXC. The number of antianginal drugs 
(nitrates, £-blockers and calcium antagonists) was similar. 
Table 4.3 Management strategies in each hospital in relation to angiography. 
TXC SFG 
angio discharge angie discharge 
n (%) n (%) n (%) n (%) 
<2 antianginal drugs 8 (21) 31 (79) 15 (16) 78 (84) 
~ antianginal drugs 42 (53) 37 (47) 39 (30) 91 (71) 
additional medication 
none 27 (33) 56 (67) 23 (14) 137 (86) 
oral medication 13 (54) II (46) II (31) 24 (69) 
iv-medication 10 (91) 1 (9) 21 (75) 7 (25) 
no exercise test 39 (57) 30 (43) 43 (44) 54 (56) 
exercise test 11 (22) 38 (78) 12 (10) 114 (90) 
pain during test 6 (43) 8 (57) 8 (40) 12 (60) 
ECG changes 9 (39) 14 (61) 12 (24) 38 (76) 
TXC ~ Thoraxcenter; SFG ~ Sint Franciscus Gasthuis; angio ~ decision for angiography 
and interventions; discharge = decision for discharge without coronary interventions. 
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Figure 4.1. Managemen1 in each /wspital expressed as the decision 'angiograplry' (angio) 
or 'discharge without angiography' (discharge) in relation to the time since lwspital 
admission. The white area represents the proportion of patients for whom no decision has 
been made yet at each moment in time. The upper and lower grey areas represent the 
proponion of patients for wlwm the decision 'angiograplry' or 'no angiograplry' has been 
made. Decisions made after exercise testing (X-test) are indicated in the lighter areas. 
In patients who were stabilised with medical treannent an exercise test was 
performed to assess the level of exertion and to evaluate the effect of medication 
before discharge. Exercise testing was used less often in the TXC than in the SFG, 
but more tests were positive (pain or ECG changes during the test) in the TXC (table 
4.3). Mter the test more angiography procedures were ordered in the TXC than in 
the SFG, especially when ECG changes were present during the test. 
The angiography rate was higher in the TXC, especially for patients treated 
with multiple anti-anginal drugs and for patients who needed additional medication 
after recurrence of pain (table 4.3). Furthermore the decision for angiography was 
made earlier in the TXC. Figure 4.1 shows the proportion of patients for whom a 
decision to initaite angiography, 'angiography', or the decision to discharge on 
medical treatment, 'discharge', had heen made in the course of time. The median 
time until the decision for angiography was made was 1 day (range 0-8.5 days) in 
the TXC and 3 days (range 0-12 days) in the SFG. The time until the decision to 
discharge was similar in both hospitals, with respective median times of 3.0 and 3.5 
days in the TXC and the SFG. 
The angiography decision 
Detailed analysis of the difference in angiography rates between both hospitals was 
performed with two mnltivariate analyses. 
1. Logistic regression 
The contribution of clinical variables known at admission to the decision to initiate 
angiography was explored in a logistic regression model. The decision to perform 
angiography was made more often for patients with the following characteristics: age 
under 70 years, hypercholesterolemia, progression of angina, multiple pain episodes 
before admission, the use of antianginal medication before admission, ST-T 
deviations on the baseline ECG and ST-T changes during pain present at admission 
(table 4.4). No interaction terms of clinical variables and hospital were selected. 
Thus, overall there was no difference in judgement of the importaoce of clinical 
variables between physicians in one or the other hospital. The hospital as a main 
effect variable was included into the model, indicating a difference in threshold for 
ordering angiography. The crude odds ratio for angiography was 2.25 (95% CI 1.4-
3.7). Statistical correction for the difference in patient population changed this odds 
ratio to 1.8 (table 4.4). 
2. Proportional hazards model 
Results of the proportional hazards analysis of the association between patient 
characteristics and the physicians' inclination at any moment in time to perform 
angiography or to discharge without angiography, are given in table 4.5. Results are 
presented as hazard rate ratios, after exponential transformation of the coefficients 
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Table 4.4 Association between clinical characteristics and hospital with the decision 
for angiography. 
angio crude adjusted 
N (%) OR (95% Cl) OR (95% Cl) 
admission variables 
age 2: 70 yean; 93 (20) 
< 70 years 248 (35) 2.2 1.2-4.1 !.9 l.0-3.8 
hypercholesterolemia 
no 290 (26) 
yes 51 (57) 3.7 1.9-7.1 2.1 l.0-4.4 
progression of angina 
no 171 (19) 
yes 170 (43) 3.3 1.9-5.5 3.0 1.7-5.2 
> 3 pain episodes during last 24 hours 
no 298 (27) 
yes 43 (58) 3.7 1.8-7.2 2.7 1.2-5.8 
use of B-blockers or ca-antagonists before admission 
no 171 (19) 
yes 170 (42) 3.1 1.8-5.1 2.8 1.6-4.9 
abnormal STT on baseline ECG, normal QRS 
no 255 (26) 
yes 86 (45) 2.3 1.3-3.9 1.9 1.1-3.5 
ECG changes during pain or no ECG recording during pain 
no 72 (18) 
yes 269 (34) 2.3 1.2-4.7 2.5 1.1-5.0 
hospital 
SFG 223 (25) 
TXC 118 (43) 2.3 1.4-3.8 1.8 1.0-3.1 
Seven variables, known at admission, were retained in the model with independent 
association with angiography. After selection of the clinical variables the hospital term 
was added and served a significant determinant for angiography after adjustment for 
clinical characteristics. Crude odds ratios (OR) were estimated by univariate analysis; 
adjusted OR were calculated with multivariate logistic regression; 95% Cl = 95% 
confidence interval, test-based. 
(~ .. B,). Two sets of hazard rate ratios are reported, one for the angiography decision 
and one for the discharge decision. A hazard rate ratio greater than one indicates an 
increased inclination to make the respective decision, while a hazard rate ratio less 
than one indicates a decrease of inclination. For example, age under 70 years is 
associated with an increased inclination to decide for angiography. This means that, 
conditional on the other characteristics in the model, a decision for angiography will 
be made more often for younger patients, compared to elderly patients. 
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Thus the decision for angiography will be made more often in patients younger 
than 70 years, with a history of progression of angina before admission and multiple 
pain episodes in spire of use of B-blockers or calcium antagonists, with ST-T 
abnormalities on the baseline ECG, with one or more recurrent pain episodes in 
hospital, and with accompanying by ECG changes. On the other hand for patients 
with nausea at admission and abnormal QRS complex on the baseline ECG, both 
characteristics which are often associated with infarction or other disease, the 
decision for angiography is less likely. 
Table 4.5 Association between patient characteristics and hospital with the inclination 
over time to decide for angiography or to decide for discharge without 
angiography. 
admission variables 
age under 70 years 
hypercholesterolemia 
progression of angina 
use of B-blockers or ca-antagonists 
>3 pain episodes during last 24 hours 
nausea 
BASELINE ECG 
abnormal STI, normal QRS 
abnormal QRS, normal STI 
abnormal QRS & STI 
no ST -changes while pain present 
in-lwspital variables 
nr of pain within last 24 hours 
1 
2 
3 
ECG-changes during pain 
lwspital 
TXC vs SFG (first 36 hours) 
angio 
HRR 95%-CI 
2.1 
2.4 
2.2 
1.4 
0.5 
1.5 
0.7 
0.4 
2.6 
4.5 
17.2 
2.5 
7.4 
1.2-3.6 
1.6-3.8 
1.4-3.4 
0.8-2.2 
0.3-0.9 
0.9-2.5 
0.3-1.4 
0.2-0.7 
1.6-4.3 
2.2-9.1 
6.4-46.5 
1.6-3.8 
3.7-15.0 
discharge 
HRR 95%-Cl 
0.6 0.4-1.0 
0.7 0.5-0.9 
0.7 0.5-1.0 
0.6 0.4-1.0 
0.7 0.5-0.9 
1.5 1.1-2.0 
0.6 0.4-1.1 
0.4 0.3-0.6 
HRR (hazard rate ratio) : inclination over time for the respective decision, given the 
presence of the characteristic divided by the same inclination given the absence of the 
charachteristic; estimated by exponential transformation of the coefficient of the relevant 
characteristic in the proportional hazard models; 95% CI = 95% confidence interval, test-
based. 
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Cardiologists were more inclined to decide for discharge without angiography if 
ECG changes during paiu at admission were absent. Factors influencing the 
inclination for discharge decisions negatively were known hypercholesterolemia, 
B-blocker or calcium antagonist use, abnormal baseline ECG, and recurrent paiu or 
ECG changes in hospital. 
There was an increased inclination for angiography in the Thoraxcenter, even 
after correction for the patient characteristics mentioned above. The hospital site did 
not affect the inclination for discharge. The proportionality assumption of the 
proportional hazard model was checked for the hospital variable. As can be seen in 
figure 4.1 the rate of angiography was higher in the TXC, particularly during the 
first days. This was confinned by allowing the effect of the hospital site in the model 
to vaty over time. If no decision was reached in the first 36 hours the difference 
between the two hospitals disappeared. 
Comparison of the proportional hazard models with the actual angiography rates. 
In figure 4.2 the proportion of actually performed angiography procedures is depicted 
for patients within each quartile of angiography score and within each quartile of 
discharge score. It shows that in patients within the same quartile of angio score the 
decision for angiography was made more often with decreasing discharge score. 
Otherwise within the same quartile of discharge score, the decision to perform 
angiography was made less often when the discharge score increased. 
Angiography % 
:J.oo 
eo 
eo 
~ 
o/c;:> 
9-e 
9--7 
Figure 4.2. Percentage of angiograpgy performed in patients with low scores (QJ), 
intermediate low (Q2), intermediate high (Q3) and high (Q4) scores for angiography and 
discharge, respectively. 
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DISCUSSION 
The management strategy applied to patients with unstable angina was studied in two 
hospitals in Rotterdam, that differed with respect to the patient population served, the 
availability of resources, and teaching responsibilities. Both statistical models 
revealed a basic difference in management strategy between the two hospitals. This 
difference was most apparent with respect to the use of diagnostic procedures, while 
therapeutic measures were similar. In the hospital with in-house catheterisation 
facilities the proportion of exercise tests was lower and of angiography procedures 
higher. Medical therapy was similar in both hospitals, as were the proportions of 
revascularisation procedures after angiography. 
Several clinical characteristics could be identified as independent predictors for 
subsequent decisions by eitl1er modeL In fact the results obtained by both models 
were remarkably similar, which suppons the validity of the observations. People of 
younger age were referred to angiography earlier and more often17• Progression of 
angina and the presence of multiple pain episodes were interpreted as indications of 
severe angina18•19, and increased the hazard for angiography. In the same way the 
level of medication and the presence of ST deviations on the baseline ECG increased 
inclination for the decision to initiate angiography. The presence of nausea implies 
infarction or other non-cardiac disease"', and delayed the decision and lowered the 
hazard for angiography. QRS abnormalities on the baseline ECG delayed the 
decision without giving direction to either of the two decisions. This propeny 
indicates earlier infarction and complicates the decision making process. Finally 
when a normal ECG was present during pain at admission, the situation was judged 
as mild and these patients were sent home in an early phase. The presence of 
hypercholesterolemia increased the odds toward angiography in the logistic model, 
and reduced the inclination for discharge without angiography in the proportional 
hazards modeL It was tested whether this surprising fmding was a proxy of known 
coronary anery disease, but neither the presence of a previous infarction, nor earlier 
revascularisation procedures were associated with hypercholesterolemia. Possibly, 
symptoms are interpreted in a different manner, and more often as a sign of coronary 
disease in the presence of this risk factor'. 
None of the interaction terms was included into either model, suggesting that 
clinical variables were judged similarly by physicians in both hospitals. The hospital 
site was still an independent predictor for coronary angiography, even after 
adjustment for differences in clinical characteristics. 
Wennberg has suggested that variation in practice styles derives from lack of 
consensus and from diversity of accepted opinions on the need and value of 
alternative treatrnents22• Other studies do not confrrm this idea'·". Contrary to belief 
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that population differences are not related to variation of medical services'·' our data 
suggested the opposite. The relation between a number of patient characteristics and 
the decision for angiography persisted after adjustment for other patient 
characteristics and for hospital site. Thus, although we found a difference in 
threshold for angiography between the two hospitals, physicians did attend to clinical 
variables when making decisions. 
The exercise test was used more selectively in the presence of a catheterisation 
laboratory. An exercise test was ordered less often in the Thoraxcenter and was 
followed by angiography in a larger proportion of patients. This implies that the 
exercise test played a different role in each hospital. In the Thoraxcenter the test 
served as an intermediate argument to decide whether or not to proceed to 
angiography, whereas in the Sin Franciscus Gasthuis it was more often used as an 
evaluation of the status of a patient before discharge. 
Comparison with other studies 
Variability in use of diagnostic measures has been described with respect to different 
regions2, different specialities23 as well as different practice settings5·11 • Conti11 
compared data of 111 patients admitted for unstable angina in a University hospital 
and interviews with cardiologists in a community hospital, which revealed a higher 
angiography rate in the community hospital. Similarly, Hlatky et a!.' reported a 
higher rating of the need for coronacy angiography by community cardiologists when 
reviewing case summaries. These reports seem to contrast the findings of the present 
study. However, the before mentioned studies did not mention explicitly the 
availability of angiography facilities in the different practices, which was the major 
difference between the two hospitals in the present study. In fact, it is likely that the 
financial rewards of angiography in private practice in USA hospitals may have 
contributed to a tendency toward angiography and intervention in that setting. 
Limitations of this investigation 
Data were collected prospectively in order to achieve a complete database with equal 
information for all patients. However, no detailed information was collected on the 
type of pain, and no attempt was made to decide in an objective manner whether the 
symptoms were typical for angina or not. ln the present study the decisions of the 
physician on duty at the lime of admission and those of the hospital staff during 
admission were accepted at face value. It was appreciated that the history was 
sometimes interpreted differently at different times by the various physicians who 
were involved with the decision making process. Nevertheless, tltis approach was 
chosen because we were interested in the factors which contributed to the medical 
decisions, and less in the correctness of the decisions per se. 
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The multivariate analyses were confined to patient characteristics only. 
Although the level of medication and the results of an exercise test were important 
factors for the subsequent decisions, they were omitted from the models because of 
the nature of this information. In fact these factors are intermediate decisions made 
by the same physicians who eventually decide whether to order angiography or not, 
and are likely to be influenced by the same patients characteristics as the final 
decision to perform or not to perform angiography. Therefore, inclusion of these 
variables would dilute the weights of the patient characteristics in the analysis. 
The present analysis provides information on hospital-based utilisation rates. 
The presented rates represent the average rate of the physicians in each hospital, and 
do not supply information about individual clinical decisions. Neither were 
differences in weights of patient characteristics between physicians considered. 
Statistical analysis of these data did not reveal a difference in judgment of the 
importance of clinical characteristics. Furthermore, other factors than those in the 
models, may have played a role in the decision making process, and were not 
accounted for in the analysis. 
Quality of care 
A vital question is whether the difference in practice between hospitals implicates a 
difference in quality of care. The most important measure for quality of care is 
mortality and infarction rate, and no difference in this outcome was observed either 
with or without statistical correction for differences between the patient populations 
(chapter 3). Although the rates of angiography differed, the findings during 
angiography and the decisions for interventions after angiography were similarly 
distributed. Thus the more restricted use of angiography in the Sint Franciscus 
Gasthuis did not result in selection of a subset of patients with more advanced 
coronary disease. Less frequent use of angiography and coronary interventions will 
reduce the number of complications due to performing an invasive procedure, but 
may also identify fewer patients with severe coronary artery disease who may benefit 
form subsequent revascularisation. We therefore cannot determine whether the more 
aggressive or the more conservative approach represents the best quality of care for 
these patients. 
Conclusion 
The observed difference in angiography rate between two hospitals can be attributed 
to differences in patient populations and in availability of facilities for angiography 
and interventions, and not by different judgment of patient's characteristics. 
Angiography was performed more often in younger patients, with known 
hypercholesterolemia, who present with a progression of angina and mnltiple pain 
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episodes prior to admission and with ECG deviations, and are already treated with £-
blockers or calcium antagonists. After adjustment for patient characteristics the 
hospital site was still an important factor, associated with the decision for 
angiography. However, this effect was most prominent during the first 36 hours after 
admission. Thus the decision to perform angiography was made rapidly early after 
admission in the presence of angiography facilities. When the decision had not been 
made in the first 36 hours then physicians in the Thoraxcenter followed a similar 
policy as physicians in the Sint Franciscus Gasthuis. 
APPENDIX 
Definition of time dependent variables. 
The effect of recurrent pain in hospital on either hazard was modelled as one where 
the occurrence of pain acts directly on the hazard rate24• This variable was therefore 
included as a time-dependent variable and the covariate function for each decision 
becomes 
J..~,;,(h,x1 • .x~h<JSp) ='),(h) * exp(B1x1 + B2x2 + ... + B,x, + y,hosp)exp(9Y*g(t-T}) 
where g(t-T} is some function of T, the failure time of the pain to occur, with 
g{t-T}=O for t5r and Y=l if pain occurred and Y=O otherwise. Thus if g is such that 
g{O}=l the model assumes that the respective hazard rate is multiplied by exp(9) on 
the recurrence of pain. The functional forms of g can he considered as an immediate 
increased risk which remains thereafter or, alternatively, a temporary increase of the 
hazard which disappears after some time. 
Table 4.6 
T= 6 hrs 
T=12 hrs 
T=24 hrs 
T=36 hrs 
T=48hrs 
T=unlimited 
Values of Log-Likelihood (LogL), the hazard rate ratio (HRR) of recurrent 
pain in-hospital with 95% confidence interval (Cl) for each hypothesis 
adjusted for covariates age, clinical presentation. medication and ECG. 
angiography discharge 
LogL HRR (95% Cl) LogL HRR (95% Cl) L(LogL) 
-468.76 3.14 (1.9-5.2) -1065.95 0.33 (0.1-1.0) -1534.71 
-466.84 2.26 (1.4-3.7) -1064.60 0.35 (0.2-0.8) -1531.44 
-464.09 2.57 (1.6-4.1) -1065.43 0.62 (0.4-1.0) -1529.52 
-463.80 2.23 (1.4-3.7) -1066.21 0.67 (0.4-1.1) -1530.01 
-462.65 1.95 (1.2-3.3) -1068.07 0.87 (0.6-1.3) -1531.72 
-466.97 1.41 (0.8-2.5) -1068.18 0.94 (0.7-1.3) -1535.15 
T=x hrs: various time periods of the effect of recurrent pain upon the hazard funtions for 
the decision to perform angiography and for discharge without angiography, respectively. 
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To test the hypothesis that the effect of pain on the hazard rate was a temporary 
increase, the duration of this effect was explored in various models varying the lime 
period from 6, 12, 24, 36, 48 hours to continuous effect after the occurrence of pain. 
The results are described in the table. For both 'angiography' and 'discharge' the 
LogLikelihoods are reported for the models including all other variables mentioned 
in table 4.6 and the hazard rate ratio for the recurrence of pain in-hospitaL The sum 
of both values of the LogLikelihood represents a measure of fit of each modeL The 
higher the total LogLikelihood, the better the fit. This means that the best description 
could be made by considering the occurrence of pain within the previous 24 hours. 
In a similar way it was hypothesised that the effect of the hospital site upon the 
inclination at any moment in lime to decide for angiography was most prominent 
immediately after admission and declined after some lime. A series of models where 
compared where the hospital effect was allowed to differ before and after 12, 24, 36, 
48 and 60 hours. According to the likelihood criterion the hospital effect had 
disappeared after 36 hours. 
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ABSTRACT 
Definitions of unstable angina and management strategies vary in different repons. 
Twenty cardiologists were interviewed in order to explore areas of individual 
variability in definitions, in judgment of symptoms and signs during hospitalisation, 
and in treatment options for unstable angina. Definitions varied from the whole 
spectrum of angina between stable angina and myocardial infarction to the more 
restricted, severe conditions, as pain at rest accompanied by ECG changes. Judgment 
of the clinical course was predominantly based on the recurrence or absence of 
angina by some physicians, whereas others paid more attention to the presence of 
ECG changes. Different time periods, varying from a painfree period of 1-3 days to 
several weeks, were mentioned until the situation would be stabilised. Transient ECG 
changes in patients without pain (silent ischemia) were considered as a sign of 
instability and would be treated more aggressively by more than half of the 
physicians. The pattern of pain and the level of medication were important criteria 
for angiography for all physicians, as was a positive exercise test result. Exercise 
tests were performed more often by physicians in hospitals without angiography 
facilities. The presence of facilities for angiography would result in more procedures 
according to all physicians, while the attitude towards exercise testing seemed not to 
be influenced by the presence of a catheterisation laboratory. Differences in 
interpretation by individual physicians may be reduced in part by more detailed 
descriptions of patients with unstable angina. 
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INTRODUCTION 
Unstable angina pectoris consists of a number of conditions intermediate between 
chronic stable angina and acute myocardial infarction, characterized by severe 
transient myocardial ischemia1·' as summarised in chapter L The attitude of 
physicians towards patients presenting with chest pain of unstable character can be 
influenced by the various definitions of 'unstable angina' and by the many treatment 
options, including medical therapy with nitrates, Jl-blockers, calcium antagonists, 
heparin and aspirin, and coronary interventions, which are performed in part of the 
patients. It is therefore not surprising that treatment regimens vary between different 
countries and regions4•5• An earlier analysis of the management of unstable angina in 
two hospitals in Rotterdam (chapter 4) indicated that availability of angiography 
facilities was associated with more frequent use of coronary angiography and 
subsequent revascularisation procedures. 
In order to explore areas of variability among individual physicians, 20 
cardiologists were asked to give their opinion on the importance of various aspects 
of unstable angina, pertaining to diagnosis and treatment of this syndrome. The 
differences in response to this open interview, in combination with the structured 
policy analysis (chapter 6) may help to explain differences in management strategies 
between hospitals with and without angiography facilities. 
METHODS 
Twenty physicians were asked a structured series of open-ended questions 
concerning several aspects of unstable angina (see appendix). Physicians were 
selected for patticipation because they worked in one of the two hospitals where the 
prospective study, described in chapter 4, was performed or because of close 
relationship with these hospitals. Eleven of the cardiologists worked in a university 
hospital with angiography facilities and the other nine worked in four hospitals 
without such facilities. Most of the cardiologists had received their cardiology 
training in the same centre and were working in closely related practices in the city 
of Rotterdam. The interview was divided in five subsections, dealing with 1. the 
definition of unstable angina and criteria for admission of patients with suspected 
unstable angina, 2. initial management after admission, 3. the importance of 
electrocardiographic signs, 4. indications for angiography, and 5. the role of exercise 
tests in these patients. The answers in the interviews were categorised and described 
according to these subdivisions and analyzed for fields of differences between 
individual cardiologists as well as for differences between hospital settings. 
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Table 5.1 Opinions of 20 physicians with respect to definition and management of 
unstable angina. 
Definition 
recent onset, progressive- and rest angina 
angina at rest only 
ECG changes required 
ECG changes NOT necessary 
Admission 
ECG changes 
level of medication 
cardiac history 
risk factors 
Stabilisation 
painfree during 1-3 days 
painfree during 4-5 days 
painfree during more than 5 days 
Silent ischemia 
regarded unstable 
reason for angiography 
Multiple pain episodes; all with 
concomitant ECG changes or only once 
no difference for management 
difference: more aggressive therapy 
Indication for elective angiography 
pattern of pain. reduced exercise tolerance 
level of medication 
ECG changes 
history of coronary disease 
Purpose of elective angiography 
coronary interventions 
diagnostic purpose and risk estimation 
I ndicarion for exercise test 
diagnostic purpose 
treatment evaluation, risk estimation 
CLINICAL COURSE 
pain without ECG changes 
pain + ECG changes 
no pain + ECG changes 
104 
14 
6 
7 
2 
4 
9 
13 
10 * 
12 
4 
2 
13 
8 
11 
9 
20 
15 
12 
5 
20 
6 
8 
16 
19 
9* 
!!* 
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RESULTS 
Definition of unstable angina and admission criteria 
The pattern of symptoms was mentioned as a major criterium for the definition of 
unstable angina and for hospital athnission by all physicians. Most physicians 
referred to a wide definition, including recent onset angina, progressive angina and 
angina at rest, although six physicians restricted their definition to pain at rest only. 
The presence of ECG changes in relation to pain at rest was required by seven 
doctors, while two others explicitly stated that ECG changes were not necessary for 
the definition (table 5.1). 
Progression of angina and pain at rest would be a reason for athnission 
according to all physicians, while patients with recent onset angina would only be 
athnined in case of pain at rest or in the presence of ECG changes. The presence of 
ECG changes was not a strong criterium for athnission and the physicians who 
mentioned it, said to use it as additional information. They stressed that the ECG 
could be normal after a recent episode of myocardial ischemia. Half of the 
physicians referred to the level of medication as an important factor for athnission. 
When explicitly asked, 13 physicians agreed to admit a patient earlier when a history 
of coronary artery disease was present and ten wonld be more inclined to athnission 
in the presence of risk factors for coronary artery disease. Eight of the latter ten 
cardiologists worked in hospitals without angiography facilities. 
Physicians were not able to give a precise estimation of the one-year risk of 
myocardial infarction in patients with unstable angina. Ten interviewees mentioned a 
percentage, which ranged from 10% to 60% (median 30%). 
In-hospital management 
Medical treatment was said to be started after admission according to local protocols. 
Periods of unstable angina were said to have stabilised after medical treatment when 
the patient would be free of pain for a certain time period, or if the pain pattern 
would become predictable. The length of this period varied from 24 hours to several 
weeks (table 5.1). This difference was in part related to the deparnnent where the 
physicians worked. The shortest periods were mentioned by physicians working 
predominantly at a coronary care unit. 
(table 5.1) * difference in opiDlon between physicians in hospitals with and without 
angiography facilities. Risk factors lowered the admission threshold in respectively 2 out of 
11 and 8 out of 9 physicians in hospitals with and without angiography facilities. Exercise 
testing was performed after occurrence of pain with ECG changes during clinical observation 
by respectively 3 and 6 physicians and after observation of ECG changes without pain by 
respectively 3 and 9 physicians in hospitals with and without angiography facilities. 
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The interviewed cardiologists disagreed about the importance of silent 
ischemia. ECG changes without chest pain were considered as unstable by 13 
physicians, and eight of them would perform angiography, depending on the location 
of the ECG changes for four doctors. The other seven physicians relied 
predominantly on the presence or absence of symptoms. They would continue 
medical treatment and start a mobilization scheme in patients without pain, despite 
ECG changes. 
The occurrence of multiple pain episodes was judged to be more severe when 
concomitant ECG changes were present during all episodes than when ECG changes 
were observed only once. Eleven physicians said to be more aggressive in the rrrst 
situation and to decide earlier for angiography. For the remaining nine, the pain was 
of major importance for management decisions, while ECG changes served as mere 
confirmation of the diagnosis. 
Angiography 
The pattern of pain and level of medication were mentioned as the most important 
criteria for elective angiography. ECG changes were reqnired by twelve physicians. 
The intention of angiography should be directed to subsequent interventions, 
according to all interviewees. Six physicians said to use angiography also for 
diagnostic purposes without need for intervention, and for risk estimation in patients 
with post infarction angina or in young patients. 
All physicians in hospitals without angiography facilities said they would 
perform angiography more often if they would have access to a catheterisation 
laboratory in their own hospital, and nine of eleven physicians in the hospital with 
angiography facilities thought they would perform fewer angiography procedures if 
they worked in a hospital without catheterisation laboratory. 
The role of the exercise test 
An exercise test is predominantly used after stabilisation of symptoms, for evaluation 
of medical therapy, for risk assessment at the time of discharge, and to a Jesser 
extent for diagnostic purposes. Exercise testing was indicated less often according to 
physicians working in a hospital with angiography facilities, when ECG changes had 
been observed during pain in hospital. Physicians in hospitals without angiography 
facilities used the test frequently, also when pain and ECG changes had been 
recorded during observation. 
Consequences of the exercise test would depend on its results, independent of 
the previous clinical course. A positive test result would be followed by angiography 
for all but two physicians. All but one cardiologists, who said to perform an exercise 
test, would discharge the patient on medical treatment after a negative test result. 
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In hospitals without angiography facilities, all physicians but one said that 
they would not do fewer exercise tests if they had their own catheterisation 
laboratory. On the other hand, in the hospital with angiography facilities six 
physicians thought they would do more exercise tests if they worked in a hospital 
without catheterisation laboratory. 
DISCUSSION 
The interviewed physicians expressed different opinions about diagnosis and 
management of unstable angina. lt is surprising to find such differences between 
physicians working so closely together. 
Definition 
Many physicians referred to the traditional classification as described by Conti6 
(recent onset angina, progressive angina and angina at rest). Others mentioned 
definitions as used in clinical trials 7 (angina at rest with ECG changes during pain) 
or more recent classifications as proposed by Braunwald8• Braunwald described three 
important aspects for classification of unstable angina, including the severity of 
clinical manifestation (progressive angina of effon, angina at rest occurring within 2 
months but more than 48 hours before presentation, or angina at rest occurring 
within the previous 48 hours), the clinical circumstances in which unstable angina 
occurs (secondary angina, due to external conditions disturbing the oxygen balance, 
primary angina, and post infarction angina) and the absence or presence of transient 
electrocardiographic changes during pain. In addition the intensity of treatment at 
the onset of angina is regarded as helpful information to classify the patients (no 
antianginal medication, oral antianginal medication or maximally tolerated doses of 
triple medication, including intravenous nitrates). Most physicians in the present 
survey included the whole spectrum of clinical manifestations in their definition, 
whereas one third of the cardiologists emphasised the more severe conditions 
including pain occurring at rest, accompanied by ECG changes. The time interval 
after the most recent pain episode became important in the judgment of the clinical 
course. 
Objective evidence of ischemia 
The presence of ECG changes was not included in the definition or required for 
admission by the majority of physicians. Cardiologists reacted differently to 
frequency of ECG changes during multiple pain episodes. Nine physicians said to 
rely on the ECG signs whereas others emphasized the imponance of pain, and 
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regarded the presence of ECG changes as additional information. Similarly, ECG 
changes without pain (silent ischemia) were regarded as a sign of continuing 
instability by 13 physicians, who would start invasive therapy in this situation, 
whereas others relied specifically on pain for management decisions. The presence of 
silent ischemia in patients with unstable angina is indeed associated with impaired 
prognosis"1', and treatment with antianginal medication or with PTCA result in a 
reduction of the ischemic episodes12-15• However, no data are available on the effect 
of treatment of silent ischemia with respect to prognosis. 
Thus similar patients would receive different treatment, depending of the 
judgment strategy of the treating physician. For proper understanding, management 
discussions about individual patients with unstable angina should be clarified with a 
description according to the absence or presence of the various clinical characteristics 
as mentioned by Braunwald (the severity of symptoms, the clinical circumstances, 
the absence or presence of ECG changes and the level of medication), and not just 
as 'patients with unstable angina', as physicians interpret the characteristics of the 
syndrome differently. 
Time until stabilisation 
Twelve of 20 respondents indicated that they consider a patient as stabilised after 1 
to 3 days. The others mentioned periods of one week or several weeks. Braunwald 
suggested a stepwise indication of stabilisation, referring to subacute angina after a 
painfree period of 48 hours and to a stable situation after an asymptomatic period of 
two months'. In the registry described in chapter 2 it was observed that indeed most 
recurrent pain episodes occurred within the first 24-48 hours. Still, 30% of the 
patients developed new pain after a painfree interval of more than 24 hours, 20% 
after 48 hours, and less than 10% after a painfree interval of 5 days or more (fig. 
5.1). Also, in angiographic studies a higher frequency of the presence of 
nonocclusive thrombi has been reported on angiograrns performed early after the 
occurrence of pain compared to angiograrns made after several days16• The gradual 
decrease of symptoms as well as pathophysiologic signs of instability does not allow 
us to indicate exactly when the unstable episode would be over. Clinically, the risk 
of recurrent pain has been reduced to less than 10% after 5 days (fig. 5.2), and 
pathophysiologically the presence of intracoronary thrombi had been reduced to 20% 
after this period16• The disnibution of the occurrence of a new pain episode over time 
was similar for the first interval since admission, as well as for the occurrence of a 
second episode after a first pain episode, and a third after a second pain episode. 
This similarity in clinical course suggests similar pathophysiologic mechanisms of 
each pain episode. These findings indicate that a period of at least 4-5 days after the 
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time from admission until irrst pain episode (n=137) 
time after first pain :p~:_until second (n=78) 
time after second p~_:pisc:?e until third (n=45) 
time after third pain _e.E_~.! until fourth (n=24) 
6 7 8 
days 
9 10 11 12 13 14 
Figure 5.1. Cumulative incidence of recurrent pain over time. The time interval since 
admission until the first pain in hospital is given for patients who experienced ~ 1 recurrent 
pain episodes. The time interval between the first and second pain episode is given for patients 
who experience '2:: 2 recurrent pain episodes, the interval between the second and third episode 
for patients who had ~ 3 episodes, and the interval between the third and fourth interval for 
patients with ~ 4 pain episodes. 
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Figure 5.2. Probability of the occurrence of pain after admission, recurrence after a first pain 
episode, and after a second pain episode. Probabilities are calculated using Kaplan Meier 
estimates, where patients who were discharged without recurrent pain were considered as 
censored observations. 
last pam episode is needed for stabilisation of the pathophysiologic process 
responsible for the unstable episode and the risk of new episodes of chest pam. 
Prognosis 
Although the estimated risk for myocardial infarction depends on the definition of 
unstable angina, and of the individual perception of the severity of a clinical 
situation, the risk of progression to myocardial infarction angina was highly 
overestimated. Six of the ten estimates exceeded 30%, with a maximum of 60%. 
Although it was appreciated that prognosis depends on the def"mition used, I year 
infarction risk varies from 9% to 17% in the literature17•7• Follow-up data of the 
patients in two hospitals, where most of the interviewed physicians worked, indicated 
a cumulative infarction risk of 10% after 6 months (chapter 3). No subgroup could 
be identified with an infarction risk between 30 and 60%. Only recurrent pam was 
associated with myocardial infarction, and the presence of recurrent pam resulted in 
a risk of 14%. The high risk estimates be could explained by misinterpretation of 
data describing the association between unstable angina and myocardial infarction 
and vice versa. It has been reponed that 30-60% of the patients who present with 
acute myocardial infarction experience a prodtome of unstable angina before 
reaching the hospital18• These numbers are not to be reversed, and do not imply that 
such high frequency of patients admitted for unstable angina will develop myocardial 
infarction. A excessive estimation of the infarction risk may increase the use of 
coronary interventions in patients with unstable angina, although the interviewed 
physicians with high risk estimates did not express a higher likelihood for coronary 
interventions. 
Assessment of prognosis 
Both exercise testing and angiography were mentioned as methods for risk 
assessment, although it was not specified which factors were considered to be 
associated with prognosis. It should be appreciated that exercise testing in patients 
with unstable angina is contraindicated within 48 hours of the most recent pam 
episode19, which is consistent with the high risk of recurrent pain during this period. 
On the other hand, exercise testing before discharge, after a pamfree period of 
several days, adds prognostically imponant information to several clinical and 
electrocardiographical descriptors in patients with unstable angina20• A low rate-
pressure product (product of heart rate and systolic blood pressure at peak exercise) 
and ECG changes during the test are independent predictors of cardiac events during 
follow-up. Furthermore, exercise tests may be helpful in clinical decisions on the 
necessity for funher investigation and coronary revascularisation. Although 
mentioned less often by the physicians, exercise testing is especially useful for 
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diagnostic purposes in patients without objective evidence of ischemia in hospital19• 
Several angiographic !mdings are associated with increased risk of future 
complications, such as the number and the severity of the coronary lesions (stenoses 
:2: 70% or left main disease)21•23, and are used to assess the need for revascularisation. 
Still, it should be appreciated that revascularisation studies of patients with stable 
angina pectoris have shown that symptoms are reduced after bypass surgery but that 
prognosis is improved ouly in patients with severe multivessel coronary disease and 
with impaired left ventricular function24• Similarly, angioplasty in patients with stable 
angina, and single vessel disease, resulted in a reduction of recurrent pain, but not in 
improvement of prognosi~. 
Physicians' opinions and actual practice 
While physicians said to proceed to angiography if the exercise test was positive, 
this was not observed in clinical practice. In the registry of patient management, ouly 
40% of the patients with pain or ECG changes during the test were referred for 
angiography (chapter 4). Such discrepancies berween physicians descriptions of their 
own policy and what they really do in clinical practice have been described by 
Kirwan et al.26, and invite caution in interpreting physicians' opinions about the 
importance of different measures of disease severity. Opinions expressed in surveys 
and conferences may differ from actual practice. Clinical judgment analysis provides 
a more accurate method for modelling judgment policies of physicians, a method 
which will be described in chapter 6. 
Implications of the availability of angiography facilities 
All physicians admitted that their use of coronary angiography would change in 
different practice settings, which is in agreement with the !mding that the availability 
of facilities served as a major explanatory factor for differences in angiography rates 
between rwo hospitals (chapter 4). In contrast physicians expressed different opinions 
with respect to their change of use of the exercise test. In the hospitals without 
angiography facilities physicians were inclined to perform this test routinely in all 
patients, whereas their colleagues in the hospital with angiography facilities used the 
exercise test predominantly in patients for whom the diagnosis was not cornmned by 
ECG changes. On the other hand, the physicians indicated that the availability of 
angiography facilities would have little effect upon the use of exercise tests, although 
the results of an exercise test were of more importance in the decision making 
process for coronary angiography for physicians who worked in a hospital without 
angiography facilities, than for physicians in a hospital with angiography facilities. 
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Conclusion 
Physicians expressed different opinions with respect to unstable angina and its 
management. Part of the physicians relied mainly on symptoms when making their 
management decision, whereas others based their decisions on the presence of 
objective signs of ischemia on the ECG. When describing patients with unstable 
angina more detailed information has to be provided in order to reduce differences in 
individual interpretations. Patients may be considered as 'stable' after 5 days since 
the most recent pain episode. Such a waiting period is also recommended for the 
performance of an exercise test in order to assess the need for further treatment. 
The difference in opinions could explain management variation between physicians. 
Some differences were related to hospital setting. In patticular, physicians agreed that 
the availability of angiography facilities lowered the threshold to perform invasive 
procedures. 
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APPENDIX 
The purpose of this interview is to assess cardiologists' opm10ns on unstable angina 
pectoris and contains a number of open questions. Although several aspects of the 
management are related to each other we aim to handle them separately. The issues we 
would like to discuss are: definition of unstable, medication treatment, electrocardiographic 
changes, coronary angiography, and the use of exercise testing. 
Sometimes, the questions seem easy or it looks like we already know the answers. 
However, an earlier study in the Thoraxcenter of the University Hospital Rotterdam and 
the Sint Franciscus Gasthuis revealed considerable differences in the management of 
unstable angina (chapter 4). Coronary angiography was performed more often in the 
Thoraxcenter (43%) than in the Sint Franciscus Gasthuis (25%). 
The answers of the interview will be used to explore variability among individual 
cardiologists. 
1. The syndrome 'urtstable angina' 
1) How would you define unstable angina? 
2) Based on your definition, which percentage of patients do you think will develop 
myocardial infarction within one year? 
3) Which criteria are important for you to decide for admission when a patient presents 
with chest pain? 
4) Do you change your admission policy when a patient has a history of coronary anery 
disease? 
5) Does the presence of risk factors influence your decision for admission? 
2. Medical treatment 
Could you describe briefly a patient you admitted for unstable angina recently. 
6) Once you have decided for admission do you act according to a certain protocol? 
Which are the first measures you take for such patient? 
7) Imagine that you visit the patient the next day. 
-The patient had no more pain episodes. What would you do in this situation? 
-What would be your next step if the patient had recurrent pain? 
(an ECG during pain has been recorded and shows ST-depression in lead V5-V6 of 
O.Smm) 
8) When do you consider the unstable episode stabilised:! 
9) Imagine that the patient is painfree for a period of 24 hours, but the ECG has 
changed compared to earlier recordings~ e.g. T-wave inversion. Would you consider 
this situation as "stable"? 
-What would you do in that situation? 
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3. ECG-cltanges 
10) What kind of ECG changes during pain are most important to prove ischemia? 
-What consequence do these changes have? 
1!) Do you interpret ECG changes differently when they are recorded during all pain 
episodes than when several pain episodes are accompanied by ECG changes only 
once? 
4) Coronary angiography 
12) What do you consider as the most important criteria for coronary angiography? 
13) Are there any contra-indications for angiography? 
14) When do you consider acute angiography (on the same day)? 
When acute intervention is nor indicated, but you still decide to perform an elective 
angiography, within what period has an angiography to be done? 
15) What is the main purpose that you want to achieve with angiography in patients with 
unstable angina who initially responded to medical therapy, and in patients who do 
not respond to medical therapy? 
16) Do you think you would decide for angiography more often when you have 
immediate access to an in-house catheterisation laboratory than when you are 
working in a hospital without catheterisation facilities? 
5. Exercise tolerance test 
17) What is an indication for a exercise test after stabilisation for a patient admitted for 
unstable angina? 
18) Would you perform an exercise test (after initial stabilisation) 
-if ECG changes have been observed during pain in the previous clinical observation 
period? 
-if pain has occurred without ECG changes? 
-if no pain has occurred, but the ECG has changed (silent ischemia)? 
19) What are the consequences of a positive test result in each of the situations 
mentioned in the previous question? 
.what are the consequences of a negative result test in the same siruations? 
20) Do you think you would do more exercise tests when you have no in-house 
catheterisation laboratory. or fewer exercise tests when you do have in-house 
catheterisation facilities? 
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ABSTRACT 
A previous study of management in unstable angina revealed substantial differences 
in management between two hospitals in the same city, especially with respect to the 
use of coronary angiography·. Physicians in the hospital with angiography facilities 
were more inclined to perform angiography than physicians in the hospitals without 
these facilities, even when differences in patient population were taken into account. 
In order to assess individual variability between physicians we examined 
management strategies of 18 cardiologists. A series of paper case summaries with 
different patient characteristics was used to establish how physicians in different 
practice settings respond to similar medical problems. Individual cardiologists 
showed considerable differences in likelihood of using various medical services. 
Differences in individual· policies could be explained by different weight given to 
clinical information. Three subgroups of physicians with similar policies could be 
identified. The f'rrst group (n=4) of physicians based their decisions predominantly on 
the prehospital history, the second group (n=5) used mainly the in-hospital course, 
and the third group (n=6) considered both the prehospital history and the in-hospital 
course equally important. Independent of the patient description, physicians who 
worked in a hospital with in-house angiography facilities were more inclined to 
perform angiography procedures and coronary interventions. These results conf'rrm 
that the same patient's medical problem would be evaluated and treated differently 
by physicians in different practice settings. 
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!N1RODUCTION 
Uncertainty about optimal treatment results in heterogenous management for many 
diseases'. Unstable angina is such an area of uncertainty, because different 
definitions are used'"" and because many new modes of therapy have been introduced 
in the past two decades. Medical treatment with nitroglycerin and B-blockers has 
been extended with calcium antagonists, platelet inhibitors and anticoagulants<-7• 
Furthermore, cardiac catheterization followed by bypass surgery or angioplasty is 
used frequently in addition to medical treatment'·9• 
The analysis in chapter 4 it showed that the management of unstable angina 
varied considerably between two hospitals in the city of Rotterdam. Both hospitals 
served a different patient population, but apart from the variability of case-mix the 
availability of angiography facilities appeared to be a major explanatory factor for 
this difference. In this analysis of 'overall' hospital policies it was not feasible to 
account for individual differences between cardiologists in the decision making 
process. Individual variability and differences in use of clinical information have 
been demonstrated for many conditions1,.12• Therefore a separate study was set up to 
establish how physicians in different practice settings respond to case summaries of 
identical patients in a management simulation: a so-called 'policy capturing' or 
'judgment analysis'". 
Cardiologists were asked to rate the need for admission, angiography and 
exercise testing for a series of written case viguenes and to indicate the medication 
they would prescribe. Linear regression models portray judgments as the sum of 
important factors either for or against a decision multiplied by the relative 
importance (weight) of each factor, and were used to study the apparent weighing 
physicians gave to clinical information and to explore reasons for variability among 
the physicians. The purpose of this study was to assess the inclination to use of the 
various services of individual cardiologists, and to estimate the relative importance of 
a number of elements in the patient's history, the presentation of angina, and in the 
in-hospital course on the management strategy in unstable angina, especially on the 
decision to order coronary angiography. Second it was estimated to what extent 
individual variability among cardiologists contributed to the difference in 
angiography rates in hospitals with and without angiography facilities. 
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METHODS 
Participating physicians 
Eighteen physicians in Rotterdam took part in this study. Physicians who were 
selected worked in either of the two hospitals, where the follow-up study, reported in 
chapters 2, 3, and 4 was performed, and two other related community hospitals in 
Rotterdam. Eleven physicians worked as cardiologists in the university hospital with 
in-house angiography facilities, the other 7 were cardiologists working in 3 different 
hospitals without angiography facilities. 
Design of the case summaries 
Each cardiologist evaluated twelve case vignettes, describing different patient profiles 
(see appendix for example). The patient profiles varied on seven clinical variables, 
which were elicited from the analysis presented in chapter 4 and the clinical 
experience of a senior cardiologist, and were modified after six tty-out policy 
analyses. These clinical variables included (a) presence or absence of a history of 
myocardial infarction, (b) presence of risk factors for cardiovascular disease (none, 
hypercholesterolemia only, or smoking and a positive family history for coronary 
disease) (c) the amount of anti-anginal medication at presentation (none, B-blockers 
only, or multiple drug therapy), (d) the mode of onset of the present complaints (i.e. 
sudden onset versus gradual progression of pain), (e) presence or absence of ECG 
changes during pain at presentation, (f) recurrence or absence of pain during the f'rrst 
48 hours in hospital, and (g) presence or absence of ECG changes in hospital. 
Representation of all possible combinations of these seven variables at two and 
three levels would require 288 cases. However, if the possibility to explain 
interaction terms is abandoned, a fractional factorial design of 12 cases can be 
used14• A fractional factorial design selects out cases so that each level of any given 
factor appears in combination with all levels of every other factor. Thus the 
independent main effect of each factor on the decision can be established. 
The same set of twelve case vignettes was presented to all physicians. For each 
case they were asked to indicate what type of management was indicated for a 
patient with a specific profile. The decision to initiate coronary angiography was of 
primary interest, because this is the key decision in view of subsequent angioplasty 
or bypass surgery. This decision was embedded in a presentation of the cases 
describing the various steps made in daily practice. Three decision moments were 
simulated in the case presentation (figure 6.1). First, each physician was asked to 
indicate the propensity for admission based on the data available at presentation and 
the inclination to decide for angiography immediately at admission. Second, 
physicians were asked to indicate which medication they would statt or continue 
122 CHAPIER 6 
1 hour after admission 
48 hrs after admission 
8 
~---------------admission no admission 
+---------------medication angiography 
~ 
8 
...------------~---------------
exercise test additional medication angiography 
Figure 6.1. Flow c/um illustrating the structure of the case summaries. PATIENT : 
description of clinical characteristics at presentation. COURSE : description of the in 
hospital course during the first 48 hours. Three decision 17U)m£nts were simulated: 1. 
admission or not, 2. (after 1 hour) medical therapy or immediate angiographY and 3. 
(after 48 hours observation) exercise test, additional medication or angiographY. 
in-hospital. Then information was given about the in-hospital course and thereupon 
three policies were given for consideration: exercise testing, intensification of 
medical treatment, and angiography. For each decision a seven-point scale, ranging 
from !:'definitely not' to 7:'definitely', was used to indicate the inclination for each 
alternative. 
Statistical analysis 
Frequency of use of medical services 
Since 18 physicians participated in the study, 216 ratings were obtained for each 
decision. The initial analysis of these responses involved tabulating of the ratings. 
Results were then summarized as the number of ratings lower than or equal to four 
and those greater than four for each decision. Frequencies were compared between 
physicians in hospitals with angiography facilities and those in hospitals without 
angiography facilities. Differences between hospital sites were analyzed with chi-
square tests. 
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The decision to order angiography after clinical observation was analyzed in 
detaiL For each case the mean rating was calculated and the amount of variation 
among cardiologist was assessed. The results are presented for each hospital serting 
separately. 
Judgment of clinical variables 
In addition to examining the levels of utilization of various treatment options and the 
(dis)agreement among physicians. a second purpose of the study was to determine 
the symptom profiles associated with a specific decision. Thus. having found the 
amount of variability, it was attempted to understand why physicians differed in their 
choices. 
The relation between clinical information and the initiation of angiography after 
clinical observation was explored using linear regression analysis, with the response 
on the 7 -point scale as dependent variable and the seven clinical characteristics as 
independent variables. The five variables with two levels were coded as indicator 
variables, assunting the value 1 if the property at issue is present and 0 if otherwise. 
The risk factors appeared to have a linear relationship to the decision and were 
coded as one discrete variable on 3 levels. The medication level was coded as two 
separate indicator variables, because of the absence of a linear relationship. The 
Policy PC'"' program was used for policy analysis, applying the EX1RACT module 
for the regression analysis. The weight of each clinical variable was calculated for 
each physician. Weights were expressed as a percentage of the total weighing. 
Cluster analysis was applied to identify groups of physicians with similar 
policies16•17, using the actual answers of the question whether angiography was 
preferred or not. This analysis was performed with the BMDP program 1M, where 
variables are grouped according to the minimum distance criterium". A policy 
profile was calculated for each cluster, using the mean response of the individual 
cardiologists in each cluster as dependent variable. 
RESULTS 
Frequency of use of medical services 
Wide variation in ratings was found between individual cardiologists. In table 6.1 the 
responses are summarized as the number of answers greater than four for each 
individual physician and combined for the physicians at each hospital type. The 
physicians agreed upon the need for admission and immediate angiography, but they 
showed a wide variation with respect to the management after admission. Some 
physicians have a basic tendency towards angiography and coronary interventions 
whereas others appear reluctant to initiate invasive therapy. For example, physician 2 
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Table 6.1 Answers given at each decision moment by 18 physicians 
At admission After 48 hours of observation 
admission immediate angiography exercise additional 
angiography test medication 
physician 
1 7 2 4 8 5 
2 12 3 8 4 10 
3 8 2 4 5 5 
4 10 2 3 8 3 
5 9 2 0 6 5 
6 12 0 2 10 10 
7 12 0 2 6 6 
8 12 0 7 4 4 
9 12 0 2 1 3 
10 12 1 7 4 7 
11 12 1 6 4 7 
12 12 0 8 3 2 
13 9 0 I 5 7 
14 11 3 6 3 5 
15 12 2 6 3 9 
16 9 5 5 2 6 
17 12 1 6 0 6 
18 12 2 5 5 5 
Hospital; angiography facilities 
no (n=84)* 70 (83) 11 (13) 23 (27) 47 (56) 44 (52) 
yes (n=l32) 125 (95) 15 (ll) 59 (45) 34 (26) 61 (46) 
p-value l.:i test) 0.006 0.703 0.011 0.000 0.377 
numbers indicate frequency of answers greater then 4 at each decision moment 
physicians 1 to 7 represent cardiologists in hospitals without angiography facilities, and 
physicians 8-18 represent cardiologists in a hospital with angiography facilities. 
• number of cases evaluated by physicians at respective hospital type 
For hospital types absolute numbers and percentages (between brackets) are given. 
would perform coronary angiography in almost all patients, while physicians 5 and 9 
were very restrictive and choose for watchful waiting. The physicians' mean answer 
for all 12 cases varied between 4.9 and 7.0 for admission, and between 1.0 and 3.8 
for immediate angiography. After the clinical course was available, the average 
rating for angiography varied from 1.3 to 5.0, for exercise testing from 1.0 to 5.6 
and for prescription of additional medication from 2.3 to 5.6. 
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Figure 6.2. 
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Combining the data for each hospital type revealed that physicians in hospitals with 
catheterization facilities were more inclined to admit patients and to initiate 
angiography after clinical observation, while in the hospitals without angiography 
facilities more physicians would order an exercise test. However, there was no 
difference between the hospital types with respect to the decision for early 
angiography, or to the decision to increase medical therapy during observation. 
The decision to initiate angiography was analyzed in detail. Figure 6.2 shows 
for each case the ratings of the individual physicians and the mean answers in each 
hospital setting. The individual variation was wide for both groups of physicians, and 
there were only a few cases in which all physicians agreed. Nevertheless a 
systematic difference was apparent between the two hospital types when the 
variables in the cases were varied. On average physicians in a hospital with 
angiography facilities rated the need for angiography 1 point higher than physicians 
in a hospital without these facilities. The mean rating was 4.0 in the former group, 
with a range of 1.8 to 5.0 for the individual physicians, and a mean rating of 2.9 in 
the latter group, with a range from 1.3 to 5.0. 
Judgruent of clinical variables 
Individual judgment analyses revealed wide variation between physicians with 
respect to the weights they gave to the clinical variables when making a decision for 
coronary angiography. On average, this decision was based for 27% on the use of B-
blockers before admission. The relative contribution was 15% for the use of mnltiple 
drug therapy, 18% for the presence of risk factors, 11% for the presence of ECG 
changes during observation, 9% for the recurrence of pain during observation, 8% 
for the presence of a coronary history, 7% for progression of angina before 
presentation and 5% for the absence of ECG changes at athnission. Similarity 
between individual policies was explored with cluster analysis, using the actual 
ratings for each case. Three clusters resulted, including respectively 4, 5 and 6 
physicians. Three physicians could not be grouped into one of the clusters, implying 
a highly individual policy. 
Figure 6.2. Means and individual ratings for coronary angiography per case for each 
hospital. For each case two lines represent the range of ratings. The lower line represents 
the variation of physicians in the hospital with catheterization facilities, with mean values 
for each case represented as black squares. The upper line represents the variation of 
physicians in the hospitals without catheterization facilities, with mean ratings for each 
case indicated by black triangles. The numhers along the line indicate the numher of 
individual physicians giving one specific answer. The cases were ordered according to the 
overall likelihood for angiographJ, with the lowest likelihood on the bottom and the 
highest likelihood at the top. 
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Figure 63. Relative weights of clinical variables for groups of physicians with similar 
policies, as detennined with cluster analysis. The clusters included respectively 6, 5, and 4 
physicians. Three physicians could rwt be included in any cluster. For description of the 
policies, see text. Ml=Myocardial infarction; ECGpain=ECG changes during pain at 
presentation; pain48=recurrence of pain within 48 hours; ECG48=ECG changes within 
first 48 hours. 
For each of the three clusters a policy analysis was performed, using the cluster 
mean rating for each case as dependent variable. Results are presented as relative 
weights in figure 6.3. Physicians included in cluster 1 based their policy 
predominantly upon prehospital characteristics. Cluster 2 represents physicians whose 
policy was predominantly based on medication level and in-hospital events. The third 
cluster represents physicians whose policy was based on a combination of both 
prehospital and in-hospital characteristics. The clusters included respectively 1, 3 and 
4 physicians working in a hospital with angiography facilities, and 3, 2, and 2 
physicians from hospitals without such facilities. The three physicians not included 
in one of the clusters worked in a hospital with angiography facilities. 
DISCUSSION 
In this study physician's decisions in the management of unstable angina were 
characterized, in order to assess interindividual variability with respect to the 
frequency of use of various management options. In addition it was attempted to 
identify factors influencing the decision to initiate coronary angiography. The first 
issue concerns the likelihood of a decision by a certain physician, while the second 
issue concerns the reason of that decision in a particular patient. 
Differences in the likelihood of use of certain medical services have been 
reported between countries19.20, between regions within countries21 .22, within different 
practice settings23•24 and also among physicians in different specialties25 • These 
differences were attributed to cultural differences, different patient populations, 
specialty, and organization and size of practices. In addition, Gillis et a1.26 
demonstrated that physicians working in the same psychiatric institution not only use 
various drugs in different frequencies, but also show little agreement on prescriptive 
strategies. Similarly, we observed a wide variability among cardiologists working in 
the same city in the likelihood of performing coronary angiography in patients with 
unstable angina. Apparently some physicians had a basic tendency to choose for 
medical therapy, while others were more inclined to proceed to invasive treatment. 
Several studies have suggested that the degree of variation in medical care for a 
particular procedure is linked directly to the degree of consensus concerning the 
indications for its use27•29 • Uncertainty in diagnosing illness and choosing the 
appropriate treatment may stem from difficulties to classify a particular patient, lack 
of information on the probabilities of treatment outcome and divergence among 
physicians on the value they assign to different outcomes. Indeed, the physicians had 
expressed in an earlier interview (chapter 5) variations in the definition of unstable 
angina, and in the assessment of the risk of progression to myocardial infarction. 
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However, the present study indicated that the observed variability is also due in pan 
to the judgment of patient characteristics and to the availability of angiography 
facilities. Similarly, in two other studies21.22 variability between physicians were 
attributed to lack of consensus, but also to difference in severity of patients' 
conditions and to the number of physicians in a certain department. 
In general, physicians working in a hospital with angiography facilities were 
more inclined to perform angiography. This was also found in a prospective 
registration of consecutive patients admitted for unstable angina (chapter 4) in two 
hospitals, where 15 of the 18 physicians who participated in the present study 
worked. Thus the availability of angiography facilities lowered the threshold for 
invasive procedures. This may be due to self selection of physicians who decide to 
work in a certain hospital. However, it is more likely that the threshold for invasive 
procedures is a properry of the organizational structure itself, since individual 
variability of the likelihood to perform angiography exceeded the variability among 
practice settings, as is clearly shown in figure 6.2. The observation that physicians 
responded to variation of patient characteristics, and that their response is modified 
by practice settings suppons the conclusions of other repons indicating that 
comparisons of the use of health services in different populations should be 
controlled for patient variabilir·". 
In the second pan of the study, having found how physicians vaty in their 
decisions, we explored why they made different management decisions, by 
determining which patient profiles were associated with the decision to perform 
coronaty angiography. Although guidelioes for angiography have been proposed", 
there are no well-established rules for weighing the pettinent factors, except for so-
called 'refractory angina', where medical treatment fails to control the symptoms'~". 
The relative imponance of clinical variables was assessed using linear regression 
analysis, as described by Hammond34• Linear regression models ponray judgment as 
the sum of imponant factors either for or against a decision multiplied by the relative 
imponance (weight) of each factor. A judge's strategy can be inferred from decisions 
over a series of cases where the status of these factors is known. For example, one 
can calculate the weight a physician assigus to the presence or absence of ECG 
changes during pain by observing how his decision changes as ECG patterns vaty 
over a sample of cases, while controlling for other factors. This method is called 
'policy capturing' or 'judgment analysis'". 
Similar to analyses of other technologies 1o. 1~".26-" the present study confirmed 
that physicians used different weights for clinical variables when they decide to 
perform coronaty angiography or not. Three groups of physicians with similar 
policies could be identified: physicians whose decision was predominantly directed 
by the patient's prehospital history, physicians who based their decisions on recent 
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in-hospital information, and physicians who balanced both the prehospital data and 
the in-hospital course. All physicians based their decision in pan on the use of 
medication before admission. However, physicians in cluster 1 were influenced 
predominantly by the use of 8-blockers, while physicians in cluster 2 would perform 
angiography only if multiple drug therapy was given. 
The importance assigned to clinical variables was not related to the overall 
preference for angiography. For example, the physicians in clusters 2 and 3 
expressed similar tendencies for coronary angiography, but based their decisions on 
different patient characteristics. Similarly Holzman et al10 showed little relationship 
between the regression weights and the likelihood of prescription of estrogen 
replacement therapy for menopausal women, and Gillis et al.26 described that 
physicians who relied on the same psychoactive drugs for psychiatric illnesses base 
their decision whether or not to give those drugs on different patient characteristics. 
In our study physicians from different clusters were present in both types of 
hospitals. Accordingly, decision policies in each hospital type were an amalgamation 
of the three cluster policies, while the likelihood of performing angiography was 
significantly different. This is in accordance with the analysis of the patient registry, 
where no difference in weighing of clinical variables was found (chapter 4). 
Recognition of judgment strategies is of interest for several reasons. First, this 
allows individual physicians to gain insight in their own decision making process, 
which may help them to reflect on and modify their policies. Second, it provides 
insight in the factors which could cause disagreement, and thus may facilitate 
communication between clinicians when discussing indications for coronary 
angiography in a specific patient, for example when a patient in a hospital without 
angiography facilities has to be referred to a hospital with those facilities. Third, it 
may be of help in medical teaching, when it is perceived that part of the whole set 
of textbook variables may be rejected as superfluous by subsequent experience. 
All variables which were included in the case vignettes were used indeed in the 
decision making process, although to a different extent by various physicians. Most 
physicians based their decision on four or five variables only. This is consistent with 
earlier studies showing that only a small number of clinical variables is needed to 
describe judgment policies adequately"·". Nevertheless, the analysis did not reduce 
the number of clinical variables which were related to the decision to initiate 
angiography. This is not surprising, because the important variables were derived 
form earlier analysis of actual patients, but it supports the validity of the 
representation of real patients by the written case descriptions. 
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Limitations of the study 
The use of 'paper' case summaries have been applied in many studies on practice 
variation"J2,I6,23'36• One might question whether decisions made about case vignettes 
represent actual behaviour, since the case vignettes do not mimic the complicated 
interaction between doctor and patient. It does not allow the physician to obtain 
additional patient information, which he or she might request otherwise, and which 
might change his or her approach. On the other hand the presentation of paper cases 
isolates judgment from the process of gathering information and allows comparison 
between physicians in their judgment of similar cases. Kirwan et al.38 indicated a 
remarkable similarity between judgments of disease activity in rheumatoid arthritis 
made on 'paper' cases with those made on actual patients. This is supported by our 
findings: the likelibood of angiography shifted appropriately when patient 
characteristics were varied: the same patient characteristics were used as those used 
for real patients (chapter 4); the trend towards more angiography in hospitals with 
angiography facilities was observed in clinical practice (chapter 4) as well as in this 
policy analysis. Therefore the marked variations in management in this study is 
unlikely to be due to the design of the paper cases, but appeared to reflect existing 
trends in clinical practice. 
The study population was small and limited to 18 cardiologists working at 
various departments in a few hospitals in one city. Therefore it remains uncertain 
whether these observations will be applicable to other groups of cardiologists. 
The number of 12 cases was small for assessment of individual weights. This 
small number was deliberately chosen for practical purposes. First the number of 
cases was restricted to make sure that the physicians were able to complete the set in 
a reasonable amount of time, and second of the purposes of this study was to 
establish the feasibility of the method. However, the present data were sufficient 
study the individual inclination of using the various medical services, and by using 
the actual responses in as selection criterium in the cluster analysis the combined 
weights could be established by using a larger number of responses provided by the 
physicians included in each cluster. 
Conclusion 
Physicians varied considerably in the likelihood to use coronary angiography and in 
the reason why it is used. Physicians in a hospital with angiography facilities were 
more inclined to perform coronary angiography, although similar individual 
variability in the likelihood to initiate coronary angiography was observed in both 
hospital sertings. Variability in the use of coronary angiography could be explained 
in part by differences in weighing clinical information. Three groups of physicians 
with similar policies could be identified, who emphasized the prehospital history, the 
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recent in-hospital course or both. 
These results demonstrate a wide variability in preference and in decision strategies 
for coronary angiography among cardiologists and support earlier observations of a 
different management in hospitals with or without facilities for angiography. 
Judgment analysis provides a means of elucidating important physician and patient 
related factors in medical decisions and may be helpful to improve co-ordination 
between clinicians and clinical investigators in different hospitals. 
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APPENDIX 
Two case examples. The bold sections indicate the variable pans of the descriptions. 
EXAMPLE 1 
The 57 years old man RJ. is referred to your department because of chest pain, radiating 
to the left ann. The pain was accompanied by severe perspiration, but without shortness of 
breath, and lasted for approximately 30 minutes. 
According to R.J. these pain attacks existed for several weeks now. The attacks 
occurred during daily activities, such as car driving, but stopped after a period of 
rest. Recently, the pain attacks became more severe and occurred more frequently. 
Today's pain was so severe, thai he called the family doctor. 
The family doctor sent the patient to hospital, with the diagnosis of suspected unstable 
angina pectoris. The pain subsided after nitroglycerin sublingnal. After arrival at the 
hospital, a pain ECG was made. 
Mr J was admitted for unstable angina pectoris four years ago as well. He then 
developed myocardial infarction. AI this moment he uses beta blockers. 
Furthermore, the patient is in a good condition. 
PHYSICAL EXAMINATION 
hean rate 
blood pressure 
ECG without pain 
pain ECG 
: 60/min 
: 130/80 mmHg 
:normal 
: no changes compared to the previous 
routine ECG 
1 :WOULD YOU ADMIT THIS PATIENT? 
definitely not definitely 
l--------------1--------------l----------------l-------------l-------------l------------l 
2: WOULD YOU IMMEDIATELY DECIDE FOR ANGIOGRAPHY? 
definitely not definitely 
1--------------l--------------l----------------l------------l------------l-------------l 
3 :WHICH MEDICATION WOULD YOU START? 
(encircle those drugs you would prescribe) 
a: none 
b : B-blockers 
c : calcium antagonists 
d : oral nitrates 
e : intravenous nitrates 
f: aspirin 
g: heparin 
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We follow the patient at your department. Mr. RJ. is treated with the therapy, you have 
indicated at question 3. 
Within 48 hours after admission, RJ suffers another attack of dull chest pain. 
The ECG shows ST depression of 1.5 mm in leads VS and V6. 
The other findings, like pulse and blood pressure remain stable. 
4 : WIDCH OF THE FOLLOWING WOULD BE YOUR NEXT STEP? 
a : coronary angiography 
definitely not definitely 
l------------l-------------l--------------1-------------l-------------1-----------l 
b : exercise tolerance test 
definitely not definitely 
1------------l-------------l---------------l------------l-------------l-------------l 
c : additional medication 
definitely not definitely 
l-------------l-------------l----------------l-------------l------------1------------l 
(encircle the dmgs you would prescribe - both existing and additional medication) 
a: none 
b : B-blockers 
c : calcium antagonists 
d : oral nitrates 
e : intravenous nitrates 
f: aspirin 
g: heparin 
CHAPTER 6 135 
EXAMPLE2 
The 57 years old man RJ. is referred to your department because of chest pain, radiating 
to the left arm. The pain was accompanied by severe perspiration, but without shormess of 
breath, and lasted for approximately 30 minutes. 
The pain occurred at rest on the day of admission. He did no! have any anginal 
complaints during the previous period. 
The family doctor sent the patient to hospital, with the diagnosis of suspected unstable 
angina pectoris. The pain subsided after nitroglycerin sublingnal. After atrival at the 
hospital, a pain ECG was made. 
Mr J has no cardiac history, but he is known with high cholesterol levels (most 
recent value 7.8 mmo!l!). He uses no medication. 
Furthermore, the patient is in a good condition. 
PHYSICAL EXAMINATION 
hean rate 
blood pressure 
ECG without pain 
pain ECG 
: 60/min 
: 130/80 mmHg 
:normal 
: 1.5 mm ST depression compared to the ECG 
without pain 
1 :WOULD YOU ADMIT THIS PATIENT? 
definitely not definitely 
l-------------l-------------l----------------l------------l-----------1------------l 
2: WOULD YOU IMMEDIATELY DECIDE FOR ANGIOGRAPHY? 
definitely not definitely 
1------------l-------------l---------------l------------l------------l-----------l 
3 :WHICH MEDICATION WOULD YOU START? 
(encircle those drugs you would prescribe) 
a: none 
b : £-blockers 
c : calcium antagonists 
d : oral nitrates 
e : intravenous nitrates 
f: aspirin 
g: heparin 
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We follow the patient at your department. Mr. R.J. is treated with the therapy, you have 
indicated at question 3. 
Within 48 hours after admission, R.J suffers another attack of dull chest pain. 
The ECG shows no changes compared to the ECG without pain. 
The other findings, like pulse and blood pressure remain stable. 
4 : WHICH OF TilE FOLLOWING WOULD BE YOUR NEXT STEP? 
a : coronary angiography 
definitely not definitely 
1 .............. 1 .............. 1 .. -·-.......... 1 ........ -.... 1 ............ -1---.. --.... 1 
b : exercise tolerance test 
definitely not definitely 
1-----·------l---·-----···l···-----------l---··------1··---------l---·---·---1 
c : additional medication 
definitely not definitely 
1---·------··l··------·---l------·-·---··-1·---------·l------·----l-·---------1 
(encircle the drugs you would prescribe · both existing and additional medication) 
a: none 
b : B·blockers 
c : calcium antagonists 
d : oral nitrates 
e : intravenous nitrates 
f: aspirin 
g: heparin 
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CHAPTER 7 
AN EXAJ\1PLE OF AN INTERVENTION STUDY IN PATIENTS 
WITH UNSTABLE ANGINA: 
Tissue plasminogen activator in refractory unstable angina. 
A randomized double blind placebo controlled trial in patients with 
refractory unstable angina and subsequent angioplasty. 
· Eur Heart J 1991; 12:1208-14 
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Tissue plasminogen activator in refractory unstable angina. A 
randomized double-blind placebo-controlled trial in patients 
with refractory unstable angina and subsequent angioplasty 
M. VAN DEN BRAND, A. VAN ZIJL, R. GEUSKENS, P. J. DE FEYTER. P. w. SERRUYSAND M. L. StMOONS 
From the Department of Cardiology. Thoraxcenter. Erasmus University and University Hospital Rouerdam Dijkzigt. 
Rotterdam. The Netherlands 
KEY WORDS: Unstable angina, tissue plasminogen activator, angioplasty. 
To evaluate the effect of recombinant tissue plasminogen activator ( alteplase) on the clinical course. angiographic changes 
and the outcome of subsequent coronary an~ioplast_v. 36 patients with angina at rest. despite bedrest and medical treatment 
including heparin, and with concomitant ECG changes. were studied. After diagnostic angiography. patients were 
randomized to receh·e either alteplase 100 mg in 3 h ( 19 patients). or placebo ( 17 patients). The mean inten·al between 
qualif.;:ing anginal episode and initial angiograph_v was 10 and 9 h for the a!teplase and placebo group. respectively. 
Angiograph_v was repeated and angioplasty was performed within 24 hours. 
Between the first and the second angiogram.five paJients in the alteplase and seven in the placebo group had recurrent 
ischaemic episodes. while four alteplase and three placebo patients showed signs of myocardial necrosis (creatine kinase 
(CK) rise ~twice the upper limit for normal). /!Ilracoronar.v clots were recognized in three alteplase patients and one 
placebo patient at the .first angiogram. while two alteplase patients and one placebo patient showed total occlusion of the 
ischaemic-related vessel. After infusion. thrombi II" ere present in four alteplase patients and one placebo patient. and total 
occlusion in three alteplase patients and one placebo patient. Quantitative coronary angiography showed no change in the 
percentage diameter stenosis of the ischaemia-related segment after drug infusion. ( alteplase 67 ± 16 to 69 ± 16%; placebo 
65 ±lito 63± 12%). Angioplasty was successful in /4 of 19 alteplase and 14 of 16 placebo patients. Three patients after 
altep!ase and two placebo patiems developed m.vocardial necrosis during percutaneous trans luminal coronary angioplasty 
( PTCA). and one alteplase patient required urgent b)pass surgery. Minor bleeding complications were observed in six 
aftepfase patients before the second angiogram and in five alteplase patients and one placebo patient after PTCA. One 
patient after alteplase developed a fatal retroperitoneal haemorrhage. 
In patients with WIStableangina refractory to medical treatment. including heparin. afteplase has no beneficin.l effect on 
the severit_v of coronary stenosis. on the clinical course, or on the success of a subsequent angiop!asty procedure. Thus 
thrombolytic therapy with alteplasefor unstable angina cannol be recommended on the basis of this investigation. 
Introduction 
In patients with unstable angina pectoris. intracoronary 
thrombus has been documented by angiographyP-Sl and 
angioscopyl61. while biochemical studies have suggested 
the presence of thrombi in the circulation[7]. In some 
patients intracoronary thrombi can be resolved by intra-
coronary administration of streptokinase'~-8.91. Resolution 
of such thrombi by thrombolytic therapy may be expected 
to improve coronary blood flow. and to prevent or reduce 
subsequent ischaernic episodes. 
A few studies have reported a reduction in recurrent 
ischaemic episodes. in the incidence of sudden dca th and 
an improvement in the ischacmic threshold during atrial 
pacing!IO-tJJ_ Furthermore. it might be expected that 
thrombolytic therapy could reduce acute thrombotic 
occlusion during PTCA of the ischaemia-related segment. 
which occurs in approximately 10% of patients who 
undergo PTCA for unstable angina114•1SJ. 
Suhmined for publication on 4June 1990.:md in revised fom1 3 Octohct-1990. 
Corr".<ponden~": Marcel van den Brand, Diagno~tic nnd lnlerventiona! 
Cathcteri~tion Laboratory. Thoru:o:center, Emsmus University, P.O. Box 
1738.3000 DR Rotterdam, The: Netbe:rlands. 
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In order to assess the value of thrombolytic therapy 
with alteplase in patients with ongoing unstable angina 
despite medical therapy including heparin. a randomized 
trial was undertaken. Quanticative analysis of the coron-
ary arteriogram was performed in order to verify whether 
the culprit lesion was improved by thrombolytic therapy. 
Furthermore the clinical course and outcome of the 
subsequent PTCA procedures were compared in patients 
treated with alteplase or placebo. 
Patient selection and methods 
Included in the study were patients between 21 and 75 
years with: (a) Recurrent episodes of chest pain after 
hospital admission. despite bedrest and medical treat-
ment. with at least one episode with concomitant revers-
ible ST-T segment changes or persistent negative Twaves 
on the electrocardiogram. (b) A diagnostic coronary 
arteriogram, within 24 h after the last episode of chest 
pain. (c) The ·culprit' coronary lesion suitable for PTCA. 
Total occlusion of an ischaemia-related vessel. which 
supposedly was of recent date. was considered acceptable 
for angioplasty. (d) Ability to perform a second coronary 
© 1991 The European Society of Cardiology 
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angiogram. followed by PTCA within 24 h after the 
diagnostic angiogram. 
Excluded were patient<: with known bleeding disorders, 
recent major trauma, including resuscitation. or a 
bleeding history i.n the past 3 months, including cerebro-
vascular. gastric or genito~urinary tract bleeding. Patients 
with persistent hypertension and patients unable to give 
informed consent were also excluded. as were patients 
with previous angioplasty of the same coronary segment 
now judged to be related to the ischaemic myocardial 
zone, the so-called 'culprit" lesion. Informed consent 
was obtained after completion of the first (diagnostic) 
angiogram. 
Reversible ST-T segment changes were classified in one 
of four categories: ST segment eleV:J.tion or depression of 
at least 0·1 mV. persistent negative T-waves. or minimal 
ST-T segment changes not fulfilling the criteria for the 
other categories. 
All patients were treated with the following combi-
nation of medication: (I) Heparin IOOO IU.h - 1, or a dose 
sufficient to prolong the activated. partial thromboplastin 
time to twice the normal value, after a bolus injection 
of 5000 IU of heparin. (2) Beta-blockers. metoprolol 
50-200mg. in order to reduceheartrateto60 beats. min-t. 
(3) Calcium antagonists, nifedipine, in a dose of 
40-120 mg.day- 1• (4) Intravenous nitroglycerin in a dose 
between 50 to 300 )lg.min- 1• 
The patients were randomized to receive either alteplase 
infusion (ActilyseR) or placebo, supplied by Boehringer 
lnge!heim International. The study medication was 
started as soon as possible after the first coronary angio~ 
gram. in a double-blind manner. An injection oflO mgi.v. 
was followed by an infusion of 50 mg in the first hour and 
20 mg.h -r for the subsequent 2 h. Thus. a total dose of 
100 mg alteplase or placebo was administered in 3 h. 
Coronary angiography was performed using the 
Judkins technique as soon as possible after the qualifying 
anginal attack and repeated within 24 h after the start of 
the study medication. The coronary artery responsible for 
the ischaemia was identified by means of electrocardio~ 
graphic location of the reversible ST segment changes 
during chest pain. In patients with multiple lesions in 
the ischaemia-related vessel, the most severe lesion was 
considered the ·culprit' lesion. At least two orthogonal 
projections were made of the coronary artery segment 
with the culprit lesion. after intracoronary injection of I 
to 3 mg isosorbide dinitrate. The culprit lesion was filmed 
in exactly the same projections in the first and second 
angiogram. Low osmolar contrast medium (iopamidol) 
was employed. lntracoronary clot w-as defined. as an intra-
luminal filling defect surrounded by contrast material. A 
totally occluded vessel was considered as representing 
intracoronary thrombus, only if the distal margin had a 
convex. irregular or hazy shape. and contrast retention or 
staining occurred. All coronary angiograms were scored 
by at least two observers who were blinded with respect to 
the treatment. 
The angiogr-ams were analysed in a quantitative 
manner with the Cardiovascular Angiography Analysis 
Systemf16l_ Minimal lumen diameter (Dm) and inter-
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polated reference diameter (Dr) werCl cnlculnted in mm!161 
using the catheter tip as a calibration measure. Percent 
diameter stenosis was calculated. 
The extent of the obstruction was determined from the 
diameter function on the basis of curvature analysis and 
expressed in millimeters. ·plaque area' is the difference in 
area in mm~ between the reference and detected contours 
over the length of the lesion!l7J_ Area stenosis was calcu-
lated by videodensitometry. The densitometric profile 
was measured at the site of maximal narrowing of the 
vessel, and compared with the area of a reference segment. 
The second angiogram to be followed by angioplasty 
was scheduled between 12 and 24 hours after the first 
angiogram. If patients had recurrent ischaemia, the 
second angiogram and angioplasty were perfonned on an 
emergency basis. Before the start of the PTCA procedure. 
250 mg of acetyl salicylic acid and 100 mg of heparin were 
administered intravenously. An extra dose of 50 mg of 
heparin was administered every hour after the start of the 
procedure. Monorail Piceolino (Schneider-Shiley,Ziirich) 
balloons were employed, introduced over high torque 
floppy 0·014" guide wires. (Advanced Cardiovascular 
Systems. Billerica. Ma). In case of abrupt occlusion of 
a dilated lesion. oversized balloons. longer inflation 
duration and intracoronary streptokinase infusion were 
attempted in this order. Primary success was defined as a 
Jess than 50% residual diameter stenosis in the culprit 
lesion. without signs of myocardial infarction or recurrent 
ischaemia within 24 hours. and without urgent coronary 
bypass surgery. 
The efficacy of treatment was assessed in several ways: 
I. Frequency of recurrent ischaemic events between the 
first and the second angiogram (maximal 24 hours). 
2. Incidence of myocardial infarction during this 
observation period as assessed by serial serum enzyme 
measurements. For this purpose. serum CK was 
measured every 12 hours until at least 72 hours after 
the first angiogram. and 6 hours after each episode of 
chest pain. Myocardial necrosis was considered to be 
present when serum CK content was at any time more 
than twice the local upper limit for normal (i.e. 
~200 IU.I- 1). 
3. Quantitativeangiographicdifferences between the first 
and the second coronary angiogram. 
4. Presence or absence of intracoronary filling defects in 
both angiograms. 
5. Procedural complications during angioplasty. such as 
death. myor...-ardial infarction, abrupt closure of the 
dilated vessel and the need for emergency coronary 
bypass surgery. 
STATISTICAL ANALYSIS 
Differences between groups were analysed with a two-
tailed Student t-test. Changes in quantitatively measured 
coronary artery stenosis in each group were compared 
with a two-tailed paired t-test. Differences in incidence 
of recurrent ischaemic attacks. myocardial infarction, 
presence of intraeoronary clots and the occurrence of 
abrupt occlusion during angioplasty between groups 
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Tah/(' 1 clinical, hul.'r11<H.i..I'IICIII1iC. dce'tracardiog,raphic and anxiQ-
~raphic cllQracu:r/.wla of ('(]ell pari,-nr group 
Group Alteplase Placebo 
N 19 17 
Male/female 16/3 !3/4 
Mean age (years) 59 61 
Previous infan:::t 7 10 
Previous CABG 0 I 
ECG changes during ischaemia 
ST-Tclcvation <!0·1 mV 5 9 
ST-Tdcpr=ion :2:0·1 mV 
' 
4 
Persistent negative T waves 5 1 
Other ST. T changes 4 2 
Ischaemia-related vessel 
Left anterior descending artocy II 6 
Right coronary artery 6 7 
Left circumflex artery 2 4 
Multi vessel disease 5 5 
Ejection fraction: 
<0·50 3 2 
:2;0·50 16 14 
Mis:'>ing 0 I 
CABG. coronary artery bypass graft. 
treated with alteplase or placebo were determined with 
Fisher's exact test. 
Results 
Between November 1987 and April !989. 38 patients 
with refractory unstable angina pectoris were enrolled in 
the study. Two placebo patients were excluded from the 
analysis because bleeding disorders, already present at the 
time of randomization. had been overlooked. One patient 
had a groin haematoma, and did not receive trial medi-
cation. In the other patient haematuria and bleeding 
from a subclavian vein puncture were disclosed after a 
bolus injection of 10 mg of trial medication, which was 
subsequently discontinued. 
Clinical characteristics of the remaining 36 patients 
are summarized in Tables ! and 2. The 17 preceding 
infarctions had occurred more than I month before 
admission to the trial. At the time of the qualifying 
episode 50% of patients wen: treated with intravenous 
nitroglycerin. while 92% received oral anticoagulants, 
heparin or aspirin. At the time of the first ansiogram all 
patients except two were on intravenous nitroglycerin, 
while 94% were on intr::lvenous heparin or antiplatelct 
drugs. Antip!atelet therapy before the qualifying attack 
and at the time of the first angiogram consisted of aspirin 
80 to 500 mg per day. except in one placebo patient 
who received dipyridamol, 300 mg per day, before the 
qualifying attack. 
RECURRENT ISCHAEMlA AND MYOCARDIAL NECROSIS 
Between the start of drug infusion and the second 
angiogram. 11 patients had one or more episodes of chest 
pain, five in the alteplase group and six in the pl::tcebo 
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group (NS). Severe recurrent ischaemia. not subsiding 
with medical mea.sures, necessitated urgent PTCA in five 
patients. four in the alleplase and one in the placebo 
group. In these patients angiography and PTCA were per-
formed between 4·5 and 8·5 h after the first angiogram. 
Four of these live patients developed myocardial infarc-
tion. with peak CK values between 257 and 2019 ]U.J- 1• 
Clinical and electrocardiographic evidence. as ..vel! as the 
timing of CK peaks indicate that myocardial infarction 
occurred prior to the angioplasty procedure. Another 
eight patients had signs of myocardial necrosis, four in the 
alteplase and four in the placebo group. In retrospect, two 
of these had already a CK rise before the first angiogram, 
one had a CK rise before angioplasty, and five developed 
myocardial infarction during or directly after angioplasty 
(Table 3). 
QUALITATIVE AND QUANTITATIVE CORONARY 
ANGIOGRAPHIC DATA AND TirE PRESENCE OF 
INTRACORONARY CLOTS 
The sites of the culprit lesions are presented in Table 1. 
In the first angiogram three patients had an occluded 
ischaemia-related segment, and thrombi were recognized 
in four patients. The occlusions were resolved at the time 
of the second angiogram in all but one patient, but three 
other new occlusions appeared (Fig. 1). Thrombi resolved 
in two patients in the alteplase group, while at the same 
time new clots appeared in two other patients from the 
same group (Fig. 1). 
Data obtained by quantitative angiography are 
summarized in Table4. Twcnty-ninepatientsshowed non 
completely obstructed vessels in all three angiograms. 15 
in the treatment and 14 in the placebo group. No signifi-
cant differences were found between the two groups at 
any time. i.e. during the first angiogram, or before or 
after angioplasty. A significant reduction in obstruction 
diameter and percentage diameter obstruction was found 
in both groups after angioplasty. Changes in diameter 
stenosis, obstruction length and plaque area between the 
first and second angiogram were not significant neither 
within, nor between both groups. 
ANGIOPLASTY PROCEDURE 
Angioplasty was performed in all !9 alteplase patients 
and in 16 patients of the placebo group. One placebo 
patient did not undergo angioplasty because the second 
angiogram showed extensive clotting in the right coronary 
artery, without o significant localized stenosis. In this 
patient streptokinase 1·5 x 10~ IU was subsequently 
odministered i.v., without effect on the proximal intra-
coronary thrombus but with some resolution of a peri-
pheral embolus in the posterolateral branch of the right 
coronary artery. After elective administration of 100 mg 
of altcplase i.v., all clots resolved. leaving a virtually 
normal coronary artery. 
Dilatation was angiographically successful in all 16 
patients in the placebo group and in t7 out of 19 patients 
in the alteplase group. One patient with unsuccessful 
PTCA had a totally occluded right coronary artery at the 
beginning of an emergency angioplasty procedure. which 
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Tahle 2 Medical fh<'rapy at the time of occurrence of augina at rest and at the time of t/le fir.tt 
angiogram 
At the time of the qualifying At the time of the first 
Medical therapy anginal episode angiogram 
Alteplase Plaecbo Alteplnsc Plaecbo 
Or.tl :tnticoagulanL~ 0 2 0 0 
Intravenous hepMin II 10 16 16 
Anti platelet drugs 5 5 I I 
i.v. nitroglycerin 9 9 IS 16 
Oral nitrates 4 5 I 0 
Beta blocker 16 9 17 10 
Calcium antagonist 7 II 10 15 
No therapy 0 0 0 0 
Table 3 Incidence of myocardial n~:crosis with maximal CK ri.~(' in !U.l ' in !he aftcpfasc and p(a(·cbo 
group 
Alteplase group (n = 19) Placebo group (n = 17) 
Before PTCA (n =4) AfterPTCA (n=3) BeforePTCA(n=3) AfterPTCA(n=2) 
257• 288 222 636 
348 357 275• 656 
824• 758 490 
20!9• 
•Jndicates patients who underwent urgent angioplasty. 
F"irr.t Second 
onqu>qrom ongloqrom 
e • 
• 0 0 0111 
rt-PA 0 Ill 1m 
0 0 
® 0 
0 0 
0 0 
0 0 
• 0 Placebo 0 G (17) 
0 0 
Fi~:urc I Qualitative coronary angiogra.phic data before and after 
alteplase or placebo infusion. 0, Non-totally occluded coronary 
artery without intr::tcoronary filling defect: Cl. totally occluded 
coronary artery: 0. intracoronary filling defect. Non-totally 
occluded vessels. without iLLtr.u.coronary clots in both angiogrnms. 
are not depicted. 
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could not be reopened permanently. The other patient 
had an occlusion of the left anterior descending artery 
immediately after angioplasty and was operated on as an 
emergency. Two other patients in the alteplase group and 
two patients in the placebo group had a CK rise after 
angioplasty. Thus the primary success rate of dilatation of 
the ischaemia related vessel was 74% and 88% in the 
altepbsc and placebo groups. respectively. A second 
stenotic site was successfully dilated in three out of four 
vessels in thealteplaseand in four out offourvesselsin the 
placebo group. A third stenotic vessel was successfully 
dilated in one patient in the alteplase group. 
In the alteplast: group transient reocdusion was seen 
in two patient:;. BoU1 were treated successfully with 
oversized balloons. longer inflation duration and intra~ 
coronary infusion of streptokinase. 500 000 IU. but 
nevertheless necrosis developed. documented by elevated 
serum enzymes. One other patient sustained a side branch 
occlusion complicated by ventricular fibrillation. In the 
placebo group three patients had transient reocclusion. all 
trc-.tted successfully with standard procedures. although 
ventricular fibrillation occurred in one patient. Two 
of these patients developed elevated enzymes after the 
angioplasty procedure. 
BLEEV!NG COMPLICATIONS 
Bleeding between the first and second angiogram 
occurred in five alteplase patients. but not in the placebo 
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Table 4 Qutmlitalil'e angiograp!Jic data. The e.~lml of the oh.flruction and plaque area could only h~: measured in non-oa/udcd reHels. Vafm•s are girenm mean m!ues ±standard del·la//on. All 
d(!ferwces hetnw:n and within groups were not s(~nificant f>!{ore ang/op/(ll/)1 
E., tent obstruction (mm) Plaque area (mm:) Obstru<:tion diameter (nun) Pcr<:cntagc diameter obstruction Percentage area stenosis 
---
A p A p A p A p A 
p 
(n= 10) (n=9) 
First angiogram (I) 7-4±2·1 8·8±l8 10·2±5·3 11·8±7·0 1·0±0·4 1·1 ±0·4 67±16 65± II 87±11 84±8 
Second angiogram 7-4±2·4 7-9±3-5 10·0±6·9 9·6±5-3 0·9::0-4 1·0±0-4 69± 16 63± 12 90±9 84±14 
prePTCA(2) 
Post PTCA (J) 6·8±3·1 7·1 ±2-7 :5·7±4·7 6·l±H 1·9±0-6 1·9±0·2 37± 19 36±8 48± 17 49±11 
0 1-2 -00±1·4 -0·9±2·1 -0·2±3-0 -2·2±H -0·1 ±0·6 -0·1 ±0·5 3±17 -2±17 3±15 0±12 
PTCA =percutaneous transluminal coronary angiop!asty; A= alteplase; P =placebo. 
~ 
'" ;:; 
1': 
§ 
!l-[ 
!l 
f'. 
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group. Four had a haematoma at the puncture site in the 
groin. one at another site. 
Bleeding was observed after angioplasty in six other 
patients after alteplase and in one in the placebo group. 
One patient in the alteplase group died or the sequelae 
of intimal dissection. which occurred when the guiding 
catheter was advanced through the common iliac artery. 
The other femoral artery was punctured and a proximal 
LAD lesion was successfully dilated. At the end of the 
procedure blood pressure dropped. a retroperitoneal 
haematoma was diagnosed and the patient underwent 
laparotomy. After draina,ge of this haematoma the circu~ 
lation seemed to be restored and the abdomen was closed. 
He was treated with blood transfusions and measures to 
restore normal coagulation. The next day the patient was 
in good haemodynamic condition but showed signs of 
occlusion of the right femoral artery. Embolectomy and 
a crossover operation from the left iliac artery were 
performed. However. bleeding in the retroperitoneum 
progressed with subsequent ischaemia of the bowel and 
the right leg. The patient died 48 h after the angioplasty 
procedure. 
The other five patients had local hacmatoma in the 
groin. three of them with prolonged bleeding from the 
puncture site after removal of the sheaths. and one with 
combined microscopic haematuria. One patient in the 
placebo group had haematemesis and localized haema~ 
toma at a previous puncture site. In two patients with 
bleeding in the alteplase group. 6 and 7 units ofblood were 
administered while the patient in the placebo group was 
treated with HaemaceJR.. One patient who was excluded 
from the analysis had an uncomplicated course. The other 
patient was entered in the trial for recurrent ischaemia 3 
days after a myocardial infarction. Eight hours after 
diagnostic angiography and again 2 days later he 
exhibited signs of reinfarction with cardiogenic shock. 
He died one week later in spite of treatment with intra-
coronary streptokinase. emergency angioplasty. alteplase 
and intra-aortic balloon counterpulsation. 
Discussion 
In spite of previous reports that patients with 
unstable angina might benefit from thrombolytic 
therapyl9• 1 "- 14• 15• 1 "--~l no beneficial effect was observed in 
the present study. Administration of altep!ase neither 
reduced the angiographic severity of the culprit lesions. 
improved the clinical course, nor facilitated subsequent 
PTCA in patients who were already treated with heparin 
and/or aspirin. 
Quantitative analysis of coronary artery stenosis was 
used in the present study because this is the most sensitive 
method of detectin,g changes in diameter stenosis or other 
characteristics of the lesion. Nevertheless. we observed 
no significant decrease in the severity of the underlying 
coronary artery stenosis. either after alteplasoe. or in the 
placebo group. The extent of the obstruction. plaque area. 
minimal lumen diameter and obstruction area revealed no 
significant change in either group. Similar findings were 
reported by others!l~.l!fl. while one recent report demon~ 
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strated a small improvement in percent diameter stenosis 
in patients treated with alteplase and/or heparin1~1. In 
these studies the calculated diameters of·culprit' stenosis 
were similar to those in the present study. 
Measurement of percent diameter stenosis might not be 
the optimal indicator of the remaining i.umcn in cases of 
intracoronary thrombus or asymmetric lesionsP31• How-
ever. densitometric measurements did not disclose a 
change in severity of stenosis after alteplase infusion 
in our study population. Similarly. videodensitometric 
measurements of area stenosis did not improve after 
intracoronary infusion of 100000 to 300000IU of 
streptokinase in another study of 37 patients with 
unstable angina or non Q infarction11 9l. 
The Jack of a beneficial effect of thrombolytic therapy 
raises the question whether intraluminal thrombosis is 
indeed a major cause of 'instability" of the symptoms in 
these patients. The presence of intracoronary thrombus 
has been reported in I to 52%11-SJ of patients with unstable 
angina. using coronary arteriography as a diagnostic 
criterion. However. the individual criterion in these studies 
differed widely. ranging from occlusion. supposedly 
caused by thrombus. intraluminal defects and intra~ 
luminal staining. to :1 reduction of stenosis severity after 
streptokinase infusion. Intraluminal defects. suggestive of 
clots. were observed in four patients in this study. while 
three other patients had a total occlusion suggesting 
recent clot formation. Two out of three patients treated 
with alteplase showed resolution of clots in the second 
angiogram. and in one other patient. initially given 
placebo. extensive dotting in the right coronary artery 
resolved when alteplase was administered after the second 
angiogram. Thus thrombolytic therapy with alteplase 
may be beneficial in a few selected patients with unstable 
angina and extensive clots visible on the angiograml20l. 
However. systematic therapy with thrombolytic drugs in 
patients with unstable angina docs not seem warranted. 
In fact new clots appeared in three patients in spite of 
preceding treatment with alteplase. 
The lack of efficacy of thrombolytic therapy in the 
current study may be related to the fact that 92% of the 
patients were treated with oral anticoagulants. heparin. or 
anti platelet drugs at the time of the qualifying episode of 
angina. It is likely that factors other than intra coronary 
thrombosis contribute to the acute coronary syndrome in 
those patients who remain 'unstable' in spite of anti~ 
coagulation and anti· platelet therapy. This also explains 
the relatively low incidence of visible intracoronary clots 
in our study. 
In three studies which reported higher incidences of 
intravenous thrombosis. between 41% and 68%. the 
patients were not pre-treated with heparin[20.2l.24l_ 
ANGlOPLASTY PROCEDURAL COMPLICATIONS 
Major complications of angioplasty. defined as 
procedure~ related death. myocardial infarction or urgent 
surgery are infrequent (5'%) in patients with stable angina. 
Complications are more frequent (10%) in patients with 
unstable angina. and may amount to 20% of patients 
requiring urgent angioplasty for intractable anginaP0.l5l. 
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as in the present study. lt should be noted that after the 
first coronary arteriogram all patients were treated with 
i.v. nitroglycerin and heparin. while the majority were 
::II ready receiving heparin and/or aspirin at the time of 
the qualifying episode of angina. Despite this intensive 
medical treatment. seven paticntsdcvcloped a myocardial 
infarction before the second angiogram. In four of these 
and one other patient urgent angioplasty was performed. 
Successful angiographic dilatation (diameter stenosis 
after angioplasty of less than 50%). was achieved in 89 
nod 100% of patients in the alteplasc and placebo groups 
respectively. although five patients developed n moderate 
CK rise after intermittent reocc\usion during the pro~ 
cedurc. Thus the primary success rate was 74 and 88%. It 
should be noted that no intmcoronary dot was observed 
prior to the angioplasty procedure in the patients with 
transient reocclusion. AI! five patients with intra-
coronary clots pre angioplasty and three patients with a 
totally occluded ischaemia-related vessel had suct:essful 
uncomplicated angioplasty procedures. 
Conclusion 
Intravenous administration of alteplase in this patient 
group with unstable angina. in spite of extensive medical 
therapy. did not have any favourable effect, either on 
the culprit lesion, the clinical course. or the outcome of 
subsequent angioplasty. On the contrary one fatality 
occurred. which might be ascribed to a complication of 
the procedure and the administration of a thrombolytic 
drug. It is possible that thrombolytic therapy is beneficial 
in selected patients with angiographically demonstrated 
intracoronary clots as observed in one patient. However. 
based on the presently available data. thrombolytic 
therapy cannot be recommended in patients with unstable 
angina. 
We gratefully acknowledge the heir or Kurin Nijs.•>cn for 
monitl.'rins the trial and of Marjolcin Wapcnaar for preparing the 
manuscript. 
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Introduction 
In this chapter the main results of the studies described in the previous chapters are 
summarised. The findings with respect to diagnosis. prognosis and management 
strategies are compared with another large dutch study' and with two other large studies 
form the recentliterature2.3. Finally, suggestions for future research are given. 
Definitions used in studies on unstable angina 
A major concern in studying the clinical entity, described as 'unstable angina' is the 
definition of this disease entity. As noted in chapter 1 def'lnitions of unstable angina 
vaty from wide criteria as "all forms of angina, which are not presumed to be 'stable', 
i.e. when there has been no change in the frequency, duration, or precipitating factors 
during the preceding 60 days"\ to "persisting angina at rest, despite intensive medical 
treatment, with reversible ECG changes during pain"5•6• Patients with anginal patterns, 
recognised as unstable angina at presentation in the emergency unit, represent a different 
population than patients who have been observed in hospital and in whom the nature 
of the symptoms has been determined by objective signs of reversible ischemia and 
myocardial infarction has been ruled out by serial electrocardiograms and enzyme 
assessments. Specillcally, as indicated in the flowchart depicted in f'lgnre 1.1, several 
subgroups can be indicated, all of which are denoted as 'unstable angina'. First, the 
entry of the flowchart represents all patients presenting with symptoms, suspected of 
unstable angina at hospital admission, either with or without concomitant ECG changes. 
Some patients with evolving myocardial infarction will be included in this classillcation, 
but can only be recognised when enzyme assays have become abnormal, which may 
take several hours. The HINT trial' is an example of application of such 'admission 
diagnosis', which was def'lned as symptoms (prolonged pain at rest) and signs (evidence 
for myocardial ischemia and absence of signs of acute myocardial infarction) indicating 
acute but reversible myocardial ischemia. A second category includes patients with 
symptoms of unstable angina according to specilled criteria, in whom myocardial 
infarction has been ruled out by normal serum enzyme values. In these situations 
patients are usually included 12 to 24 hours after admission, and include a subgroup, 
indicated as UAP in the flowchart. This starting point is used in many observational 
studies and clinical trials~3 •7• Third, further narrowing of the definition may be applied 
by including the in-hospital course. For example, intervention studies, as described in 
chapter 7, define unstable angina as pain at rest despite intensive medical treatment, 
with concomitant ECG changes, where coronaty intervention is indicated. These 
subgroup of patients is indicated as 'ANGlO' in the flowchart, followed by the arrow 
directed to 'PTCA', or to 'CABG' when it concerns studies evaluating the efficacy of 
bypass operations'·'. A fourth subgroup can be identified as 'stabilised after a period of 
unstable angina', indicated as 'DISCHARGE' respectively 'med Rx' after angiography. 
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These patients are discharged on medical therapy and are of interest for studies 
evaluating certain therapeutic strategies providing 'secondary prevention'. For example, 
trials on aspirin treatment for long-term prevention of future complications start 
treatment 3 days after a!hnission and continue treatment for on year or longer'. 
Which definition is chosen in a particular clinical trial depends in part on the 
nature of the treatment option under study. The studied disease entity is defined in terms 
of a homogeneous climcal indication, with patient characteristics which are 
representative for the indication at issue, but it should also refer to a particular stage in 
the development of the disease. Given the rapidly changing nature of relevant diagnostic 
and other climcal information in patients with unstable angina, it is of importance to 
define the time of inclusion. 
In contrast to studying how a certain drug or intervention affects outcome for a 
specific group of patients, the present study was directed to study how certain drugs and 
interventions were applied in clinical practice to patient with (suspected) unstable 
angina. It was attempted to assess which patient characteristics were used to make 
cenain decisions. Patients admitted to hospital for suspected unstable angina, according 
to the physician in charge, were followed during hospitalisation, and all information 
which became available over !hne was used to describe the decision making process. 
It was appreciated that, for example, a patient's history might be interpreted as 'typical' 
angina by one physician, and could be judged as 'atypical chest pain' by another 
physician or at a later moment in time. The data used for the analyses described in this 
thesis were all based on judgments of the treating physicians, and were not directed by 
objective external criteria. 
The irutial diagnosis of suspected unstable angina, according to the physicians 
in charge, was revised into myocardial infarction in 10% of the patients after a period 
of observation, which was not recogrused at a!hnission, but became apparent after 
several hours, when results of enzyme determinations indicating myocardial infarction 
became available. This percentage was similar to the HINT trial'. In another 25% of the 
patients, the presenting symptoms appeared later to be due to other causes, including 
non-cardiac disease or non-specific chest pain. 
Based upon a!hnission diagnosis medical treatment, including nitrates, aspirin 
and/or heparin, was started in the majority of patients. This treatment strategy was 
adapted over time depending on new diagnostic and prognostic information. Medical 
treatment was considered adequate in 50% of the patients with a final diagnosis of 
unstable angina, while after a period of observation and medical treatment coronaty 
angiography was initiated in 50% of these patients with a view to subsequent coronaty 
interventions. Given this treatment strategy patients with a definite diagnosis of unstable 
angina according to the treating physicians have a relatively good prognosis. Hospital 
monality rate and infarction rate were respectively 2% and 5%. After 6 months 4% of 
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the patients with definite unstable angina had died and 10% had developed myocardial 
infarction. 
Comparison with other trials 
In order to compare the outcome of unstable angina in the current registry (chapters 2 
and 3) with other studies, three recent large trials will be reviewed. The HINT study' 
reported the effect of B-blockers, calcium antagonists and the combination of the two 
with respect to recurrent ischemia and myocardial infarction during the first 48 hours. 
These patients were followed until 2 years after admission. Both HINT, which was also 
conducted in the Netherlands, and our prospective registry included patients immediately 
upon admission, and did not include patients with possible non-coronary cause of 
angina, such as anaemia (table 8.1). Patients over 70 years, patients with recent 
infarction, and patients with maintenance treannent with nifedipine were excluded in the 
HINT trial. Accordingly, patients in the UAP registry were older than in the HINT 
study. For comparison, the numbers of those patients younger than 70 years in the UAP 
registry are given separately in table l. These patients had more often a history of 
coronary artery disease, and a shorter painfree interval at admission. However, both 
populations were comparable with respect to gender, duration of angina before 
admission, electrocardiographic characteristics and use of nitrates and B-blockers. 
Although a wider entry criterium was used, 95% of the patients with a dermite diagnosis 
of unstable angina met the HINT criteria, i.e. ST-T changes had been observed or a 
documented history of coronary artery disease was present. In both studies I 0% of all 
patients had in retrospect a myocardial infarction at admission. New infarctions occurred 
in 17% of the HINT patients, and in 10% in the present study. Mortality rates were 
similar for all patients, but was lower in the UAP registry when elderly people were 
excluded. Despite differences in baseline characteristics, some of which are associated 
with increased risk for myocardial infarction, the prognosis of patients with unstable 
angina has improved in the Netherlands over the past ten years. 
In table 8.2 the main features of HINT and two other recent trials are 
described2.10• Ail three studies excluded patients of elderly age and required objective 
evidence of ischemia for inclusion. However, enrolment was restricted to patients with 
pain at rest only in HINT, included both crescendo angina and angina at rest in the 
'Theroux' trial, and encompassed recent onset, increasing angina, angina at rest, and 
non-Q-wave infarction in RISC. It is important to note that the interval between the 
most recent pain episode and start of the study medication varied considerably between 
these studies. As was shown in the HINT trial, the interval between pain and the start 
of the trial medication is strongly related to the rate of recurrent ischemia or myocardial 
infarction within the rrrst 48 hours. (see also fignre 5.2). In HINT 10% of all patients 
had myocardial infarction at admission, but still 9% of the patients developed 
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Table 8.1 Comparison of baseline characteristics and outcome of patients in the presented 
registry and in the HINT study 
UAP registry HINT' 
Baseline characteristics 
n=417 (n=290) • n=515 
age > 65 years 44% (20%) 16% 
men 64% (70%) 75% 
history of CAD 
myocardial infarction 46% (46%) 34% 
PTCA 12% (14%) 
CABG 15% (17%) 7% 
history of angina > 4 weeks 43% (49%) 40% 
pain free interval 
< 1 hour 63% (62%) 26% 
1-3 hours 15% (15%) 35% 
;;, 3 holliS 21% (23%) 38% 
ECG 
baseline: ST.!. > 0.1 m V 18% (23%) 18% 
pain: ST-T changes 35% (35%) 61% 
medication before admission 
nitrates 24% (22%) 19% 
£-blockers 40% (42%) 34% 
calcium antagonists t 25% (24%) 1% 
aspirint 21% (21%) 3% 
Outcome 
mortality 4% (2%) 4% 
myocardial infarction 10% (9%) 17% 
* Numbers between brackets indicate the percentages for patients younger or equal to 70 
years. t Maintenance treatment with nifedipine and aspirin use were exclusion criteria in the 
HINT trial 
myocardial infarction within 48 hours after admission. As most infarctions occur early 
after admission, the differences in time interval between pain and start of the study may 
explain the high infarction rate in the HINT study, but does not explain the higher 
infarction rate in the RISC study compared to the study of Theroux. The RISC study 
patients included patients with non-Q-wave infarction, which accounted for 49% of the 
study population, and might have resulted in higher event rates. 
The reponed figures are the combined event rates of the treatment groups and 
the placebo groups. HINT reponed a beneficial effect of B-blocker use in patients not 
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Table 8.2 Summary of treatment strategy and prognosis in patients with unstable angina in three 
recent large trials 
HINT' Theroux2 RISC'·" 
Design features 
n 515 479 796 
patient description age570 yr age$75 yr men aged < 70 yr 
chest pain at rest chest pain at rest non-Q-wave :Ml 
reversible ST· T changes or with minimal exercise angina at rest 
or documented CAD ischemic ECG changes increasing angina 
recent onset angina 
ischemia on ECG or ET 
time between stan of study 
and most recent pain <12 hours <24 hours <72 hours 
treatment heparin- heparin-
nifedipine continuous infusion intermittent injections 
B-blocker aspirin aspirin 
both both both 
follow-up 1 year 3 months 1 year 
Outcomes 
cardiac events 
non-fatal infarction 
in hospital I 1 mnth 13% 4.4% 7.5% 
during follow-up 4% 2.9% 5.0% 
death 
in hospital I 1 mnth 1.7% 0.4% 1.2% 
during follow-up 2.4% 1.3% 2.4% 
interventions 
PTCA orCABG 
in hospital I I mnth 14% n.d. 1.8% 
during follow-up 25% 49% 11.8% 
Conclusion pts not on j3-blocker: heparin and risk reduction after 
metoprolol beneficial, aspirin beneficial. aspirin treatment. 
nifedipine detrimenta~ heparin favoured over no effect of heparin 
combination aspirin. or combination. 
no additional effect combination 
pts on j3-blocker: no additional effect 
nifedipine beneficial 
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on previous B-blocker treatment, and a beneficial effect of addition of calcium blockers 
in patients who already used B-blockers before admission. Theroux reponed an 
improved prognosis after heparin and aspirin treatment compared to placebo, but heparin 
was favoured over aspirin. RISC found a favourable effect of aspirin treatment, but not 
of heparin. The lack of efficacy of heparin in RISC is probably due to the dosage 
scheme of intermittent injections, resulting in insufficient anticoagulation. In patients 
with myocardial infarction it was found that patency after thrombolytic therapy was 
related to the dosage of concomitant heparin treatment. Patency after 2-5 days was 72% 
after inadequate heparin levels, 80% after suboptimal dosage schemes and 90% after 
optimal treatment". In the UAP registry 80% of all patients were treated with nitrates 
and heparin and/or aspirin aftet admission, and more than half of the patients with B-
blockers, which may account for the good prognosis. Based on the results of the above 
described studies it is recommended to start initial treatment of patients hospitalised for 
unstable angina with intravenous heparin and B-blocker treatment in addition to nitrates. 
Only if a B-blocker was already being taken before admission addition of a calcium 
antagonist is to be considered. If this pharmacologic management strategy fails and 
angina recurs, coronary angiography is performed followed by angioplasty or coronary 
bypass surgery, if feasible. Long term preventive treatment may include platelet 
aggregation inhibiting drugs or a B-blocker, or both. 
Timing of interventions 
Despite intensive medical treatment coronary revascularisation is performed in a large 
proportion of patients. Coronary interventions in patients with unstable angina are 
directed to prevent new episodes of ischemia as well as progression to myocardial 
infarction or death. As most infarctions in patients admitted for unstable angina occur 
early, it seems preferable to perform a.'lgiography and subsequent revascularisation as 
soon as possible. On the other hand, it has been reponed that emergency procedures 
have a greater risk in patients with unstable angina'~''. Acute coronary occlusion after 
PTCA occurred more frequently in patients with unstable angina, with multivessel 
disease in patients with complex lesion in an observational study of 1423 consecutive 
patients in the Thoraxcenter'4• Such complex lesions, indicating plaque rupture and/or 
thrombosis, are found more often shonly aftet a period of unstable angina15• In the 
present UAP registry 137 of 282 patients with a definite diagnosis of unstable angina 
underwent angioplasty followed by PTCA or CABG in 100 patients. Ten of these 
revascularisation procedures (10%) were complicated by procedural myocardial 
infarction of death. While these complications were not associated to emergency 
procedures, the complication rate remains high. On the other hand, 6 infarctions 
occurred during the waiting period for angiography or revascularisation. Two of these 
6 infarctions occurred in patients who waited at home for the procedure. Another 10 
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patients who waited at home were readmitted during this period because of recurrent 
pain, and needed earlier intervention, and 1 other patient, who was treated medically, 
subsequently needed angioplasty because of recurrent pain. Thus the timing of 
interventions has to be balanced between 'too early' and 'too late'. It seems beneficial 
to wait several days after the unstable period before performing coronary interventions, 
but also to try to perform the procedures before hospital discharge. 
Based upon available evidence it is concluded that prognosis in unstable angina 
is better prognosis than thought in general. Many patients can be managed with non-
invasive measures. Revascularisation procedures are not without risk. However, patients 
have a good prognosis after successful revascularisation (chapter 3), but also a high rate 
of reinterventions. Coronary intervention can be reserved for a specified subset of 'high 
risk' patients. This 'high risk' group includes patients with recurrent pain with ECG 
changes, post infarction angina, and patients with severe multivessel coronary artery 
disease and impaited left ventricular function. 
Difference in angiography rate a_nd subsequent intervention 
A major difference is observed with respect to the frequency of coronary interventions 
(table 8.2). The HINT trial was conducted between 1980 and 1984, whereas the other 
two trials were performed between 1985 and 1988. During the last decade the use of 
coronary interventions in patients with unstable angina has increased substantially16•17• 
The inclusion of patients after 72 hours may introduce a selection of patients who have 
stabilised with medical treatment, and thus reducing the need for addition interventions. 
In addition, the location of the studies is of importance as revascularisation rates are 
known to be different among countries". The Canadian study" confirmed the high 
intervention rate in this area, and the Scandinavian study10 the lower rates. The latter 
revascularisation rate may be underestimated, as a waiting time of 6 to 8 months 
between the time of referral to angiography and the intervention and several 
interventions occurred after conclusion of the study. 
Apart from these regional differences in the use of coronary interventions, 
considerable differences were found between in the two participating hospitals in 
Rotterdam in the U AP registry. The finding of these differences in one city was 
explained in part by the availability of angiography facilities. Such 'supply-driven' use 
of facilities have also been described for other resources, such as available hospital 
beds18•19• Neither the follow-up data from our UAP registry (chapter 3) nor the event 
rates described in table 2 show differences in prognosis. Whether the supply is too large 
can not be established with these data, but there is no indication that more facilities are 
needed. The present facilities seemed to be sufficient to treat the patients with an 
indication for coronary intervention. As all physicians admitted that the availability 
would increase the number of procedures, more interventions would be performed if 
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more facilities were available, without evidence for better outcome. However, the 
waiting time for patients referred from other centres was significantly longer than in the 
hospital with in-house facilities. To prevent events in the waiting time these periods 
should be reduced. 
Suggestions for future research 
Evaluation of current practice in treatment of patients with unstable angina pectoris is 
useful to assess the effect of treatment strategies and to explore areas where further 
improvement is required. Although the prognosis of unstable angina is better than 
generally thought, there is still a considerable morbidity and mortality. The results of 
the present study suggest three fields of possible management improvement 
The diagnostic phase, or the time until definitive therapy has been selected, 
varied between several hours to over 7 days. After 48 hours in 50-70% of all patients 
no decision for definitive treatment had been made yet (figure 4.1). After alhnission 
50% of the patients remains free of pain, while 55 to 70% of the recurrent pain episodes 
evolved within 24 hours20 (chapter 5). It is known that recurrent chest pain is associated 
with cardiac events. Early recognition of the patients who are likely to remain free of 
pain could shorten the hospital period for these low risk patients. Additional measures, 
such as continuous 12-lead ECG monitoring", biochemical markers indicative for 
unstable processes in an atherosclerotic plaque22 or pharmacological stress testing"', may 
be of value to identify of low-risk patients, and thus shorten the time needed to make 
a def"rnitive treatment decision. 
Although medical treatment of unstable angina has been extended during the last 
years, and prognostic improvement has been demonstrated, some contradictions have to 
be explained. lt has been described earlier that the effect of heparin use depends in the 
level of anticoagnlation. More detailed analysis of the effect of heparin in patients with 
unstable angina, by careful monitoring of haematologic variables, may offer an optimal 
dosage regimen. To date, the value of thrombolytic therapy has not been confirmed in 
patients with unstable angina (chapter 7). However, it has been suggested that subgroups 
of patients, with evidence of intracoronary clots on the angiogram, may benefit from this 
therapy. These subgroups have to be defioed in further studies. Further work is needed 
to def"me comparative effectiveness of various drugs reducing platelet activation in 
patients with unstable angina in order to reduce episodes of myocardial ischemia and 
to improve prognosis>". 
The complication rate of coronary interventions is still a matter of concern. Angioplasty 
procedures are often complicated by acute occlusion, leading to death, infarction or 
emergency surgery. Until now no adequate solution has been found to improve the 
complication rate. Additional measures should be sought to protect the patients more 
effectively during these intervention?'. 
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SUMMARY 
This thesis provides a description of the cfurical syndrome 'unstable angina pectoris' 
and of the patients who are admitted and treated for unstable angina in two hospitals in 
the city of Rotterdam. In chapter 1 a literature review is given of the definitions, the 
underlying pathophysiologic mechanisms of unstable angina and the treatment options 
available. Unstable angina consists of a wide range of conditions intermediate between 
chronic stable angina an acute infarction, all characterised by severe transient ischemia 
Definitions vary from 'each form of deteriorating angina, including recent onset angina 
and progressive angina' to 'severe angina at rest with concomitant reversible electro-
cardiographic (ECG) changes'. In addition, the level of medication and the time interval 
between the last pain episode and presentation are considered in several definitions. 
Plaque rupture or endothelial ulceration followed by platelet aggregation or a thrombotic 
process, often in combination with coronary spasm, are considered to be the pivotal 
factors in sudden changes in the degree of flow obstruction and hence in the conversion 
from cfurical stability to clinical instability. Coronary obstruction by these mechanisms 
may develop and regress rapidly, inducing reversible episodes of myocardial ischemia 
(unstable angina). Sometimes the obstruction progresses to total coronary occlusion, 
inducing irreversible myocardial injury (infarction) or death. When a patient presents 
with symptoms suspected of unstable angina it takes some time after admission to make 
a definite diagnosis. Differentiation between reversible ischemia and irreversible 
ischemia is only possible when the cardiac enzyme values are known, which are 
released from irreversibly injured myocardial cells into the circulation during a period 
of several hours. On the other hand patients may present with chest pain, which is 
initially suspected of unstable angina, but appears in retrospect to be of non-cardiac or 
non-specific causes. 
In patients with definite unstable angina the risk of progression to myocardial 
infarction or death is on average 14% and 10% respectively. This risk is increased for 
patients with recurrent pain and with concomitant ST-T changes on the 
electrocardiogram. Treatment of unstable angina is directed to initial relief of the pain 
and to prevention of progression to infarction or death. Medical therapy of nitrates, 8-
blockers, calcium-antagonists, heparin and aspirin are usually given in various 
combinations, and thereupon coronary revascularisation procedures (bypass surgery and 
angioplasty) are available to manage the syndrome unstable angina. 
ln a prospective registry 417 consecutive patients were followed after admission 
for suspected unstable angina in two hospitals in Rotterdam. After observation 9% of 
these patients had in retrospect myocardial infarction and in 26% the symptoms 
appeared to be non-cardiac or non-specific. In 65% of the patients had a definite 
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diagnosis of unstable angina. Medical therapy was started in the majority of the patients, 
including heparin and aspirin. In addition 137 patients (33%) underwent angiography, 
followed by subsequent bypass surgery of angioplasty in 100 patients (24%). Despite 
frequent recurrent pain episodes during admission (53% of all patients) only 4% of the 
patients developed myocardial infarction and 1.4% of the patients died in hospital. The 
occurrence of death was related to elderly age and recent infarction (chapter 2). 
During a follow-up period of six months the infarction rate was 9.6% for patients with 
a definite diagnosis of unstable angina and the mortality rate was 4.3%. The occurrence 
of infarction or death was associated with elderly age and the presence of ECG changes 
during pain. The risk of death was also increased for men, for hypertensive patients and 
for patients who already used B-blockers before adntission. Ten percent of the patients 
underwent as yet an angiography after discharge, followed by angioplasty of bypass 
surgery in 7% of the patients (chapter 3). 
A difference between the two hospitals was found with respect to the 
angiography rate. In chapter 4 an analysis of the origin of this difference is presented. 
The angiography rate for patients younger than 80 years without recent infarction or 
revascularisation procedure was nearly twice as high in the Thoraxcenter of the 
university hospital Dijkzigt, a hospital with in-house angiogtaphy facilities, compared 
to a community hospital without such facilities, the Sint Franciscus Gasthuis. The 
patients in the Thoraxcenter were younger and had a more severe history of coronary 
artery disease than the patients in the Sint Franciscus Gashuis. Multivariate analyses 
were used to assess the patient characteristics associated with a subsequent decision for 
angiography. Patients younger than 70 years, with known hypercholesterolentia, with 
progression of angina and multiple pain episodes before admission, who were already 
treated with ce-blockers, and had ECG abnormalities at admission underwent 
angiography more often. After adjustment of the patient characteristics the hospital site 
still remained an independent factor associated with subsequent angiography. This 
difference disappeared 36 hours after admission. This means that for comparable 
patients in the hospital with angiography facilities the decision to initiate angiography 
is made more often and also earlier in time. 
In chapter 5 the results of an open interview are reported. Physicians were asked 
to describe their definition of 'unstable angina' and the preferred treatrnent strategy. 
Individual cardiologists used different definitions and expressed different risk estimates 
for progression to myocardial infarction. These risk estimates were significantly higher 
than the rates reported in the literature. In addition individual differences existed in the 
judgment of the clinical course, in particular of the painfree period until the situation 
is no longer considered unstable. The individual differences in opinions were 
independent of the hospital situation. All cardiologists admitted that they would decide 
for angiography more often and earlier when they worked in a hospital with 
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angiography facilities. 
In addition, a series of paper cases, varying on seven clinical factors, were given to the 
cardiologists. For each case description they were asked to indicate what kind of 
treatment they would prefer. Using linear regression analysis the relative importance of 
clinical variables for the decision to initiate angiography was calculated. Three groups 
of physicians, who used similar information, could be identified. The rrrst group of 
physicians (27%) made their decision predominantly upon the prehospital information, 
the second group (33%) relied on the new events in hospital, a11d the third group (40%) 
based their decision on both the prehospital and in hospital information. Recognition of 
these patterns may be helpful in the communication between physicians and can explain 
why individual cardiologists come to a different decision in the san1e patient (chapter 
6). 
Finally in chapter 7 a clinical nial is presented on new treatment options. A 
double-blind randomised placebo-controlled trial was performed in order to assess the 
efficacy of thrombolytic therapy before angioplasty in patients with unstable angina, 
despite intensive medical therapy. Angiographic nor clinical endpoints revealed any 
differences between the placebo group and the treatment group. Based on these results 
and those reported in other nials thrombolytic therapy can not be recommended in 
patients with unstable angina. 
In the general discussion the results are summarised and compared to several 
large studies from the recent literature, which were performed in different counnies 
under similar circumstances. The described results lead to suggestions for future 
research are given, such as the evaluation of diagnostic measures to come to earlier 
recognition of 'low risk' patients and earlier decisions for the definite therapy and hence 
shorten the admission period. Additional medical therapy should be further evaluated 
and for presently used drugs, such as heparin, optimisation of the efficacy may be 
obtained by improved dose regimens. Finally, the complication rate ofrevascularisation 
procedures is still a matter of concern and additional measures to reduce these 
complications may further improve me prognosis of patients wim unstable angina. 
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SAMEN:V A TTING 
Dit proefschrift bestaat uit een beschrijving van het zie!ctebeeld 'onstabiele angina 
pectoris' en de patienten die als zodanig opgenomen en behandeld werden in twee 
Rotterdamse ziekenhuizen. In het eerste hoofdstuk wordt een overzicht gegeven van de 
kennis die de literatuur verschaft omtrent de definitie, de pathogenese en de behandeling 
van onstabiele angina. De definities van onstabiele angina !open uiteen van 'elke vorm 
van angina pectoris die in ernst is toegenomen' tot 'langdurige pijn op de borst in rust 
met reversibele e!ectrocardiografische (ECG) veranderingen zonder enzymstijgingen·. 
Aanvullend worden het niveau van de medicatie waaronder de pijn ontstaat en de 
tijdsduur tussen de laatste pijnaanval en de presentatie in de dermitie betrokken. Een 
periode van onstabie!e angina pectoris wordt veroorzaakt door een ruptuur van een 
atherosclerotische plaque in een kransslagader, mogelijk gevolgd door vaattonus-
verhoging en thrombocytenaggregatie, waardoor de bloedtoevoer naar de hartspier wordt 
belemmerd. Wanneer dit proces reversibel is en er geen blijvende schade aan het 
hartspierweefsel is ontstaan spreekt men van onstabiele angina. Voortschrijding van 
ktansslagadervernauwing kan leiden tot totale afsluiting met als gevolg een hartinfarct 
(permanente beschadiging van een dee! van de hartspier) dat tot de dood kan leiden. Bij 
opnarne van een patient met klachten die verdacht zijn voor onstabiele angina, zijn de 
anarnnese en het ECG de belangrijkste diagnostische middelen. Er is na opnarne enige 
tijd nodig om tot een definitieve diagnose van onstabiele angina of een andere diagnose 
te komen. De k!achten bij opnarne kunnen achteraf blijken te berusten op een infarct op 
grand van verhoogde enzymwaarden die op weefselversterf duiden en die pas na enkele 
uren aantoonbaar zijn in het bloed. Anderzijds kunnen de k!achten berusten op niet-
cardiale of aspecifieke oorzaken. 
Patienten met onstabiele angina hebben een risico om binnen een jaar alsnog een 
infarct te ktijgen of te overlijden van gemiddeld 14% respectievelijk 10%. Dit risico is 
verhoogd bij patienten met frequente pijnaanvallen en met ST-afwijkingen op het ECG. 
De behandeling van onstabiele angina is erop gericht nieuwe aanvallen van pijn en de 
ontwikkeliog van een hartinfarct te voorkomen. Medicarnenteuze therapie bestaat uit 
(een combinatie van) nitraten, B-blokkers, calcium-antagonisten, heparine en aspirine. 
Daarnaast kunnen een bypass operatie of ballondilatatie worden uitgevoerd teneiode de 
bloedtoevoer naar de hartspier te verbeteren. 
In een prospectief onderzoek werden 417 opeenvolgende patienten in twee 
ziekenhuizen in Rotterdam gevolgd, die opgenomen werden onder verdenking van 
onstabiele angina pectoris. Na observatie werd bij 9% van de patienten alsnog een 
myocardinfarct gediagnostiseerd, bij 26% was de diagnose niet -cardiaal of aspecifieke 
borstpijn en bij 65% werd de diagnose 'onstabiele angina' gehandhaafd. De patienten 
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werden met intensieve medicamemeuze therapie behandeld, inclusief heparine en 
aspirine. Aanvullend werd bij 137 patienten (33%) een angiografie verricht, gevolgd 
door ballondilatatie of bypass chirurgie bij 100 patienten (24%), Ondanks frequent 
voorkomende recidief pijnaanvallen tijdens opname (53% van de patienten) ontstond bij 
slechts 4% van de patienten een hartinfarct en overleed 1.4% van de patienten tijdens 
opname. Bijna de helft van de infarcten was gerelateerd aan een revascularisatie-
procedure. Overlijden was geassocieerd met een hoge leeftijd en met een recent infarct 
voor opname (hoofdsruk 2). 
Gedurende een vervolgonderzoek van zes maanden werd een totale infarct 
frequentie van 9.6% en een mortaliteit van 4.3% geregistreerd voor patienten met een 
definitieve diagnose 'onstabiele angina'. Het risico voor een infarct of overlijden was 
verhoogd voor patienten boven de 70 jaar en voor patienten met ECG veranderi.-1gen 
tijdens pijn. Het overlijdensrisico was bovendien verhoogd voor mannen, voor mensen 
met hypenensie en bij B-blokker gebruik v66r opname. Na ontslag onderging 10% van 
de patienten met onstabiele angina alsnog een angiografie, gevolgd door bypass 
clrirurgie of een ballondilatatie bij 7% van de patienten (hoofdstuk 3). Het ziektebeeld 
onstabiele angina pectoris zoals dat in de twee deelnemende ziekenhuizen werd gezien 
heeft een goede prognose onder het huidige beleid, met intensieve medicamenteuze 
behandeling en een groot aantal interventies. 
De registratie liet een verschil zien tussen de twee ziekenhuizen in het aantal 
patienten waarbij een hancatheterisatie werd verricht. In hoofdstuk 4 is een analyse 
verricht naar de mogelijke oorzaken voor dit verschil. Bij patienten onder de 80 jaar 
zonder een recent infarct of een recente revasularisatieprocedure werd in het academisch 
ziekenhuis Dijkzigt ruim 2 maal zo vaak een angiografie verricht als in het Sint 
Franciscus Gasthuis. Het eerste ziekenhuis beschikt over eigen hancatheterisatie-
faciliteiten, terwijl het tweede ziekenhuis deze faciliteiten niet heeft en zijn patienten 
moet verwijzen voor angiografisch onderzoek. De patientenpopulaties in beide 
ziekenhuizen verschilden met betrekking tot de leeftijd en de cardiale voorgeschiedenis. 
Patienten in het Dijkzigt ziekenhuis waren gemiddeld jonger, hadden vaker een 
voorgeschiedenis van coronairlijden en hadden een langere periode van angina voor 
opname. Multivariate analyses werden toegepast om na te gaan welke patienten-
karakteristieken konden voorspellen welke patienten een angiografie zouden ondergaan. 
Patienten jonger dan 70 jaar, met bekende hypercholesterolemie, met progressie van 
bestaande angina, met meerdere pijnaanvallen recent voor opname, die al behandeld 
werden met 8-blokker therapie, en met ECG afwijkingen bij opname werden vaker 
geangiografeerd. Het verschil tussen de twee ziekenhuizen bleef aanwezig, nadat 
gecorrigeerd was voor de verschillende patientenkarakteristieken. Dit verschil verdween 
36 uur na opname. Dit betekent dat bij vergelijkbare patienten in het ziekenhuis met 
angiografie faciliteiten vaker en vooral eerder tot een angiografie werd besloten. 
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In hoofdstuk 5 is onderzocht hoe individuele cardiologen het ziektebeeld 
'onstabiele angina' definieren en behandelen. In open interviews werd duidelijk dater 
verschil is in de definitie die de cardiologen hanteren en de prognose die ze aan het 
ziektebeeld toekennen. Voor zover aangegeven werd gevreesd voor een hager infarct 
risico dan in de literatuur en in de beschreven registratie is gerapporteerd. Er werd 
tevens verschillend gedacht over de situatie waarin en wanneer een patient 
'gestabiliseerd' genoemd mag worden na een onstabieie periode. De individue!e 
verschillen waren niet gerelateerd aan de ziekenhuissituatie waarin men werkte. Echter, 
aile cardiologen gaven aan dat zij vaker en eerder een angiografie zouden verrichten 
wanneer zij beschikten over een catheterisatie !aboratorium of minder vaak wanneer zij 
hier niet over zouden beschikken. Aanvullend werd aan de cardiologen een serie 
beschrijvingen van 'papieren' patienten voorgelegd, waarin een zevental klinische 
gegevens werden gevarieerd. V oor elke casus werd een uitspraak gevraagd naar het te 
voeren beleid in de gegeven situatie. Met lineaire regressie analyse werd voor elke 
cardioloog bepaald welke gegevens hij/zij belang achtte om tot angiografie over te gaan. 
Drie groepen van cardiologen, die hun besluit namen op grond van vergelijkbare 
combinaties van gegevens, konden onderscheiden worden. De eerste groep kan worden 
beschreven als cardiologen die tot angiografie besloten voomarnelijk op grond van 
gegevens met betrekking tot de voorgeschiedenis en de presentatie bij opnarne (27% ). 
De tweede groep nam dit besluit voomamelijk op grond van nieuwe gebeurtenissen 
tijdens opname (33%) en de derde groep gebruikte zowel de voorgeschiedenis als het 
beloop in het ziekenhuis om tot een besluit te komen (40%). Herkenning van dergelijke 
patronen kan behulpzaam zijn bij de discussie over het beleid voor een bepaalde patient 
en kan verklaren waarom cardiologen in een gegeven situatie tot een ander besluit 
komen (hoofdstuk 6). 
Tot slot wordt in hoofdstuk 7 een klinisch onderzoek gepresenteerd naar het 
gebruik van een nieuwe therapievorm om de bestaande behandelingsmogelijkheden te 
verbeteren. In een dubbelblind gerandomiseerd placebo-gecontroleerd onderzoek is 
nagegaan of een behandeling met trombolytische therapie voorafgaand aan een 
ballondilatatie bij patienten met onstabiele angina ondanks intensieve medicarnenteuze 
therapie de complicaties bij deze procedure kan verminderen. Angiografische noch 
klinische eindpunten lieten een verschil zien tussen de patienten behandeld met 
trombolyse en de patienten behandeld met placebo. Op grond van deze en andere 
onderzoeksresultaten is er geen reden om trombolytische therapie toe te passen bij 
patienten met onstabiele angina 
In een afsluitende discussie worden bovenstaande resultaten samengevat en 
vergeleken met enkele grote onderzoeken nit de recente literatuur die in verschillende 
Ianden werden uitgevoerd onder vergelijkbare omstandigheden. De beschreven resultaten 
leiden tot mogelijke onderzoeksvelden in de toekomst. Met betrekking tot de diagnostiek 
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zouden aanvullende procedures een eerdere herkenning van de 'laag risico' patienten 
kunnen bieden en zodoende kunnen leiden tot een snellere besluitvorming ten aanzien 
van de definitieve behandelingsvorm en verkorting van de opnameduur. Uitbreiding en 
aanscherping van medicamenteuze therapie dient verder te worden onderzocht. 
Aanvullende mogelijkheden om complicaties bij bypass operaties en ballondilataties te 
voorkomen kunnen in de toekomst mogelijk leiden tot een nog verdere verbetering van 
de prognose bij patienten met onstabiele angir.a pectoris. 
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